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4. List of Abbreviations  
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LDA   Lithium diisopropylamine 
MAAS   Methacrylic acid 
P(MAA)  Poly(methacrylic acid) 
mCPBA  meta-Chloroperoxybenzoic acid 
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5. Abstract 
Funtional CL monomers have been successfully synthesised utilising a primary amine 
(protected as a CBZ or BOC carbamate) and also a protected ketone (using an acetal 
protecting group).  Amine derivatives were synthesised from the commercially available 
trans-4-aminocyclohexanol.  The acetal protected ketone was synthesised from the 
commercially available 1,4-cyclohexanedione monoethylene acetal.       
The subsequent exposure of these monomers to ring opening polymerisation conditions 
(using stannous octanoate) in the presence of CL, yielded random copolymers with a 
functionalised polyester backbone.  The acetal copolymer was successfully deproteceted and 
reduced to yield an alcohol pendant.  A polymer – drug composite was successfully 
synthesised through the use of this alcohol polymer reacting with ciprofloxacin. 
A polymer – drug conjugate was also successfully synthesised using surface chemistry on 
PCL and PLA films.  PCL and PLA films were cast as films and subsequently aminolysed 
using 1,6-hexamethylene diamine in aqueous media at pH = 11.5.  These aminolysed films 
were then treated with both ciprofloxacin and penicillin G, together with amide coupling 
chemistry to synthesise biologically active surfaces.  Ciprofloxacin and penicillin G were 
successfully attached to the PCL surface with ciprofloxacin being attached to the PLA 
variant. 
A functional PCL monomer was also successfully synthesised from the commercially 
available PCL diol.  Both methacrylate and acrylate varients were synthesised through acid 
chloride chemistry.  The acrylate and methacrylate analogue were UV cured using both type I 
(Irgacure 2959) and II (DETX/EDB) photoinitiators.  The relative ratios of these initiators 
were changed along with the composition of the curing material to investigate curing 
parameters, to aid in 3D printing conditions.  To achieve viscocity criteria for 3D printing a 
ratio of 70:30 (PCL DMA:PEG DA) was used, utilising PEG DA as a reactive diluent.  A 
ratio of 3 wt% DETX and 3 wt% EDB was found to give the best UV curing results and were 
successfully applied on a jetting machine to yield 3D printed constructs. 
 
 
17 
 
6. Thesis overview 
 
This thesis will consist of three chapters each utilising a different feature or route of pendant 
functionalised polyesters.  The first of these sections will concentrate on what coronary artery 
disease is and how medical stents are being employed to tackle the needs of patients.  This 
will be followed by a look at a potential material to solve this problem, the degradable 
polymer polycaprolactone (PCL).  Synthesis of this polymer with a detailed look at how the 
polymerisation is catalysed from a literature standpoint will be discussed.  This will be 
focused around ring opening polymeristaion, as it will be the method of choice in this line of 
research.  This will then move onto synthetic efforts to synthesise pendant functional PCL 
and then their attachment reactions, to yield a drug eluting biodegradable polyester.     
The focus on functionalising polyesters is then further explored through surface modification 
via aminolysis.  Aminolysis of a polyester surface is extremely advantageous as it requires 
only a single step to generate a functional surface.  Various types of surface chemistry will be 
explored as an introduction to the field, along with analysis techniques and finally the field of 
aminolysis will be introduced and how the technique is utilised in surface modification.  This 
modification will be employed synthetically to functionalise both PCL and poly(lactic acid) 
(PLA) surfaces.  X-ray photoelectron spectroscopy will be utilised a a key method in 
analysing aminolysed surfaces, with these substrates being further reacted to yield 
biologically active surfaces. 
The final section of the thesis will discuss the use of 3D printing with particular attention to 
the use of radical polymerisation, as a tool for curing materials being the primary focus.  The 
types of 3D printing will briefly be explored, with the radical curing being the main area of 
focus.  Radical chemistry will also be discussed highlighting it’s versatility in the synthesis of 
polymers.  The synthesis and curing of an acrylated semi-biodegradable polymer will be 
explored, with the results leading a jettable ink from which to generate 3D constructs.     
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7. Aims 
 
The aim of this research project is to utilise various types of functional polyesters in the fields 
of drug delivery and 3D priting.  The first area of research will concentrate on the field of 
drug delivery for use in cardiovascular stents.  The purpose of this line of research is to 
synthesise a polymer that can be used not only as the structural scaffold of a stent to help 
support the artery, but also to act as a drug delivery system to aid recovery. 
 
Scheme 1:  Functional polyester retrosynthetic route 
 
The polymer could be generated from the co-polymerisation of commercially available -
caprolactone and a synthesised functional analogue.  Once polymerised, a biologically active 
molecule could be reacted using the functionality present on the polymer backbone (Scheme 
1).  The biologically active molecule could be attached in such a way so that it is released 
using the same route as the degradable polyester. 
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As a further project surface chemistry could be investigated as a route towards a drug 
delivery system using polyesters.  This route would explore the use of aminolysis as a one 
step method in generating functional polyesters from which to attach biologically active 
molecules (Scheme 2).       
 
Scheme 2:  Aminolysis retrosynthetic route 
 
Using pure polycaprolactone films could be cast and then treated with a diamine to yield an 
amine functionalised surface.  This in turn could be reacted with a drug compound to yield a 
biologically active surface. 
The final theme of research aims to look at the use of a functional polyester as a jettable ink 
for 3D printing.  Linking back to the drug delivery theme, if a drug molecule was dispersed in 
the ink they could act as drug eluting scaffolds once printed.  
 
Scheme 3:  UV curing ink retrosynthetic route 
 
Polycaprolactone (PCL) again could be used with a commercially available diol being a 
potential starting point.  The diol could be reacted to form the dimethacrylate using 
methacryloyl chloride.  This could then be used in conjunction with UV initiators as a 
precursor for use in a 3D printer.  Another feature would be that the 3D printed scaffold could 
be semi-biodegradable through the use of PCL as the core backbone of the material. 
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8. Use of functional poly(caprolactone) 
as a drug delivery system 
 
8.1. Introduction 
 
In this introduction there will be an overview of what coronary artery disease is and how 
medical stents are being employed to tackle the needs of patients.  Several types of stents will 
be discussed in an attempt to introduce the need for a fully biodegrading drug eluting 
alternative.  This is because current technology has the stent implanted in the body for life, 
whereas having a biodegradable stent allows the implant to be removed after the required 
treatment period.      
This will then lead onto a detailed look at the polymerisation of lactones, as they are key 
materials in the field of biodegradability.  These polyesters are commonly produced through a 
process known as ring opening polymerisation therefore the types of this polymerisation 
along with the wide variety of catalysts will be discussed.  This then introduces the field of 
functional polyesters from which the idea of a fully biodegradable drug eluting stent can take 
form.  This will be via the attachment of a drug to one of these functional polymers and is a 
key idea within this research. 
Following on from the overview of functional polyesters, the synthetic efforts to synthesise a 
variety of these will be discussed followed by the successful attachment of a biologically 
active molecule. 
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8.2. Coronary artery disease 
 
Coronary artery disease (CAD) is the blocking or narrowing of the arteries surrounding the 
heart (coronary artery).  The blockage, called atherosclerosis, is usually caused by the build-
up of cholesterol and fatty deposits, commonly linked with unhealthy lifestyles and poor diet.  
As the deposits thicken and harden, the artery becomes narrower, reducing the amount of 
blood flow to the heart (Figure 1).
1
 This in turn reduces the flow of oxygen and essential 
nutrients into the heart, which can cause a heart attack.  If the deficiency becomes too high 
cells begin to die causing angina, this can then result in a heart attack.   
 
 
Figure 1:  Diagram showing the restricted blood flow when atherosclerosis is present 
 
With a proportion of today’s population not exercising, consuming high fat diets or both, 
heart disease is becoming more common.  This has lead to an increase in the types of 
treatments available to those suffering of atherosclerosis.  Treatments can take the form of 
medicines or operations with prefered preventative measures being more lifestyle driven than 
medical intervention.  Preventative measures include a lower cholesterol diet, regular 
exercise and quitting smoking.  Medical treatments are varied and include calcium channel 
blockers, which relax the muscles surrounding the heart causing the arteries to open, 
therefore increasing blood flow.  Aspirin can also be used which thins the blood decreasing 
the chances of clots, but also allows the blood to bypass blockages easier.  The final 
treatment, which is considered as invasive, is surgery.  This is seen as far more specific to the 
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patient’s needs, for instance for a single blockage an angioplasty may be performed, which is 
the mechanical widening the artery in question using a balloon catheter.  The balloon is 
inflated and the hardened calcium deposits are broken under the pressure.  If there are several 
blocked arteries, then a coronary bypass may be required.  This technique grafts another 
vessel, such as an artery from the leg in such a way that allows blood to flow around the 
blockage.  This method is often reserved for extreme cases, as open heart surgery is required.  
The final surgical, less invasive, method is the use of cardiovascular stents. 
8.3. Cardiovascular stents 
 
Stents are cylindrical structures that can be inserted into the body to help support weakened 
blood vessels and were first implanted in 1985 by Palmaz et al.
2
 Cardiovascular stents, or 
coronary stents, are placed into arteries using the same procedure as angioplasty. A catheter 
with a balloon attached is inserted into the blocked artery.  Once at the site of the blockage, 
the balloon is inflated forcing the previously narrowed artery to widen.  The inflation of the 
balloon not only widens the artery but also expands the stent, which in turn allows support for 
the newly widened artery.  At this point the structural integrity of the artery is supported by 
the cardiovascular stent, and the balloon can be deflated and the catheter removed (Figure 
2).
3
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Figure 2:  Implantation of coronary stent 
The first generation of stents were made of metal and were known as bare metal stents 
(BMS).  When a narrowed artery is widened by angioplasty, with or without a stent, and the 
artery begins to narrow post-treatment this is called restenosis.  This process can be viewed 
through coronary angiograms when previously narrowed coronary arteries (Figure 3, parts A 
white arrow and E) are successfully widened through stent implantation (parts B white arrow 
and F), followed by late stage restenosis being observed after 20 months (parts C white 
arrow, D, G and H).  Yellow arrows (parts A, B and C) show no signs of restenosis when 
using a bare metal stent.
4
  In the early treatment of CAD when only a balloon catheter was 
being used (angioplasty), re-narrowing of the artery was a common problem, with ~30% of 
all patients receiving the treatment for cardiovascular disease developing the symptoms of 
restenosis.  With the introduction of BMS there has been a significant decrease in the chances 
of restenosis.  Although promising, ~20 – 30 % of patients still develop restenosis due to 
scaring of the inima, the inner layer of the artery. 
24 
 
 
 
Figure 3:  Coronary angiograms showing the treatment of CAD using a sirolimus-eluting stent 
  
The challenge that scientists face is to create a stent that is radially strong enough to 
withstand the pressures in an artery with a design that does not require thick struts, therefore 
reducing the amount of artery coverage.  Bare metal stents are excellent for that role, 
however as previously discussed, carry compatibitlity problems.  This compatibility problem 
crates a significant challenge in choosing a material which can as strong as the BMS but also 
that could potentially act as a drug delivery system (but also degrading in such a fashion that 
does not release inflammatory by-products). 
 
8.3.1. Drug Eluting Stents 
 
A drug eluting stent (DES) is a design in which a standard metal stent has a polymer coating 
on the exterior surface.  This polymer coating is designed to contain drug molecules which 
are released upon degradation of the polymer.  These drugs can then be tailored to aid the 
healing response after the angioplasty operation.  The chance of restenosis is lessened as the 
artery wall inflammation can be reduced by the imbedded drug compounds.  This can be 
observed in the results of the Taxus (Boston Scientific Co.) V clinical trials where restenosis 
in patients was found to be 13.7 % compared to the 31.9 % in the bare metal equivalent.
5
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8.3.2. Biodegradable stents 
 
The reasoning behind a biodegradable stent is that the degradation is tailored so that once the 
artery is fully recovered; the stent is removed from the body and is no longer present.  This 
could be advantageous as there would be no chance of any problems occurring with 
prolonged stent implantation.  This tailoring can be achieved through the rate of different 
polymers to degrade. A fully biodegradable stent was first developed, and implanted into 
humans, by the Japanese company Igaki Medical Planning Company.  The stent, called the 
Igaki – Tamai stent, was made of poly-L-lactic acid (PLLA) and is comprised of a zig-zag 
helical coil connected with straight bridges (Figure 4).
6
  The biodegradability comes from the 
hydrolysis of the ester linkage liberating lactic acid, water and carbon dioxide.  Absorption of 
the stent occurs at both the surface and inside the structure.  This allows the stent to maintain 
structural function until absorption is in the late stages. 
 
 
Figure 4:  The Igaki-Tamai biosorbable stent, constructed from poly-L-lactic acid 
 
Another example where PLLA is used is the everolimus eluting bioabsorbable stent made by 
Abbott Vascular.
7
  This stent has a PLLA core with a poly-D,L-lactide coating which 
contains the antiproliferative drug.  The release of the drug is 80 % within 30 days with the 
stent itself being absorbed by bulk erosion. 
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Figure 5:  Magnesium stent developed by Biotronik 
 
Biodegradable stents do not use polymer exclusively, with Biotronik in Germany 
manufacturing a magnesium stent (Figure 5).
8
  The magnesium degrades through surface 
erosion, with the stent thickness decreasing as absorption increases.  The stent is completely 
degraded within 2 months, but the radial strength was lost much earlier giving rise to issues 
regarding practical application.  Another troubling statistic was the high rate of restenosis, 
with 50 % of patients showing re-narrowing of the artery vessel within 4 months. 
A promising example of a stent aiding the patient’s recovery is in the bioabsorbable 
therapeutic stent made by Bioabsorbable Therapeutics Inc.  They have made a stent that upon 
degredation releases salicylic acid which counteracts the inflammation caused by the 
angioplasty stretching.
9
 
In the previous examples of stents, the materials used act not only as a source of support but 
also biocompatibility.  This leads to the idea that not only is the design of the stent, from 
clasps lock in place or intricate arching styles, important but also the material used in their 
construction.  This has lead to research into biomedical polymers. 
8.4. Biomedical polymers 
 
Polymeric materials that are biocompatible, and in some cases are biodegradable, can be used 
in medical applications.  These polymers can therefore be categorised as biomedical 
polymers.  Biocompatibility refers to the body’s ability to integrate the implant without 
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causing rejection issues.  As well as limiting the rejection issues, the implant should be 
recognised by the body, and also not be toxic in any way.  Biodegradability implies that the 
polymeric material will degrade in a controlled fashion after the implant has performed its 
desired effect.  This makes the polyesters of lactones and lactides very attractive, with their 
desirable mechanical properties and biodegradability through the hydrolysis of their ester 
linkages.  The importance of the polyester’s biodegradability is twofold, with respect to their 
use in cardiovascular regeneration.  The main advantage over the current metal stents would 
be that the biodegradable process can be finely tuned to begin after the stent has completed its 
purpose.  An ideal situation would be one in which the stent is implanted, restores function to 
the blocked artery, and is then removed via a biodegradation pathway when it is no longer 
required.  The second more interesting improvement to existing stent designs would be to 
exploit the degradation of the polymer, through ester hydrolysis, to allow the release of drug 
molecules into the body.  This would not only allow the specificity of the stent to increase but 
also may hold potential towards decreasing the treatment time of the patient, i.e. increasing 
the recovery rate of the blocked artery.  
 
Figure 6:  Degredation pathways for biodegradable polymers 
 
Figure 6 shows the potential routes through which biodegradation of polymer may occur and 
within these routes two different modes exist, which are through chemical interactions or 
physical ones.  Chemical interactions are concerned with the chemical bonds found within the 
polymer, whereas the physical types are the attractive forces between polymer chains.  
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Primary bond degradation is the process of breaking bonds to form smaller or more 
compatible polymers.  This can occur through either side-chain or crosslink scission.  The 
former creates smaller water-soluble fragments whereas the latter turns a previously insoluble 
crosslinked polymer into a potentially soluble one.  Scission can also occur within the bulk of 
the polymer.  These types of scissions can be broken down into two categories, random and 
zipper-type.  Random scission, as the name would suggest, involves the cleaving of bonds in 
a random fashion.  Zipper-type cleavage is so called because it occurs at the end of the 
polymer chain and continues from one repeat unit to the next, almost unzipping the 
monomers in sequence. 
The use of biodegradable polymers in medical implants was first seen in the 1960s by the 
company Cyan- amide Co. who used polyglycolide to create absorbable sutures under the 
trade name Dexon.  The use of polyesters were shortly introduced in the form of a copolymer 
poly[(L-lactide (8 %)-co-glycolide (92 %)] under the trade name Vicryl
®
.
10
  Since these early 
developments in the field, polyesters have been researched in depth for drug delivery 
purposes, including antimalarial,
11
 contraception
12
 and optical drugs for use within the eye.
13
 
 
Figure 7: Poly(lactide - co - glycolide polymer motif found in Vicryl
® 
 
A polymer which has not received a vast amount of attention in the past is polycaprolactone 
(PCL).  This is due to the fact that poly(lactic acid) (PLA) has better physical characteristics 
and has inadvertently pushed PCL from the forefront of research.  This however is changing 
as the area of biomedical research in biocompatible polymers, is becoming an increasingly 
important field.  With the increase popularity of PCL the following chapter will introduce the 
chemistry of the polymer with a focus towards the various polymerisation techniques used to 
synthesis it. 
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-Caprolactone and polycaprolactone 
 
-Caprolactone (CL, 3) is the monomer to the biodegradable polymer polycaprolactone, and 
is an example of a cyclic ester (lactone) (Figure 8).  This polymer could be of potential use in 
both biodegrading stents and also the drug eluting variety, therefore the properties and 
synthesis will be discussed as this will be the polymer of choice in the following research.  
CL is a liquid at room temperature which makes it an attractive possibility for a jetting 
material (to be discussed later).  This lactone is miscible with a variety of solvents including 
CH2Cl2, CHCl3, toluene, cyclohexanone, with low solubility in acetone, ethyl acetate 
(EtOAc) and dimethylformamide (DMF).  Solvents which CL is insoluble in include 
petroleum ether, alcohols, diethyl ether (Et2O) and water.
14
  
 
Figure 8:  Structures of different lactone 
 
CL can be polymerised to form polycaprolactone, which exists as hexanoate repeating units 
and is becoming highly desirable in the biomaterials field of research (Scheme 4).  This is 
due to the favourable properties of biocompatibility, biodegradability and that the polymer 
itself creates a porous network allowing permability, all of which allow stable incorporation 
into the body.  Another rare property is that the polymer itself is miscible with various other 
polymers including poly(vinyl chlorides), polycarbonates, and various others.  Although the 
mechanical properties of PCL are not hugely impressive, the polymer is compatible with 
other, more mechanically strong polymers such as polyethylene and natural rubber. 
 
Scheme 4:  Polymerisation of -caprolactone to polycaprolactone 
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The rate which a polymer degrades depends largely on its molecular weight, crystallinity and 
the environment it is situated in, with all of these being important factors when wanting to 
tailor this rate.  The glass transition temperature (the temperature at which the polymer 
exhibits a glass like state) can also impact degredation by altering the physical state of the 
polymer (PCL has a glass transition temperature of -65 
o
C and a melting temperature which 
ranges between 56 – 65 oC), as the morphology of the crystalline material could impact the 
degradation (surface area change for example).   The degradation time can range from 
months to years and is a key parameter in creating biomedical implants.  It has been observed 
that the amorphous phase of the polymer degrades first, leading to an increase in crystallinity 
with no loss of molecular weight.
15
  The by-product of this degradation are carboxylic acids, 
which catalyse the degradation process, with the rate being significantly increased with the 
use of enzymes.
16
  Although enzymes can be used to hydrolyse the polymer it has been 
shown that this process does not occur in the body.
17
  
The monomer CL is industrially produced by the Baeyer-Villiger oxidation of 
cyclohexanone using peracetic acid.
18
  Thomas et al.
19
 found that it can also be synthesised 
using bacteria, where CL (3) and 6-hydroxyhexanoic acid (19) are intermediates in the 
conversion of cyclohexanol (17) into adipic acid (21) (Scheme 5). 
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Scheme 5:  Oxidation of cyclohexanol to adipic acid using Acinetobacter sp. strain SP19 
 
Polycaprolactone is one of the polyester family of polymers and is mainly formed through 
ring opening or condensation reactions.  Braud et al.
20
 carried out the condensation of 6-
hydroxyhexanoic acid to produce PCL.  The reaction was catalyst free and required a gradual 
increase of temperature from 80 – 150 oC, and it took 6 h.  One practical drawback was that it 
had to be carried out under a vacuum to remove the water produced from the condensation.  
The removal of water acts as the driving force, shifting the equilibrium towards the formation 
of polymer.  Ring opening polymerisation has however been implemented far more 
successfully leading to PCL being commercially available in large quantities.   
Using enzymes as catalysts during ester formation is another method towards polyester 
synthesis.  An example of an enzymatic catalyst is Candida antartica Lipase B (Scheme 6). 
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Scheme 6:  Enzymatic synthesis of polyesters using Candida antarctica Lipase B 
 
The lactone (red) enters the active site of the enzyme (22) to create the acyl enzyme (24) via 
the first transition state (23).  An initiator (blue) enters the active site attacking the acyl 
enzyme via the second transition state (25).  This regenerates free enzyme and the opened 
lactone.  Propagation is achieved through the attack of the acyl enzyme by the propagating 
chain (green) to regenerate the free enzyme and longer polyester chain.
21
  The advantage of 
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using enzymes is the generally mild and non-toxic reaction conditions required for the 
polymerisation, with the structure of the enzyme also giving rise to control of the 
stereochemistry (when using lacides).  The only limitation of enzymatic polymerisation is the 
lack of high molecular weight polymers.  This is shown when using the lipase enzyme from 
Candida antarctica as this gives rise to PCL polymers with molecular weights of 9,000 
g/mol, with a polydispersity of under 1.5 in 2 days. 
The most common method to polymerise a cyclic lactone however is ring opening 
polymerisation (ROP), where the lactide or lactone’s internal ester is cleaved and the polymer 
grown from there using a ‘living’ process (where a living process is one in which the polymer 
is constantly growing rather than in any equilibrium with reagents for example).  This 
technique has been shown to give high molecular weight polymers with the main drawback 
being racemisation of the repeating ester linkages (in the case of lactides).  The following 
section will highlight the ways in which ROP is achieved, and the catalytic systems that are 
used to initiate the polymerisation. 
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8.6. Ring opening polymerisation  
 
As previously mentioned the main polymerisation method for -caprolactone is ring-opening 
polymerisation, and will be the method employed during this research.  This type of 
polymerisation is characterised by the chemical cleavage of the ester linkage which acts to 
propagate the polymerisation cycle, with the general mechanism for ROP is shown in 
Scheme 7.
22
.  ROP of lactones is generally carried out in either bulk or solution 
(tetrahydrofuran, toluene, etc) but can also be undertaken in more specialised methods e.g. 
emulsions
23
 or dispersions.
24
    Bulk polymerisation conditions can range from 100 – 150 oC, 
depending on the required kinetics, but undesired side reactions can be reduced at lower 
temperatures, often requiring more specialised initiators and/or catalysts.  Although the 
polymerisation occurs through the cleavage of the ester linkage, how the reactions are 
initiated, and therefore catalysed, can be divided into three sub-categories, which are cationic, 
anionic and coordination insertion.  Which of these methods is responsible for the 
polymerisation depends on which catalyst and initiators are used.   
 
Scheme 7:  General mechanism for ROP using lactide as an example
22 
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8.6.1. Cationic polymerisation 
 
As mentioned above one catalytic method is cationic in nature.  Although not used in this 
research, both cationic and anionic polymerisations will be briefly covered to broaden the 
understanding of ring opening polymerisation.  Cationic ROP begins with the formation of a 
cationic species to which the CL can attack.  The carbonyl oxygen is usually the cationic 
species formed through the use of the oxygen’s lone pair towards an electrophile.  The 
positive charge is stabilised through the resonance of the carbonyl (31), forming the tertiary 
carbocation (32).  This positive charge resonates between the carbon and the endocyclic 
oxygen (33).  The positive charge at this position is neutralised through the nucleophilic 
attack of another CL monomer at the alkyl-oxygen carbon in a SN2 fashion (Scheme 8).
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Scheme 8:  Mechanism for the initiation step of cationic ROP 
 
8.6.2. Anionic polymerisation 
 
The previous catalytic method utilised a positive species but there are also examples of 
negative species being used.  The polymerisation of lactones anionically is most common 
when using alkoxide based catalysts.  The polymerisation is initiated by the nucleophilic 
attack of the negatively charged catalytic species at either the acyl carbon of the carbonyl 
group or attack of the alkyl – oxygen (Scheme 9). When the monomer is a -lactone both 
instances can occur creating alkoxide (36) or carboxylate (37) species from which to 
propagate from.  This is not the case however when polymerising larger lactones, e.g.  and 
-lactones.  In these cases only the acyl-carbon is attacked, leading to the alkoxide species as 
the sole propagator.   
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Scheme 9:  Mechanism for the initiation step of anionic ROP 
 
8.6.3. Coordination insertion 
 
Although anionic and cationic catalysis have been discussed, the main method of technique 
used when polymerising lactones, is the coordination insertion approach.  Coordination 
insertion will be the method of choice when carrying out polymerisations in this research; a 
brief overview will be discussed, followed by a more in-depth look towards the different 
catalysts used later in the thesis.  Coordination insertion has been used extensively in the 
polymerisation of aliphatic polyesters with well-defined structures and architectures, through 
the use of multifunction initiators, e.g. ethylene glycol.  This method of catalysis also 
produces polymers with narrow molecular weight distribution and mass.  The general 
mechanism is shown in Scheme 7, where the metal oxygen bond of the catalyst (26) 
coordinates with that of the carbonyl bond in the monomer (27).  The electrons in the 
carbonyl form a new metal oxygen bond (28) while the metal attached oxide migrates to the 
acyl carbon (30).  Propagation occurs through the reformation of the carbonyl, cleavage of 
the ester linkage and the migration of the newly formed alkoxide end onto the metal.  
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8.6.4. Transesterification reactions 
 
Before moving on to discuss the catalyst used in ROP it is important to understand that 
although this technique is associated with low polydispersities, when incorrect reaction 
conditions are used side processes can occur. Certain conditions can lead to deactivation of 
the catalyst, side products and loss in molecular weight together with an increase in 
polydispersity, with ultimately loss of polymerisation control.      
A transesterification reaction is one in which polymers react with either another polymer, or 
itself, and usually occurs during the late stages of polymerisation at elevated temperatures.  
Intermolecular transesterification occurs between polymer chains when a propagating species 
(38) (one bound to the metal alkoxide) reacts with a polymer chain (39).  This causes the 
metal to stop the growth of one chain (40) and begin on another (41).  This in turn leads to 
irregularity in polymer chain length thus increasing the polydispersity of the final product.  
Intramolecular transesterification occurs when the propagating end of the polymer reacts with 
a section of itself (42).  This process cyclises the polymer leaving no terminal ends from 
which to propagate from (Scheme 10). 
 
Scheme 10:  Inter- and intramolecular transesterification reactions 
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These transesterification reactions can be influenced by a variety of parameters.  Kricheldorf 
observed the production of octanoic acid, when using tin (II) octanoate, above 100 
o
C.
26
  This 
may appear harmless but when combined with alcohols (used as initiators) esterification 
reactions can occur, liberating water.  This water can coordinate with the metal forming a 
range of oxides and hydroxides.  With the presence of a variety of catalytic species, the 
molecular weight would be hard to control and thus a broad distribution of weights would be 
observed. 
Kowalski et al.
27
 found that upon addition of carboxylic acids, especially ethyl hexanoic acid, 
the ‘growing’ or propagating chain of the polymer can be put into a dormant state.  The 
carboxylic acid inserts into the metal – polymer bond, removing the ‘living’ end of the 
polymer.  This then leaves it dormant with a hydroxyl end as opposed to an active metal 
species (Scheme 11). 
 
 
Scheme 11:  Formation of a dormant chain during ROP when catalysed by tin octanoate 
 
The polymerisation of lactones has been shown to proceed via a variety of mechanisms, but 
these pathways are all a product of which catalyst is used.  These can be as varied as the types 
of catalysis they exhibit, with the biggest research being carried out toward co-ordination 
complexes of transition metals. 
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8.7. Catalysts used for ROP 
 
The research into catalysts for the ROP of lactones is vast and varied, although the post-
transition metal catalysts are the most common, and the one that will be used in this study, 
the following section will introduce a broad range of catalysts to give a broader scope to the 
field.  They include alkali bases, metal alkoxides, alkali earth metals, enzymes and even 
inorganic acids.  Some are far more commonly used than others, with different conditions 
required for polymerisation, yielding varied molecular weights.   
 
8.7.1. Alkali-base catalysts 
 
The first class of catalysts to be discussed, in this brief look at different catalytic systems, are 
alkali – based catalysts, which are compounds that are ionic in nature and proceed through an 
anionic catalysis route. As a result of this they experience a high degree of tranesterification 
with little control of polymerisation. An example of an alkali-base catalyst can be found in 
lithium diisoproplyamine (49) (LDA).  Bhaw-Luximon et al.
28
 used LDA in dioxane to 
polymerise CL in just 25 minutes at 25 oC, with a molecular weight of 5,700 g/mol.  This 
catalyst initiates the reaction through the attack of the carbonyl which creates a negative 
charge on the oxygen (51).  This negative charge can then be used to reform the carbonyl 
which then breaks the ester linkage, or to directly attack the next lactone monomer.  The 
former leaves an isopropyl amine group as the end group of the polymer (53), and the latter 
leaves an intact ring as the end group (52) (Scheme 14). 
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Scheme 12:  ROP of -caprolactone using LDA as a catalyst 
 
8.7.2. Transition metal catalysts 
 
Although not used in this research, the transition metal catalysts would be more than 
applicable for the polymerisations that are to be employed in this research; therefore a brief 
overview will be discussed about their use in this field.  Transition metals are far more 
controlled when compared to the previous example and the types used are titanium 
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complexes, with zirconium based catalysts growing in popularity.  Davidson et al.
29
 used 
titanium complexes using the catechol ligand, giving rise to a PCL polymer with a narrow 
polydispersity, indicating a controlled polymerisation.  They also tried a range of titanium
(IV)
 
and zirconium
(VI)
 amine bis(phenolate) ligands complexes with the titanium complexes 
yielding polymer only with the most bulky groups.
30-31
  This is not the case however with the 
zirconium complexes where the less bulky substituents favoured polymerisation.  The 
synthesis of titanium
(IV)
 complexes with bisphenolate ligands bearing no amine functionality 
has also been shown to have interesting effects.
32
  The polymerisation is twofold, with each 
catalyst molecule (54) facilitating the growth of two separate polymer chains (55) (Scheme 
13). 
 
 
Scheme 13:  Synthesis of two polymer chains for one molecule of catalyst when using a titanium
(IV)
 
complex 
 
Zinc complexes have also been found to be useful in CL polymerisation.  Zinc mono- and 
di-alkoxides have been found to initiate the ROP process with the catalysis following the 
coordination insertion mechanism, and giving rise to well defined range of molecular weights 
(polydispersity of 1.1).
33
  
Other zinc alkoxides bearing either alkyl or amine ligands have been shown to surpass their 
magnesium analogues in stability and reactivity.  Both catalysts showed high throughput 
achieving 300 kg (mol metal)
-1
 h
-1
, with the silyl amine bearing complex yielding polymers 
with high molecular weights (55,000 g/mol) with polydispersity of 2.3.
34
  
Other metals that have been researched include molybdenum
(VI)
 and vanadium
(V)
 compounds, 
with results indicating that the metals were reduced and became inactive during 
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polymerisations under an inert atmosphere.
35
  One potential drawback for these catalysts, 
from the view of biodegradable stents, is that the metals used are not compatible within the 
body therefore residual catalyst in polymers would be an issue. 
 
8.7.3. Organocatalysis 
 
The use of metals can be undesireable (due to potential toxicity for example) with ligand 
design and synthesis lengthening any synthetic route, organocatalysis could be an elegant 
alternative.  These catalysts fall under the same idea expressed in the transition metal 
overview, with these catalysts more than applicable for the polymerisation covered in this 
research however not being used.  For that reason they will be briefly covered to give a 
broader overview of the ROP of lactones.   
Organocatalysis has been used in the form of a dual activation ROP using 1,8-
diazabicyclo[5.4.0]-undec-7-ene (57) (DBU) and a thiourea (56).
36
  In this example, the 
thiourea molecule hydrogen bonds to the carbonyl oxygen of the lactone increasing the 
reactivity of the CL monomer (6959  The reactivity of the alcohol (58) is increased through 
the hydrogen bond to the DBU (60) (Scheme 14).  This then allows initiation and ring 
opening of the lactone through the now more reactive alcohol.  The carbonyl of another 
monomer is then activated using the thiourea, with the DBU activating the hydroxyl of 
propagating species (61). 
43 
 
 
Scheme 14:  ROP through dual activation using thiourea and DBU 
 
 
 
 
 
 
44 
 
8.7.4. Post-transition metal based catalysts 
 
The catalyst used in this research falls into the category of the post-transition metal based 
catalysts.  These are the most commonly used catalysts for ROP and are either aluminium or 
tin based, with tin being the more reactive of the two.  Aluminium catalysts, although less 
reactive, are used because they allow good control over the polymerisation.
37
  This is 
observed through work by Wang and Kunioka who screened a variety of metal triflates, with 
both aluminium
(III)
 and copper
(II)
 proving to be excellent catalysts for the ROP of CL.  
Metals that did not catalyse the polymerisation were sodium
(I)
, ytterbium
(III)
 and 
magnesium
(II)
 triflates, with samarium
(III)
 and lanthanum
(III)
 producing oligomers only.
38
  
Work by Duda et al.
39
 with aluminium alkoxides with formula R2AlOR, has elucidated that 
the alkyl groups play no role in the ROP of lactones but the alkoxides only.  It was found that 
with each catalyst molecule, a polymer chain is formed, giving rise to the observation that 
only the alkoxide groups initiate the ROP and the alkyl groups do not.  The only effect the 
alkyl groups appear to influence is rate of polymerisation, with the larger the alkyl group the 
faster the reaction. 
 
Scheme 15:  Six-coordinate complex formed when aluminium
(III)
 isopropoxide is dissolved in CL 
 
The most common of all aluminium catalysts is aluminium
(III)
 isopropoxide (62), which exists 
as a six-coordinate complex (63) when dissolved into CL (3).  This then acts as the initiator 
of the ROP (Scheme 15).
40
  Kricheldorf compared the use of various metal alkoxides against 
aluminium isopropoxide, with Al(O
i
Pr)3 being the only one showing a lack of 
transesterification reactions, this not being the case with other alkoxides.
41
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A tin based catalyst that is used routinely is tin
(II)
 ethylhexanoate (73), which is commonly 
referred to as tin octanoate  (Figure 9).  The catalyst is efficient, soluble in a large variety of 
solvents and is a cheap commercially available reagent.  Although very efficient, tin 
octanoate requires a nucleophilic initiator such as an alcohol if a controlled polymerisation is 
to be achieved.  The foremost drawback is that the catalyst requires elevated temperatures, 
which increases the amount of transesterification reactions, leading to a broadening of the 
molecular weight distribution. 
 
Figure 9:  Tin (II) octanoate 
 
Solvent choice can be important when using tin octanoate, with it determining the conversion 
percentage of monomer.  When using dioxane and toluene Bhaw and Luximon found a 
conversion of 40 % after 42 hr, but when using pure toluene the polymerisation was complete 
and in 21 hr.
28
  In this work ethanolamine was used as an initiator, with both the amine and 
alcohol used to initiate the polymerisation. 
The amount of initiator is also crucial as the active catalytic species is first made by the 
nucleophilic attack of this initiator, giving rise to this component being the limiting factor of 
the polymerisation.  As previously mentioned introduction of carboxylic acids into the 
polymerisation reactions give rise to dormant polymer chains, this is also the case when using 
too much initiator.  Simple alcohols are the usual choice for initiators but others such as 
ureidopyrimidinone-alcohol (65) have been studied.
42
  An unexpected problem was observed 
when conducting the reaction at 80 
o
C, the initiator began to switch between a mono- and 
dimeric form (66) (Scheme 16).  This dimer is formed through the formation of a quadruple 
hydrogen bond.  When in this form there is no free initiator to activate the catalyst, therefore 
the polymerisation is postponed until the monomeric form is formed. 
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Scheme 16:  Dimerisation of an ureidopyrimidinone-alcohol compound 
 
The use of ROP is broad and is of key importance in the manufacturing of vast amounts of 
polyesters.  The use of this catalysis is not limited to simple monomers and their relatively 
simple polymers.  The field of functional polymers and in particularly functional polyesters is 
ever growing.  The following section will focus on displaying a variety of functional 
polymers and describe how they can be further utilised in conjunction with other chemistries 
to create further functionality. 
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8.8. Functional polyesters 
 
The use of polyesters is very established but research into functionalising the polymer 
backbone is becoming more and more prominent.  The main purpose of functional polymers 
with respect to this research is that this will be the route which is used to attach a biologically 
active molecule to the polymeric backbone, therefore literature in this area will be discussed.  
Functional PCL is a polymer with hexanoate repeat units with functional groups present 
along the back bone.  The polymerisation of these functional polyesters is comparable with 
that of pure PCL, including polycondensation and ROP reactions being used.  One method is 
based around post-modification of a PCL chain.  When using a base, such as LDA, the acidic 
protons on the alpha position to the carbonyl are deprotonated leaving a negative charge able 
to attack introduced electrophiles, a halogen or acid chlorides for example.
43
  There are 
however problems with this method including side reactions using the negative charge. 
As the last point suggests the use of post-polymerisation functionality is not desirable.  The 
pre-polymerisation route involves the use of monomers with functionality already installed.  
These functional monomers are then incorporated into the same style of polymerisations 
previously mentioned for CL to form copolymers (ROP, condensation and enzymatic 
although not previously mentioned).  The functional monomers are usually protected pre-
polymerisation, so that they cannot interfere with the polymerisation conditions (e.g. an 
amine protected as a carbamic benzyl ester). 
 
Scheme 17:  Synthesis of an iodo functional CL 
 
As with before the main type of polymerisation is ROP, with the functional monomers 
usually being based on CL ring systems (Figure 10).44  One of the most frequently used 
functionalities is halogen bearing CL (68, 69 and 71).  This can be achieved through the use 
of a strong based, LDA, and a halogen containing electrophilic species.  An example of this is 
the use of iodine monochloride as the electrophile (Scheme 17), where the polymerisation 
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was carried out using tin octanoate at 100 
o
C, with methanol as the initiator and the solvent as 
toluene.
45
  
 
Figure 10:  Functionalised CL monomers 
The use of halogens is extremely important from a synthetic point of view, with the work of 
Sripha et al.
46
 showing that the use of a chloride group could easily be converted to the azide, 
using sodium azide, with the formation of a triazole ring when reacting this with DBU in the 
presence of a copper
(I)
 salt.  This however is not the only use found for the chloride 
functionality.  Lenoir et al.
47
 used this pendant chloride to graft poly(methyl methacrylate) 
blocks by atom-transfer radical-polymerisation (ATRP). 
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The choice of functionality is not limited to halogens, with research branching out into a huge 
variety of moietic groups.  These include the use of a triethylsily group (70), which is 
removed by acid hydrolysis post polymerisation, to give an alcohol.
48
  This alcohol could 
then be used as an initiating point from which to make copolymers. 
Unsaturated aliphatic polyesters have been synthesised using the unsaturated CL monomer 
6,7-dihydro-2(5H)-oxepinone (74).  This monomer was synthesised by Lou et al.
49
  who were 
able to copolymerise with CL using Al(OiPr)3 in toluene at room temperature (Scheme 18). 
 
Scheme 18:  Synthesis of an unsaturated CL monomer 
 
A functional polymer with an amine pendant has been synthesised with the amine 
functionality being protected as a carbamic benzyl ester (78).
50
  The protecting group was 
removed by hydrogenolysis using a Pd/C catalyst under hydrogen gas.  This amine pendant 
was then reacted with Biotin, also known as vitamin H, demonstrating the accessibility of 
these functional PCL for use with important bioactive molecules. 
Although rare there has been research into the medical uses for these functional polyesters.  
One such use is in the delivery of therapeutic peptides/proteins.  The polymer poly(L-lactide-
co-hydroxymethyl glycolide) has been shown to form microspheres when using a double 
water-oil-water solvent-emulsion method (Scheme 19).
51
  These microspheres were used to 
successfully deliver lysozyme in different amounts of polymer solutions.  This in comparison 
to the poly(lactic-co-glycolic acid) (PLGA) which showed no delivery of the enzyme, shows 
that there is promise in this field.  It is important to note that the lysozyme released was 
completely enzymatically active showing no loss of structural integrity. 
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Scheme 19:  Synthesis of a hydroxy functional polymer based on lactic-co-glycolic acid 
Another use is in the field of tissue engineering.  The usual aliphatic polyesters used in tissue 
engineering, e.g. PCL, PLA and PLGA, have the drawbacks of hydrophobicity and lack of 
functionality.  These attributes are disadvantageous with respect to cell adhesion, an 
important factor when constructing scaffolds.  Work by Wang et al.
52
 has shown how a 
functional polymer, poly(glycerol-sebacate) (90) (Scheme 20), was able to culture NIH 3T3 
fibroplast cells with normal morphology and an increased growth rate when compared to a 
pure PLGA  coated petri dish. 
 
Scheme 20:  Synthesis of poly(glycerol-sebacate) 
Another example of a functional polymer was shown by Dove et al.
53
 who uses functional 
polycarbonates bearing norbornene pendants (Scheme 21).  The key significance in this 
research is the use of post-functionalisation as a simple and elegant way of introducing a 
wide array or different functionalities.  The monomer was synthesised in four steps from 3-
hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid, with the first step being the protection 
of the diol using 2,2-dimethoxypropane.  This was then coupled to 5-norbornene-2-methanol 
followed by deprotection of the diol.  The diol was then treated with triphosgene to create the 
carbonate monomer . 
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Scheme 21:  Post-functionalisation of a pendant norbornene polycarbonate 
 
The monomer is polymerised through the use of the organocatalyst DBU together with a 
thiourea derivative as a co-catalyst.  Once polymerised (91) the pendant norbornene can be 
reacted in a variety of ways.  The thiol-ene reaction can be utilised using a photoinitiator and 
UV light (93), while click chemistry is exploited between the norbornene and an azide (92).  
The alkene of the pendant norbornene can be used together with tetrazine in an inverse 
electron demand Diels-Alder reaction (95).  The real power of all these reactions is that they 
can be performed sequentially in one-pot as they all require different conditions (96). 
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8.9. Results and discussion 
 
The functional caprolactone molecules showed in Figure 10 shows a wide variety of 
versatility to synthesis of functional polymer precursors.  These precursors, as mentioned in 
the functional polymers section, can then be reacted in several ways as a platform to generate 
new chemistries.  A particular example of note is the amine pendant caprolactone, as the 
molecule is polymerised as the CBz protected amine, deprotected and then biotinylated.
50
  
 
Scheme 22:  Biotinylation of a functional PCL polymer 
 
Biotin is a specific protein binding receptor for streptavidin with a high binding affinity (10
13-
15
 M
-1
).
54
  Yan et al.
50
 clearly show that a functional polymer can be used to generate a 
polymer – drug conjugate.  With the principle tested and the research concept plausible, the 
Christie group began looking into a route to create more polymer – drug conjugates using this 
technique.  This was to build on previous work within the group where ciprofloxacin was 
successfully attached to a titanium surface, with the differing approach of a biodegradable 
polymer.
55
 
 
8.9.1. Research plan 
 
The initial aim of the project is to create functionalised monomers from which to synthesise a 
functionalised PCL backbone.  These polymers have the structure shown in Figure 11, where 
X denotes the functional tether (2).  It should also be noted that the location of the tether is 
not limited to the one shown in the figure and can be altered depending on the initial 
monomer. 
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Figure 11: Functionalised PCL backbone 
 
The initial plan for the beginning of the research would be to utlize the chemistry of Yan et 
al. to create the ciprofloxacin – polymer conjugate.  The retrosynthetic analysis shown in 
scheme 23 will be the basis of the functional monomer synthesis.  It was envisaged that this 
functional polymer could be synthesised from the commercially available trans-4-
aminocyclohexanol through protection of the amine to allow further oxidation of the alcohol.    
 
Scheme 23:  Reterosynthetic analysis of primary anime containing CL monomer 
 
A challenge that may be needed to over come would be the potential for rearrangement upon 
deprotection to the amine.  The deprotected monomer could rearrange to the five membered 
lactam with a pendant alcohol.  The way in which this could be overcome would be to co-
polymerise with CL in the protected amine state and then deprotect post polymerisation as 
there would be far less chance of the rearrangement due to the chain conformation of the 
polymer. 
The scope of the functionality would then be increased to include other functionalities 
including alcohols, to investigate their potential as polymer – drug conjugates.  This is of 
interest as the linkage to the drug molecule will be different in nature (ester compared to 
amide for example) therefore giving rise to analogous materials from which to investigate 
further. 
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8.9.2 Primary amine monomer using CBz protection 
 
The synthesis of the primary amine monomer began with the protection of the amine of 
trans-4-aminocyclohexanol.  Due to the difference in functionality, alcohol and amine, the 
primary amine was protected using benzyl chloroformate in a 67 % yield, without 
compromising the alcohol (104) (Scheme 24).
50
  The 
1
H NMR spectrum showed a singlet at 
5.08 and a multiplet between 7.29 – 7.40 ppm, indicating a benzyl group and successful 
protection of the amine.   
 
Scheme 24:  The protection, oxidation and Baeyer-Villiger conditions for 4-aminocyclohexanol 
 
The alcohol was then subsequently oxidised to the corresponding ketone (105) using 
pyridinium chlorochromate, PCC, with a high yield of 86 %.
56
  The oxidation was proven 
with the disappearance of the hydrogen peak at 3.59 ppm in the 
1
H NMR.  This signal 
corresponded to the hydrogen on the same carbon as the hydroxyl group and the 
disappearance indicated the loss of this hydrogen due to the formation of a ketone.  This is 
further proved in the 
13
C NMR, where there is the disappearance of a signal at 66.6 ppm and 
the appearance of one at 209.5 ppm indicating the presence of a ketone (this signal is also not 
visible in the DEPT, again showing a new quaternary carbon centre).   The ketone was then 
treated with mCPBA to form the lactone (78) in a 93 % yield, via a Baeyer-Villiger oxidation.  
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The successful oxidation to the lactone is shown by 
1
H NMR spectroscopy with the 
appearance of two signals at 4.17 and 4.30 ppm, each corresponding to the hydrogens in the 
CH2 next to the newly inserted oxygen atom.  The 
13
C NMR of the ketone shows four signals 
for the cyclohexane ring (due to symmetry), whereas the spectra for the lactone has six 
clearly different signals.  This would indicate the successful oxidation due to the loss of 
symmetry, with a signal at 65.4 ppm indicating another CH2 next to an oxygen (the other 
being the benzyl CH2) also showing the insertion of an oxygen into the ring. 
 
8.9.3. Protected primary amine polymerisations 
 
All polymerisations of -caprolactone, including random co-polymers with the functionalised 
monomers, were catalysed using stannous octanoate (64).  The standard polymerisation 
conditions employed were 1 % catalyst loading, 130 
o
C for 17 h.  When using only -
caprolactone (3) this yielded poly(caprolactone) (16) in a quantitative yield.  After obtaining 
PCL in such a high yield, the protected primary amine monomer was then used together with 
CL to create a random co-polymer (Scheme 25). 
 
Entry Monomer used Monomer  
amount (%) 
Incorporated 
amount (%)
i
 
Yield (%) 
1 Protected primary amine (68) 5 3.33 86 
2 Protected primary amine (68) 10 6.98 60 
i
Calculated from 
1
H NMR integration. 
Table 1: Results of protected primary amine co-polymerisations 
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Scheme 25: Random copolymerisation of CL and protected primary amine monomer 
 
The CBz protected amine (78) was used at a 5 % level (i.e. a ratio of CL to functionalised 
monomer was 9.5:0.5) (Table 1, Entry 1).  This yielded the random co-polymer (106) in an 
86 % yield, with the incorporation of the functionalised monomer shown in the 
1
H NMR.  
The NMR spectra shows a singlet at 5.07 and a multiplet at 7.29-7.37 ppm with the peak 
integrals indicating the polymer actually contains 3.33 % of the functionalised monomer (this 
could be related to the relative rates of polymerisation of each monomer, i.e. CL 
polymerises faster than the protected primary amine derivative).  This polymerisation was 
repeated but using a 10 % amount of the protected amine lactone (Table 1, Entry 2).  The 
polymer was only isolated in a 60 % yield, which can be attributed to the crystallinity of the 
product.  As you increase the level of co-polymerisation, the degree of crystallinity drops due 
to an increase in random structure (i.e. there is no consistent structure therefore less 
favourable to crystallise).  It was found that when using the protected amine monomer at 
greater than 10 % there was no precipitation of solid, therefore indicating the polymer was an 
oil and not crystalline.  This accounts for the loss of yield as not all the polymer would have 
been collected by filtration. 
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Scheme 26: Deprotection of primary amine via hydrogenolysis 
 
The next stage was the deprotection of the amine by hydrogenolysis.  This was carried out on 
a H-Cube
®
 continuous-flow hydrogenation reactor using a palladium on carbon catalyst.  The 
initial run was carried out using CH2Cl2 as the solvent with system not being heated and left 
at room temperature.  After running the machine for 4 h, the volume reduced and the product 
precipitated in cold hexane, no removal of the CBz group was observed.  The 
1
H NMR 
clearly showed the singlet at 5.07 ppm and multiplet in the aromatic region.  The solvent was 
changed to THF, not only as the polymer is soluble in THF but also because the reaction 
could be heated to 50 
o
C where CH2Cl2 could not due to solvent evaporation.  After passing 
the protected amine polymer through the HCube
®
 for 4 h at 50 
o
C, 
1
H NMR analysis again 
showed no removal of the protecting group with the characteristic signals of the CBz being 
observed again.   
 
Scheme 27:  Deprotection of primary amine using the HCube® 
 
The reaction was then tried in a round bottom flask utilising schlenk techniques to induce a 
hydrogen atmosphere, with balloons of hydrogen to maintain the pressure.  Palladium on 
carbon was used again and the reaction left at room temperature for 48 h.  Unfortunately 
there was no deprotection observed so another set of conditions were trialled.  
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These conditions were the use of 48 % hydrobromic acid in acetic acid at room temperature 
for 24 h.  This reaction would cleave the CBz group off and leave the amine protonated 
unable to undergo and rearrangement chemistry.  As with before the 
1
H NMR showed the 
benzyl hydrogens at 5.07 ppm and the multiplet in the aromatic region indicating 
unsuccessful deprotection.  It was then decided to move towards a different deprotection 
group, therefore the BOC group was investigated.   
 
Scheme 28: Deprotection of primary amine using hydrobromic acid 
 
8.9.4. Primary amine monomer using BOC protection 
 
Due to the unsuccessful deprotection of the CBz protected primary amine, it was decided to 
move towards a group which is deprotected under different conditions.  The BOC (tert-
butyloxycarbonyl) protecting group was chosen for two reasons.  The first is that the acid 
conditions required for removal are far easier, cheaper and more commonly available than the 
previous hydrogenolysis required to remove a Cbz group.  Secondly upon removal due to the 
acid conditions the newly deprotected primary amine will be protonated.  This would mean 
that the lone pair of the nitrogen is already tied up and no rearrangement to the polylactam 
would occur.   
 
 
Scheme 29: Synthesis of BOC protected primary amine monomer 
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4-Aminocyclohexanol (103) was first protected with a BOC group using standard conditions 
of BOC anhydride and base (107).  Care needed to be taken during work-up as when using 
hydrochloric acid (1 M) to remove excess base, the protecting group can be removed and 
carbon dioxide liberated.  This would in turn regenerate the starting material, therefore a new 
approach was required.  This was rectified by the use of citric acid (1 M) with the product 
being isolated in a respectable 82 % yield.  The product was easily identifiable from the 
starting material due to carbonyl peak in the IR at 1681 cm
-1
.  Upon protection of the amine, 
the alcohol was oxidised to the ketone (108) through the use of PCC in a 72 % yield.  IR 
spectroscopy indicated the successful oxidation through the appearance of a new peak at 
1714 cm
-1
, with the disappearance of the broad hydroxyl peak.  The ketone was then oxidised 
using mCPBA to yield the carresponding BOC protected lactone (109), in 52 % yield after 
column chromatography.  
 
Scheme 30:  Oxidation of the BOC protected amine cylcohexanone to the lactone using mCPBA 
 
Following successful synthesis of the BOC lactone, co-polymerisation with CL was carried 
out using the same stannous octanoate loading of 1 mol% with an incorporation of 5 % in the 
final polymer (110). 
 
Scheme 31:  Random co-polymerisation of CL and the BOC protected amine lactone 
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8.9.5. Secondary amine monomer 
 
The aim of this monomer is to have the heteroatom as part of the polymeric chain as opposed 
to a tether.  This would allow a secondary amine to be utilised along the backbone of the 
polymer and differentiate between the primary amine reactivity.  This would require the 
amine to be part of a cyclic system from the starting material, therefore 1,4-dioxa-8-
azaspiro[4.5]decane (111) was used (Scheme 32). 
 
 
Scheme 32:  Trifluoroacetylation and deprotection of 1,4-dioxa-8-azaspiro[4.5]decane 
 
The spiro compound’s amine was protected using trifluoroacetic anhydride (112) in a 51 % 
yield.
56
  This was supported in the 
1
H NMR by the observation of a pair of triplets at 3.67 and 
3.79 ppm.  These represent the equatorial and axial hydrogens, respectively, on the alpha 
carbons to the newly protected amine.  The broad singlet at 1.40 ppm is also absent, 
indicating the protection of the amine.  It should also be noted there are two new signals in 
the 
13
C NMR at 175.5 and 155.4 ppm corresponding to the trifluoro substituted carbon and 
the ketone (both displaying the quartet characteristic of fluorine coupling within NMR 
spectroscopy).  The ethylene ketal protecting group was then removed using p-TSA in 
acetone and water to give the ketone (114) in a 66 % yield.
56
  This is shown in the 
1
H NMR 
with a disappearance of the singlet at 4.00 ppm and a chemical shift from 1.77 to 2.59 ppm 
for the CH2 signal, indicating successful protection.  There was also a new peak in the 
13
C 
NMR at 204.7 ppm again indicating the presence of the ketone. 
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8.9.6. Acetal monomer 
 
This monomer was targeted so that the polymer could have an oxygen containing 
functionality, so when utilising these functional polymers when attaching biologically active 
molecules there would be an orthogonal approach compared to using the amine functionality.  
The retero-synthetic pathway (Scheme 33) indicates that the commercially available 1,4-
cyclohexanedione (117) as a viable starting material.  The dione could be mono-protected 
(116), with the free ketone then expecting to undergo a Baeyer-Villiger oxidation to form the 
lactone (77).  This lactone would then deprotected to leave the ketone functionality ready to 
incorporate into a co-polymer (115).   
 
 
Scheme 33:  Reterosynthetic analysis of ketone containing CL monomer 
 
The first step in the forward synthesis was the mono-protection of one of the ketone groups.  
This was achieved using ethylene glycol (118) and p-TSA in toluene, with the water removed 
using a Dean-Stark apparatus. 
 
Scheme 34: Ketone protection using ethylene glycol 
 
The ratio of dione to ethylene glycol was 1:1 with the intention of protecting only one ketone.  
The mono-protected dione was synthesised with the 
1
H NMR showing a singlet at 4.03 ppm 
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and triplets at 2.01 and 2.51 ppm.  Unfortunately due to the statistical nature of the reaction 
both mono- (116) and di-protected (119) were isolated.  The crude reaction yield 
1
H NMR 
showed there was far more di-protected than mono-protected, with singlets at 1.79 and 3.95 
ppm and also a large singlet at 2.72 ppm indicating starting material.  It was found that with 
the elevated temperatures required for the Dean-Stark to function (>110 
o
C), starting material 
was degraded.  This in turn raised the ratio of ethylene glycol to dione, resulting in an 
increased amount of di-protected product.  The amount of ethylene glycol was halved to a 
ratio of 1:0.5, with respect to the dione, so the reaction would only yield mono-protected and 
dione, and it was this reaction that yielded the mono-protected in 15 % yield.  As the 
reactions yields were low and unpredictable, it was decided to persue different avenues. 
The new approach was a direct Baeyer-Villiger of the dione to afford the 5-keto--
caprolactone.  The standard reagent used to convert a cyclic ketone into a lactone is meta-
chloroperoxybenzoic acid, mCPBA, with dichloromethane, CH2Cl2, as solvent.  
 
Scheme 35:  Baeyer-Villiger of 1,4-cyclohexandione using mCPBA 
 
mCPBA, was used in CH2Cl2, due to the non-oxidisable nature of the solvent,  for the 
Baeyer-Villiger of the dione.  This was initially trialled using 1 mmol of starting material 
with no formation of product.  The reaction was repeated with the use of NaHCO3, to act as 
an in-situ base wash, with the 
1
H NMR spectrum showing a 50 % conversion (Table 2, 
Entry 1).  The NMR spectra showed the presence of starting dione (singlet at 2.72 ppm), 
with multiplets at 4.42, 2.83 ppm and under the starting material signal at 2.74 ppm 
indicating the formation of the product.  The reaction was scaled to several grams but it was 
found that the amount of product produced was far less, with product conversion of only 18 
%, with the rest being starting material.  It must also be noted that both these figures for the 1 
mmol and scaled reaction are the highest of several repeat reactions.  Each reaction exhibited 
a variety of conversions and crude yields, indicating that this reaction is not as reliable as 
previously thought. 
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The solvent was changed to chloroform to see if there was an improvement in conversion 
(Table 2, Entry 2).  This solvent was chosen as it is also a non-oxidisable solvent and would 
therefore not interfere with the reaction.  Although some conversion was observed (5 %), it 
was still far too low to be synthetically useful.  Other organic solvents used were ethyl acetate 
(Table 2, Entry 3) and dry THF (Table 2, Entry 4), but unfortunately only the dione singlet 
was observed in the 
1
H NMR.  Deionised water was used as solvent (Table 2, Entry 5), with 
only starting material isolated.  To increase the solubility of the mCPBA a 1:1 mixture of 
acetonitrile and water (Table 2, Entry 6) was tried.  Although increasing solubility, there 
was no conversion of product. 
Entry Oxidant Solvent Time (h) Temp (
o
C) Yield (%) 
1 mCPBA
a
 CH2Cl2 17 40 50
b
 
2 mCPBA
a
 CHCl3 17 60 5
b
 
3 mCPBA Ethyl Acetate 17 80 No yield 
4 mCPBA Anhydrous THF  17 -78 No yield 
5 mCPBA H2O 2 80 No yield 
6 mCPBA MeCN:H2O (1:1) 24 25 No yield 
7 mCPBA / BF3.Et2O CH2Cl2 48 40 No yield 
8 mCPBA / BF3.Et2O Anhydrous THF 17 -78 No yield 
a
NaHCO3 used in-situ, 
b
Conversion by 
1
H NMR.  
Table 2:  Baeyer-Villiger reactions using mCPBA 
 
As the best results were observed when using CH2Cl2, this system was used in combination 
with the lewis acid, boron trifluoride etherate (BF3.Et2O) (Table 2, Entry 7).  This addition 
increases the reactivity of the ketone with the intention of increasing the conversion.  This 
however was not the case with the reaction yielding only starting material.  The solvent was 
changed to dry THF (Table 2, Entry 8), but the result was the same with the 
1
H NMR 
showing only the dione singlet. 
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Entry Oxidant Solvent Time (h) Temp (
o
C) Yield (%) 
1 Oxone
®
 CH2Cl2 72 25 No conversion 
2 Oxone
®
 CH2Cl2 17 40 No conversion 
3 Oxone
®
 Ethyl Acetate 17 80 No conversion 
4 Oxone
®
 H2O 2 80 No conversion 
5 Oxone
®
 MeCN:H2O (1:2) 17 100 No conversion 
6 Oxone
®
 MeCN:H20 (4:1) 17 100 No conversion 
7 H2O2 / BF3.Et2O THF 3 25 No conversion 
8 Peracetic acid Acetic acid 17 120 No conversion 
9 Peracetic acid CH2Cl2 48 25 No conversion 
10 Trifluoroperacetic acid
a
 Anhydrous THF 17 25 No conversion 
11 Trifluoroperacetic acid
a
 CH2Cl2 2 25 No conversion 
a
Generated from trifluoroacetic anhydride and hydrogen peroxide in-situ. 
Table 3:  Use of alternative oxidising agents in the Baeyer-Villiger of 1,4-cyclohexandione 
 
Other oxidants were then investigated, with the first being Oxone.
®
  Potassium 
peroxymonosulfate, more commonly known as Oxone,
®
 exists as the triple salt 
2KHSO5
.
KHSO4
.
K2SO4 and has been used for a variety of oxidation purposes (Figure 12).  
This is due to the high stability, non-toxicity, cost and versatility.  This versatility can be 
shown in Figure 12, indicating a variety of oxidation reactions.
57
  The first solvent 
investigated with Oxone® was CH2Cl2, for an extended time of 72 h (Table 3, Entry 1).  
Unfortunately even with the longer reaction time, only the starting dione singlet was observed 
in the 
1
H NMR spectrum.  The following reaction was carried out at room temperature so the 
following one reflux was used overnight (Table 3, Entry 2).  Regrettably the reaction 
showed no conversion of the dione to the lactone, with only starting material being isolated.  
Solvent was then investigated with ethyl acetate initially chosen (Table 3, Entry 3), but no 
product was observed in the 
1
H NMR.  As Oxone
®
 is a salt it is hard to dissolve in organic 
solvents; therefore it was then decided to use aqueous media.  When using water (Table 3, 
Entry 4), the Oxone
®
 was completely dissolved but still no conversion of starting material.  
Aqueous rich Table 3, (Entry 5) and organic rich (Table 3, Entry 6) mixtures of acetonitrile 
and water were then trialled.  Even with these mixed solvent systems there was no formation 
of product. 
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Figure 12:  Versatility of Oxone® 
 
As both mCPBA and Oxone
®
 proved to be inefficient towards the Baeyer-Villiger of 1,4-
cyclohexanedione, other oxidants were explored.  This included the use of hydrogen peroxide 
in combination with a lewis acid, BF3.Et2O (Table 3, Entry 7).  The Lewis acid increases the 
reactivity of the oxygen – oxygen bond, allowing the Baeyer-Villiger reaction to occur more 
readily.  It was however found that this was not the case as there was no conversion of 
starting material to product.  Peracetic acid was also used on its own (Table 3, Entry 8) and 
also with NaHCO3 and NaOAc (Table 3, Entry 9).  The sodium acetate was used to 
deprotonate the peracid, therefore increasing the nucleophilic nature of the acid.  
Unfortunately there was no formation of product in both cases (as indicated by the presence 
of only starting material in the 
1
H NMR).  Another peracid that was used was 
trifluoroperacetic acid.  This peracid was generated in-situ from the reaction between 
trifluoroacetic anhydride and hydrogen peroxide.  Two solvents, THF (Table 3, Entry 10) 
and CH2Cl2 (Table 3, Entry 11), were used but neither produced the desired product.  It was 
decided that this route towards a ketone containing monomer needed to be approached from a 
different direction, therefore considering that as the mono-protected cyclohexanedione was 
commercially available, that was chosen as the starting point. 
 
Scheme 36:  Baeyer-Villiger of mono-protected dione 
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The Baeyer-Villiger of 1,4-cyclohexanedione monoethylene acetal (116) was carried out 
using mCPBA in CH2Cl2 (Scheme 36).  This was carried out under reflux overnight and 
afforded -(ethylene acetal)--caprolactone (77) in an 88 % yield.  This protected ketone -
caprolactone monomer can then be used in copolymerisation reactions.  The reason for 
keeping the ketone protected is that the ketone can be deprotected, and then further reduced 
to the alcohol, post-polymerisation, avoiding possible complications the ketone may cause 
during polymerisation.  With a functional CL monomer synthesised the next stage was to 
co-polymerise to generate a functional polymer.   
 
8.9.7. Acetal copolymers 
 
Reacting the functional CL monomer (77) and CL together using polymerisation conditions 
of 1 % catalyst loading of stannous octanoate at 130 
o
C for 17 h, yielded random co-polymers 
containing a functional backbone (Scheme 37). 
 
Scheme 37: Polymerisation and random copolymerisation of CL and acetal monomer 
 
These random co-polymerisations were synthesised using 5 and 10 % of the acetal monomer 
(77).  Both the 5 % and 10 % monomer concentrations were high yielding with the random 
co-polymer (120) being isolated at 90 % and 87 % respectively (Table 4, Entries 1 and 2).  
Their incorporation into the PCL polymer was observed in the 
1
H NMR spectra as a singlet at 
3.94 ppm indicating the ethylene ketal group (which was then integrated and used to find 
actual incorporation).   
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Entry Monomer used Monomer  
amount (%) 
Actual  
amount (%)
1
 
Yield (%) 
1 Protected ketone (6) 5 4.82 90 
2 Protected ketone (6) 10 8.95 87 
1
Calculated from 
1
H NMR integration. 
Table 4:  Results of acetal monomer co-polymerisations 
The acetal polymer was treated with triphenylcarbenium tetrafluoroborate, Ph3C
+
 
-
BF4, to 
remove the protecting group and yield the ketone in a 91 % yield (Scheme 38).
58
  The 
deprotection was observed by 
1
H NMR as a disappearance of the CH2 signal at 3.94 ppm and 
a shift of all other CH2 signals due to the newly formed ketone. 
 
 
 
Scheme 38: Deprotection using triphenylcarbenium tetrafluoroborate 
 
The ketone polymer was then treated with sodium borohydride to reduce the ketone to the 
alcohol.  Sodium borohydride is used in protic solvents i.e. methanol or ethanol, however 
PCL and it’s functional forms are insoluble in these solvents.  To counteract this a solvent 
system of CH2Cl2:EtOH (5:2) was used to provide solubility for the polymer, without 
impairing the performance of the sodium borohydride.  The alcohol polymer was obtained in 
a 96 % yield with complete conversion of the ketone group. 
 
 
Scheme 39:  Reduction of ketone to alcohol using sodium borohydride 
 
The complete conversion to the alcohol was observed in the 
1
H NMR spectrum through the 
shifting of the protons either side of the previous ketone shifting further down into the 
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aliphatic region, and a new signal at 3.65 ppm corresponding to the CH at the base of the 
hydroxyl. 
 
8.9.8. Alcohol polymer additions 
 
With the successful synthesis of the alcohol pendant PCL polymer, additions to this 
functionality were then investigated.  The first route chosen to attach molecules to PCL was 
to generate acid chlorides from which the hydroxyl group of the polymer can form an ester.  
The ester linkage is important as this is the same functionality that the PCL backbone has.  
This means that the attached molecule can be hydrolysed and ‘released’ under the same 
conditions as the degradation of the polymer.  This will in theory be our drug delivering 
system.  The first molecule chosen to attach was aspirin.  Aspirin, or 2-acetylsalicylic acid, 
was synthesised through the esterification between salicylic acid and acetic anhydride 
(catalysed using H2SO4) (Scheme 40).  The produced aspirin was isolated in an 80 % yield 
after recrystallization. 
 
Scheme 40:  Aspirin synthesis 
 
Once synthesised, aspirin was dissolved in CH2Cl2 and thionyl chloride added to generate the 
acid chloride.  After removal of the solvent the acid chloride was used immediately by 
addition to a CH2Cl2 solution containing the alcohol polymer, all under inert, dry conditions.  
The reaction was washed with sat NaHCO3 to ensure any unreacted aspirin was removed 
before analysis.  Upon precipitation in cold methanol a white solid was obtained with the 
1
H 
NMR spectrum showing successful attachment of the aspirin.  Upon looking closer at the 
spectrum, a hydroxyl hydrogen could be seen indicating that the attachment was 
unsuccessful.  The reaction was repeated with the amount of polymer being increased from 
0.2 g to 1.0 g.  This repeat however produced no evidence of aspirin attachment and thus 
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proved that the previous result was a false positive and must have occurred through 
insufficient washings to remove excess reagent. 
 
Scheme 41:  Addition of aspirin to alcohol polymer using thionyl chloride in solvent 
 
The reaction conditions were then changed to have thionyl chloride as the solvent rather than 
used as reagent added to CH2Cl2.  Aspirin was dissolved in thionyl chloride, reacted for an 
hour and the solvent removed under reduced pressure.  The resulting product was 
immediately added to the CH2Cl2 solution containing the alcohol polymer.  After reacting for 
one h, washed with sat NaHCO3, and the polymer recovered through the usual hexane 
precipitation, no attachment to the polymer was observed through 
1
H NMR.  After reviewing 
the conditions previously used, it was noticed that there was not any base present at the 
attachment stage to precipitate out any chloride ions formed through successful attachment.  
Therefore dry triethylamine was used, but to no avail as the 
1
H NMR spectrum again showed 
no successful attachment.  Considering that each step of the reaction was only being allowed 
to react for one hour, the reaction times were increased to six hours to generate the acid 
chloride.  The attachments were also increased to overnight reactions.  Even with these 
prolonged reaction times, no attachment was observed through 
1
H NMR. 
 
Scheme 42:  Benzoyl chloride additon to the alcohol polymer 
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The next approach was to use a pre-generated acid chloride in the form of benzoyl chloride.  
The reasoning for this was to both remove the use of thionyl chloride, and also to test purely 
the addition conditions.  Using benzoyl chloride eliminates the need for thionyl chloride and 
therefore improves the chance of reaction when compared to aspirin.  This is because there is 
no need to generate the acid chloride in-situ as the reagent can be directly added to the 
reaction.  The same conditions of an inert atmosphere, anhydrous THF, anhydrous 
triethylamine all at room temperature were used.  Upon retrieval of the polymer through cold 
hexane precipitation, the 
1
H NMR spectrum yielded no evidence of successful attachment 
(easily observed through the lack of signals in the aromatic region).  As with all initial 
reactions testing a new condition, only 0.2 g of polymer was used.  Upon reflection it was 
noticed that as the polymer only contained 10 % alcohol functionality, only 0.14 mmol, the 
use of 10 mL of solvent was creating a situation of high dilution where there was simply too 
much solvent for the reactants to collide and react.  With this information the solvent level 
was dropped to 2 mL and the benzoyl chloride reaction repeated.  This time it would appear 
that the more concentrated reaction mixture had a positive effect with the 
1
H NMR spectrum 
indicating successful attachment of the benzoyl group.  This was observed through a triplet at 
7.40 ppm and a doublet at 8.01 ppm, indicating aromatic protons. 
 
Scheme 43:  Methacryloyl chloride addition to alcohol polymer 
 
This idea of carrying out the addition reactions at a high concentration was also used for 
methacryloyl chloride.  The reaction was successful and the methacrylate polymer was 
obtained in a 45 % yield.  The attachment was confirmed by 
1
H NMR which showed the 
methyl singlet at 1.96 ppm and the two alkene proton at 5.57 and 6.11 ppm. 
With the acid chlorides proving that attachments can in-fact take place, attention was returned 
towards aspirin.  Aspirin was refluxed in thionyl chloride with a catalytic amount of 
dimethylformamide (DMF) added to aid the acid chloride generation, and then added to the 
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concentrated alcohol polymer solution.  Unfortunately, after isolating the polymer and then 
analysis by 
1
H NMR, no aspirin was attached. 
The next approach investigated was the condensation route to esters.  The alcohol polymer 
and aspirin were dissolved in CH2Cl2 and the reaction heated to reflux.  The key element of 
this reaction is that it was also carried out in the presence of 4 Å molecular sieves.  The 
reason for this is that the reaction is in constant equilibrium between reactants and products, 
therefore removal of the water should, in accordance with the Le Chatelier’s principle, drive 
the equilibrium towards the product.  However after allowing the reaction to be heated for 17 
h, no aspirin was attached through analysis by 
1
H NMR. 
 
Scheme 44:  Aspirin attachment using molecular sieves 
 
The next step was to test ester coupling agents.  A common coupling reagent is 
dicyclohexylcarbodiimide, (DCC).  This reagent was first described by Wolfgang Steglich in 
1978 and is therefore called the Steglich esterification.
59
 DCC is used together with a 
catalytic amount of DMAP to couple alcohols and carboxylic acids.  Under an inert 
atmosphere the standard DCC conditions of anhydrous CH2Cl2 at room temperature were 
used, but as before no aspirin peaks were observed in the 
1
H NMR spectra of the collected 
polymer. 
 
Scheme 45:  DCC coupling of aspirin to alcohol polymer 
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Another coupling reagent T3P
®
, propane phosphonic acid anhydride, was also tested.  This 
reagent is usually used in peptide synthesis to couple amines and carboxylic acids; however it 
has been used in ester formation also.  The attraction of using this reagent is that the by-
product of the coupling is a phosphate salt, which is completely water soluble making work-
up easier.  The coupling reagent was used together with triethylamine, DMF as the solvent 
with the alcohol polymer being added before the aspirin.  The reaction was diluted with 
CH2Cl2, so the DMF could be removed through brine washing, and the other reagents 
removed with HCl (1 M) and saturated NaHCO3.  After precipitating the polymer in cold 
hexane, it was analysed by 
1
H NMR but unfortunately there were no signals in the aromatic 
region, therefore no aspirin attachment.  
 
Scheme 46:  T3P
®
 coupling of aspirin to the alcohol polymer 
 
As the attempts to attach aspirin in a variety of methods were growing, with little or no 
success, it was decided to move on to try a different reagent in the form of the drug 
ciprofloxacin. 
 
Another biologically important molecule which would be interesting to attach is 
ciprofloxacin.  Ciprofloxacin (137) (Figure 16) is a second-generation fluoroquinoline 
antibiotic.  It has a wide spectrum of activity including bacteria responsible for respiratory, 
urinary tract, gastrointestinal and abdominal infections.  Although the previous list does not 
include cardiovascular infections/problems, ciprofloxacin has many features making it an 
ideal antibiotic of choice for a proof of concept study.   
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Figure 13: Ciprofloxacin 
 
The main reason for using this antibiotic is that it can be easily analysed through use of the 
Gram staining protocol, as it responds to both gram (+) and (-) bacteria species.  This means 
that the biological activity of any products can be easily observed in a relatively simple 
manner.  Another key point in terms of analysis is that there are distinct hydrogen 
environments within the molecule making 
1
H NMR spectra simple to analyse, with the 
presence of the fluorine atom providing a key reference point when carrying out any surface 
analysis.  This is because the only source of any fluorine signals is from successful 
attachment of the antibiotic.  Another attractive feature is that it is commercially available 
from several sources. 
 
Scheme 47:  Ciprofloxacin attachment to the alcohol polymer 
 
Rather than trialling all the reactions used to attach aspirin, the literature provided a route 
towards the ciprofloxacin attachment.  Sobczak polymerised CL and lactide to generate 
hydroxyl terminal polymers, from which he attached ciprofloxacin.
60
  He carried this out by 
simply dissolving the polymers in CH2Cl2 and adding the ciprofloxacin together with a small 
amount of pyridine.  Therefore this reaction was tested using a sample of the alcohol 
polymer.  The reaction was left to react at room temperature over a weekend.  As 
ciprofloxacin is sparingly soluble in CH2Cl2 (practically insoluble), upon collecting the 
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precipitated product there could be no way of determining if the signals observed in the 
1
H 
NMR spectrum were from attached or free ciprofloxacin.  The product was redissolved in 
CH2Cl2 to create a cloudy white solution.  The solution was then passed through a plug of 
celite in an attempt to remove the ciprofloxacin.  The resulting solution was completely 
colourless indicating that the celite had filtered out the free ciprofloxacin.  The polymer was 
precipitated out and the process repeated again to ensure all free ciprofloxacin is removed.  
The 
1
H NMR spectrum showed signals at 8.81, 8.06, 7.38, 3.57, 3.33, 3.13 and 1.23 ppm 
indicating the novel attachment of ciprofloxacin. 
 
To conclude, although removal of the CBz group on the amine pendant polymer was 
problematic, success was found when switching to the alcohol variant, with a novel polymer 
– drug conjugate being synthesised.  The research will now focus on the functionalisation of 
polymer films to generate polymer – drug conjugates utilising aminolysis. 
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8.10. Experimental 
 
Commercially available reagents and solvents were used throughout without further 
purification, except for tetrahydrofuran (benzophenone/Na) which was freshly distilled.  
Light petroleum refers to the fraction with bp 40-60 ºC. Thin layer chromatography was 
carried out on Merck Kieselgel 60 GF254 aluminum foil backed plates. The plates were 
visualized under UV light, phosphomolybdic acid stain and/or vanillin stain. Flash 
chromatography was carried out using Merck Kieselgel 60 H silica or Matrix silica 60, with 
the eluent specified. 
1
H and 
13
C NMR spectra were recorded using Bruker 400 MHz NMR 
machine (
1
H 400 MHz, 
13
C 100 MHz); chemical shifts are quoted in ppm and coupling 
constants, J, are quoted in Hz; d-Chloroform was used throughout unless otherwise stated. 
Spectra were calibrated to residual solvent peaks.  In the 
13
C spectra, signals corresponding to 
C, CH, CH2 or CH3 groups, as assigned by DEPT, are noted. High and low resolution mass 
spectra were carried out on a Thermofisher exactive (orbi) resolution mass spectrometer.  IR 
spectra were recorded using a Perkin Elmer FTIR Spectrometer (Paragon 100) as solutions 
using CH2Cl2 as solvent.  GPC was carried out on a Phenogel 10u column using polystyrene 
standards.  Samples were run at 0.2 wt% in THF with diphenylether as a flowrate marker.  
 
 
Benzyl 4-hydroxycyclohexanecarbamate
50 
(104) 
To a solution of trans-4-aminocyclohexanol 103 (0.57 g, 4.99 mmol) and sodium hydrogen 
carbonate (1.05 g, 12.5 mmol) in water (50 mL), cooled in an ice bath, was added benzyl 
chloroformate (0.93 mL, 6.50 mmol) over 5 minutes.  The reaction mixture was heated to 45 
o
C for 4 h.  This was then extracted using n-butanol (3 x 50 mL) with the combined organic 
extract washed with hydrochloric acid (0.5 M), brine, dried with magnesium, and filtered.  
Volatiles were removed, under reduced pressure, until 104 began to crystallise.  The product 
was left in the freezer overnight to crystallize which, after filtration, yielded white needles 
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crystals (0.84 g, 67 %). M.p. 161-164 
o
C (Lit 163-165 
o
C).
61
  IR (CH2Cl2) max 3389, 3341, 
2949, 1686, 1534, 1066 cm
-1
.  
1
H NMR (CDCl3, 400M Hz)  (ppm): 1.19 (q, J = 12.8 Hz, 
2H, CH2), 1.39 (q, J = 12.4 Hz, 2H, CH2), 1.46 (d, J = 4.4 Hz, 1H, OH), 1.96-2.05 (m, 4H, 
CH2), 3.49-3.52 (m, 1H, CH-NH), 3.56-3.66 (m, 1H, CH-OH), 4.59 (s, 1H, NH), 5.08 (s, 2H, 
CH2-Ph), 7.29-7.38 (m, 5H, ArH).  
13
C NMR (CDCl3, 100 MHz)  (ppm): 31.1, 33.9, 49.3, 
66.6, 69.7, 128.2, 128.6, 136.5, 155.6. MS-ESI found 272.1248 C14H19O3N, [M+Na]
+
 
requires 272.1257. 
 
 
Benzyl 4-oxocyclohexylanecarbamate
56
 (105) 
To a solution of Pyridinium chlorochromate (2.84 g, 13.42 mmol) in CH2Cl2 (100 mL) at 5 
o
C, was added 104 (2.77 g, 11.15 mmol).  The reaction mixture was stirred at room 
temperature for 2 h followed by 5 h at 45 
o
C.  The resulting reaction mixture was cooled and 
filtered through silica gel, using diethyl ether as the solvent.  Volatiles were removed under 
reduced pressure to yield a white solid (2.37 g, 86 %). M.p. 81-83 
o
C (Lit 83-85 
o
C).
61
 IR 
(CH2Cl2) max 3329, 2950, 1699, 1534, 1043 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm): 
1.65-1.75 (m, 2H, CH2), 2.25-2.27 (m, 2H, CH2), 2.37-2.49 (m, 4H, CH2), 4.00 (s, 1H, CH-
NH), 4.72 (s, 1H, NH), 5.12 (s, 2H, CH2-Ph), 7.31-7.40 (m, 5H, ArH).  
13
C NMR (CDCl3, 
100 MHz)  (ppm):  32.2, 38.9, 48.0, 66.9, 128.2, 128.3, 128.6, 136.3, 155.6, 209.5.  MS-ESI 
found 270.1092 C14H17O3N, [M+Na]
+
 requires 270.1101. 
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-(Carbamic acid benzyl ester)--caprolactone (78) 
To a solution of 105 (0.25 g, 0.99 mmol) in CH2Cl2 (20 mL), was added m-
chloroperoxybenzoic acid (77 %, 0.45 g, 1.99 mmol).  The reaction mixture was then heated 
to reflux for 17 h.  The reaction mixture was then washed with saturated sodium sulphite, 
saturated sodium hydrogen carbonate, brine, dried using magnesium sulphated and filtered.  
Volatiles were removed under reduced pressure to yield a white solid (0.24 g, 93 %). M.p. 
114-116 
o
C (Lit 116-117 
o
C).
50
  IR (CH2Cl2) max 3328, 2942, 1715, 1532, 1266, 1074 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm): 1.58 (q, J = 12.4 Hz, 1H, CH2), 1.70-1.80 (m, 1H, 
CH2), 2.17-2.28 (m, 2H, CH2), 2.56-2.73 (m, 2H, CH2), 3.82-3.84 (m, 1H, CH-NH), 4.17 (t, J 
= 10.4 Hz, 1H, CH2-O), 4.27-4.32 (m, 1H, CH2-O), 4.76 (s, 1H, NH), 5.10 (s, 2H, CH2-Ph), 
7.31-7.39 (m, 5H, ArH).  
13
C NMR (CDCl3, 100 MHz)  (ppm):  29.1, 30.5, 35.6, 51.1, 65.5, 
67.0, 128.2, 128.3 , 128.6, 136.2, 155.4, 174.8.   MS-ESI found 286.1042 C14H17O4N, 
[M+Na]
+
 requires 286.1050. 
 
 
Polycaprolactone (29) 
A flame dried round bottom flask under nitrogen was charged with -caprolactone 3 (5 mL, 
45.1 mmol) and tin octanoate (64, 0.3 M in toluene, 1.5 mL, 0.45 mmol, 1 mol%).  The 
reaction mixture was heated to 130 
o
C for 17 h.  While warm the reaction mixture was 
dissolved in CH2Cl2 (20 mL), and precipitated by dropwise addition to cold methanol (250 
mL).  A white solid was collected via suction filtration (5.03 g, 100 %).  M.p. 58-61 
o
C (Lit 
60 
o
C).
62
  IR (CH2Cl2) max 2945, 1725, 1190 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm):  
1.34 – 1.42 (m, 2H, CH2), 1.61 – 1.69 (m, 4H, CH2), 2.31 (t, J = 7.6 Hz, 2H, CH2), 4.06 (t, J 
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= 6.4 Hz, 2H, CH2).  
13
C NMR (CDCl3, 100 MHz)  (ppm):  24.6, 25.5, 28.4, 34.1, 64.2, 
173.6.  Mw = 21380 g/mol by GPC. 
 
 
Poly(-caprolactone – co - carbamic acid benzyl ester -caprolactone) (106)  
A flame dried round bottom flask was charged with -carpolactone 3 (1.05 mL, 9.5 mmol) 
and -carbamic acid benzyl ester caprolactone 78 (0.13 g, 0.5 mmol).  The reaction mixture 
was heated to 50 
o
C for 10 min to make the reaction homogeneous.  Tin octanoate 64 (0.3 
mL, 0.09 mmol, 0.3 M in toluene) was added, under vigorous stirring, and the reaction 
mixture heated to 130 
o
C for 17 h.  The reaction mixture was dissolved in CH2Cl2 (20 mL), 
and precipitated in cold methanol (250 mL).  White solid was collected via suction filtration 
(1.04 g, 86 %). M.p. 53-56 
o
C.  IR (CH2Cl2) max 3361, 2941, 1733, 1166 cm
-1
.  
1
H NMR 
(CDCl3, 400 MHz)  (ppm):  1.34 – 1.42 (m, 2H, CH2), 1.62 – 1.69 (m, 4H, CH2), 1.71 – 
1.79 (m, 2H, CH2), 1.83 – 1.89 (m, 2H, CH2), 2.29 (t, J = 7.6 Hz, 2H, CH2), 2.36 – 2.38 (m, 
2H, CH2), 3.76 – 3.79 (m, 1H, CH), 4.07 (t, J = 6.4 Hz, 2H, CH2), 4.12 – 4.15 (m, 2H, CH2), 
4.78 – 4.81 (m, 1H, NH), 5.07 (s, 2H, CH2), 7.29 – 7.37 (m, 5H, ArH).  
13
C NMR (CDCl3, 
100 MHz)  (ppm): 24.6, 25.5, 28.3, 30.2, 30.9, 34.1, 48.6, 61.2, 64.1, 64.4, 66.7, 128.0, 
128.1, 128.5, 136.5, 156.0, 173.4, 173.6.  Mw = 8270 g/mol by GPC. 
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tert-Butyl-4-hydroxycyclohexycarbamate (107) 
trans-4-aminocylclohexanol 103 (1.00 g, 8.68 mmol) was added to a flame dried flask under 
nitrogen and dry CH2Cl2 (20 mL) added.  The reaction mixture was cooled to 0 
o
C 
triethylamine (2.42 mL, 17.40 mmol) added drop wise over 30 min.  To this solution was 
then added di-tert-butyl-dicarbonate (2.09 g, 9.55 mmol) in dry CH2Cl2 (5 mL) over 1 h.  
Reaction was left to react for 17 h and allowed to warm to room temperature.  Reaction 
mixture was washed with citric acid (1 M), brine, dried using magnesium sulphate and 
filtered.  Volatiles were removed under reduced pressure with the resulting solid purified by 
column chromatography (1:1, petrol:ethyl acetate) to yield a clear oil (1.42 g, 82 %).  IR 
(CH2Cl2) max 3419, 2939, 1682cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm): 1.16 (t, J = 12.8 
Hz, 2H, CH2), 1574 – 1.32 – 1.57 (m, 11H, CH3, CH2), 1.94 – 2.01 (m, 4H, CH2), 3.417 (bs, 
1H, CH), 3.58 – 3.62 (m 1H, CH), 4.34 (bs, 1H, N-H).  13C NMR (CDCl3, 100 MHz)  
(ppm): 28.5, 31.2, 34.1, 48.9, 69.9, 79.2, 155.3.  MS-ESI found 238.1413 C11H21O3NNa, 
[M+Na]
+
 requires 238.1414. 
 
 
tert-Butyl-4-oxocyclohexylcarbamate (108) 
To round bottom flask under a nitrogen atmosphere was added pyridnium chlorochromate 
(2.25 g, 10.44 mmol) in CH2Cl2 (50 mL). To this solution was gradually added tert-butyl-4-
hydroxycyclohexylcarbamate 107 (1.50 g, 9.95 mmol).  The reaction mixture was then heated 
to reflux for 17 h.  The excess volatiles were removed under reduced pressure and the 
reaction mixture redissolved in ethyl acetate:hexane (100 mL, 1:1) and filtered through a plug 
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of celite and eluted with the same solution (100 mL).  The eluent was washed with sodium 
hydroxide (1 M, 3 x 50 mL), dried using magnesium sulphate, filtered and excess volatiles 
removed under reduced pressure to yield a clear oil (1.28 g, 86%).  IR (CH2Cl2) max 3360, 
2974, 1523 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm): 1.44 (s, 9H, CH3), 1.60 – 1.65 (m, 
2H, CH axial), 2.20 – 2.23 (m, 2H, CH equatorial), 2.39 – 2.40 (m, 4H, CH2), 3.91 (m, 1H, 
CH), 4.49 (s, 1H, NH). 
 13
C NMR (CDCl3, 100 MHz)  (ppm): 28.5, 32.4, 39.1, 47.7, 79.8, 
155.2, 209.9.  MS-ESI found 236.1255 C11H19O3NNa, [M+Na]
+
 requires 236.1257. 
 
 
tert-butyl (7-oxooxepan-4-yl)carbamate (109) 
tert-Butyl-4-oxocyclohexylcarbamate 107 (1.06 g, 4.97 mmol) was dissolved in CH2Cl2 (30 
mL) in a round bottom flask.  m-chloroperoxybenzoic acid (77%, 1.57 g, 7.00 mmol) as then 
added slowly over 15 min.  Reaction mixture was then heated to refluxed for 17 h.  The 
reaction mixture was then washed with saturated sodium sulphite, saturated sodium hydrogen 
carbonate, brine, dried using magnesium sulphated and filtered.  Volatiles were removed 
under reduced pressure to yield a clear oil.  This was purified by column chromatography 
(3:2, petrol:ethyl acetate) to yield a clear oil (0.60 g, 52%).  IR (CH2Cl2) max 1724, 1682, 
1527 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm):  1.42 (s, 9H, CH3), 1.53 (q, J = 12.4 Hz, 
1H, CH), 1.70 (q, J = 10.4 Hz, 1H, CH), 2.25 – 2.14 (m, 2H, CH), 2.57 (t, J = 12.8 Hz, 1H, 
CH), 2.68 (dd, J = 8.4, 8.4 Hz, 1H, CH), 3.73 (bs, 1H, CH), 4.15 (t, J = 9.6 HZ, 1H ,CH), 
4.28 (dd, J = 8.4, 8.4 Hz, 1H, CH), 4.53 (bd, J = 4.8 Hz, 1H, NH).  
13
C NMR (CDCl3, 100 
MHz)  (ppm): 28.4, 29.4, 30.7, 35.9, 50.9, 65.8, 80.0, 154.9, 175.0.  MS-ESI found 
252.1207 C11H19O4NNa, [M+Na]
+
 requires 252.1206.  
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Poly(-caprolactone – co - tert-butyl (7-oxooxepan-4-yl)carbamate) (110) 
A flame dried round bottom flask was charged with -carpolactone 3 (1.05 mL, 9.5 mmol) 
and tert-butyl (7-oxooxepan-4-yl)carbamate 109 (0.12 g, 0.5 mmol).  The reaction mixture 
was heated to 50 
o
C for 10 min to make the reaction homogeneous.  Tin octanoate 64 (0.3 
mL, 0.09 mmol, 0.3 M in toluene) was added, under vigorous stirring, and the reaction 
mixture heated to 130 
o
C for 17 h.  The reaction mixture was dissolved in CH2Cl2 (20 mL), 
and precipitated in cold methanol (250 mL).  White solid was collected via suction filtration 
(0.86 g, 72 %).  IR (CH2Cl2) max 3372, 1724, 1682, 1527 cm
-1
.  
1
H NMR (CDCl3, 400 MHz) 
 (ppm): 1.32 – 1.42 (m, 11H, CH3, CH2), 1.51 – 1.67 (m, 6H, CH2), 2.14 – 2.30 (m, 4H, 
CH2), 2.57 (t, J = 12.4 Hz, 1H, CH), 2.68 (dd, J = 8.4, 8.4 Hz, 1H, CH), 3.72 (bs, 1H, CH), 
4.04 (t, J = 6.4 Hz, 2H, CH2), 4.15 (t, J = 10 Hz, 1H, CH), 4.28 (dd, J = 8.4, 8.4 Hz, 1H, CH), 
4.55 (bs, 1H, NH).  
13
C NMR (CDCl3, 100 MHz)  (ppm): 24.5, 24.6, 25.6, 28.4, 29.3, 30.7, 
34.2, 35.9, 50.9, 64.2, 65.7, 80.0, 154.9, 173.6, 174.9.  Mw = 9224 g/mol by GPC. 
 
 
 
8-Trifluroroacetyl-8-aza-1,4-dioxaspiro[4,5]decane
56
 (113) 
1,4-dioxa-9-azaspiro[4.5]decane 111 (2.56 mL, 20 mmol) was added dropwise to round 
bottom flask containing trifluoroacetic anhydride 112 (5.64 mL, 40 mmol) at 0 
o
C.  The 
reaction mixture was then heated to 60 
o
C and left for 17 h.  The reaction mixture was then 
added to ice water (50 mL) and stirred for 15 min and extracted with CH2Cl2 (3 x 50 mL), 
washed with water, dried using magnesium sulphate and filtered.  Excess volatiles were 
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removed under reduced pressure, to yield an orange oil.  Product was then purified by column 
chromatography (9:1 petrol:ethyl acetate) to give a clear oil (2.43 g, 51 %).  IR (CH2Cl2) max 
2892, 1691, 1178 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm):  1.75 – 1.78 (m, 4H, CH2), 
3.67 (t, 2H, J = 4 Hz, CH, equatorial), 3.77 (t, 2H,  J = 6 Hz, CH, axial), 4.00 (s, 4H, CH2).  
13
C NMR (CDCl3, 100 MHz)  (ppm): 34.6, 35.5, 41.8, 43.7, 64.6, 106.1, 116.5, 155.4.  MS-
ESI found 262.0655 C9H12O3NF3, [M+Na]
+
 requires 262.0661. 
 
 
N-trifluoroacetyl-piperidin-4-one
56
 (114) 
8-Trifluoroacetyl-8-aza-1,4-dioxaspiro[4.5]decane 120 (2.34 g, 9.81 mmol) was added to a 
round bottom flask containing a solution of acetone (50 mL) and water (10 mL).  p-TSA 
(0.21 g, 1.12 mmol) was then added and the reaction heated to 80 
o
C for 48 h.  The reaction 
mixture was concentrated and extracted with CH2Cl2 (3 x 50 mL).  The organic extracts were 
combined and washed with saturated sodium hydrogen carbonate, water, dried using 
magnesium sulphate and filtered.  Volatiles were removed under reduced pressure to give the 
product which was purified with column chromatography (9:1 petrol:ethyl acetate) to give a 
white solid (1.32 g, 66 %).  M.p. 72-74 
o
C (Lit 75-76 
o
C).
63
  IR (CH2Cl2) max 2919, 1727, 
1691, 1176 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm): 2.58 (q, J = 6.4 Hz, 4H, CH2), 3.90 
(t, J = 6.4 Hz, 2H, CH equatorial), 3.98 (t, J = 6.4, 2H, CH axial).  
13
C NMR (CDCl3, 100 
MHz)  (ppm):  40.3, 41.0, 42.6, 44.0, 116.3, 155.9. 204.7. MS-ESI found 218.0395 
C7H8O2NF3, [M+Na]
+
 requires 218.0399. 
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1,4-cyclohexanedione monoethylene acetal (116) 
1,4-Cyclohexanedione 117 (0.11 g, 1.00 mmol), p-TSA (0.004 g, 0.02 mmol, 2 mol%) and 
ethylene glycol 118 (0.06 g, 1.00 mmol) were dissolved in toluene (20 mL) in an round 
bottomed flask fitted with a Dean Stark apparatus.  The reaction mixture was heated to reflux 
and left for 1 h.  The reaction mixture was then cooled and washed with saturated sodium 
hydrogen carbonate, brine, dried with magnesium sulphate and filtered.  Removal of volatiles 
under reduced pressure followed by purification by column chromatograohy (6:4 petrol:ethyl 
acetate) yielded a pale orange solid (0.02 g, 15 %).  M.p. 68-71 
o
C (Lit 70-73 
o
C).
64
  IR 
(CH2Cl2) max 2884, 1711, 1085 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm):  2.01 (t, J = 6.8 
Hz, 4H, CH2), 2.51 (t, J = 7.2 Hz, 4H CH2), 4.03 (s, 4H, CH2).  
13
C NMR (CDCl3, 100 MHz) 
 (ppm):  33.9, 38.2, 64.7, 107.2, 210.3.  MS-ESI found 157.0833 C8H12O3, [M+H]
+
 requires 
157.0815. 
 
 
-(Ethylene acetal)--caprolactone (77) 
1,4-cyclohexanedione monoethylene acetal 116 (0.16 g, 1.00 mmol) in a round bottom flask 
was dissolved in CH2Cl2 (20 mL) and mCPBA (77%, 0.34 g, 1.51 mmol) added slowly, and 
the reaction heated at reflux for 17 h.  Reaction mixture was washed with saturated sodium 
sulfite, saturated sodium hydrogen carbonate, brine, dried using magnesium sulphate and 
filtered.  Volatiles were removed, under reduced pressure, to yield a white solid (0.15 g, 
88%).  M.p. 47-49 
o
C (Lit 49-51 
o
C).
58
  IR (CH2Cl2) max 2891, 1732, 1158 cm
-1
.  
1
H NMR 
(CDCl3, 400 MHz)  (ppm):  1.91 (t, J = 5.6 Hz, 2H, CH2), 2.01 (t, J = 4.8 Hz, 2H, CH2), 
2.71 (t, J = 5.6 Hz, 2H, CH2), 3.99 (s, 4H, CH2), 4.29 (t, J = 4.8 Hz, 2H, CH2).  
13
C NMR 
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(CDCl3, 100 MHz)  (ppm):  28.8, 32.7, 39.0, 64.3, 64.8, 107.9, 175.4.  MS-ESI found 
195.0623 C8H12O4, [M+Na]
+
 requires 195.0628. 
 
 
Poly(-caprolactone – co - ethylene acetal -caprolactone) (120) 
A flame dried round bottom flask was charged with -caprolactone 3 (1.05 mL, 9.5 mmol) 
and -(ethylene acetal)-caprolactone 77 (0.09 g, 0.5 mmol).  The reaction mixture was 
heated to 50 
o
C for 10 min to make the reaction homogeneous.  Tin octanoate 64 (0.3 mL, 
0.09 mmol, 0.3 M in toluene) was added while the reaction mixture was stirred vigorously.  
Then the reaction mixture was heated to 130 
o
C for 17 h.  After cooling the reaction mixture 
was dissolved in CH2Cl2 (20 mL), and precipitated in cold methanol (250 mL).  White solid 
was collected via suction filtration (1.05 g, 90 %). M.p. 50-53 
o
C.  IR (CH2Cl2) max 2943, 
1733, 1165 cm
-1
. 
 1
H NMR (CDCl3, 400 MHz)  (ppm): 1.34 – 1.42 (m, 2H, CH2), 1.61 – 
1.69 (m, 4H, CH2), 1.95 – 2.03 (m, 4H, CH2), 2.31 (t, J = 7.6 Hz, 2H, CH2), 2.37 (t, J = 8 Hz, 
2H, CH2), 3.94 (s, 4H, CH2), 4.06 (t, J = 6.8 Hz, 2H, CH2), 4.16 (t, J = 7.2 Hz, 2H, CH2).  
13
C 
NMR (CDCl3, 100 MHz)  (ppm): 24.6, 25.5, 28.4, 28.7, 32.6, 34.1, 36.0, 60.2, 64.2, 65.1, 
109.4, 173.4, 173.6.  Mw = 24570 g/mol by GPC. 
 
 
Poly(-caprolactone – co  - keto--caprolactone) (121) 
The co-polymer poly(-caprolactone – co - ethylene acetal -caprolactone) 120 (6.14 g, 
3.56 mmol acetal content) was dissolved in CH2Cl2 (100 mL) in a round bottom flask.  
Triphenylcarbenium tetrafluoroborate (1.77 g, 5.35 mmol) was added and a colour change 
from colourless to green was observed.  The reaction mixture was then stirred at room 
temperature for 24 h.  The reaction mixture was concentrated and precipitated in cold 
methanol (250 mL) to yield a white solid (5.42 g, 91 %).  M.p. 56-59 
o
C.  IR (CH2Cl2) max 
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2944, 1726, 1190 cm
-1
.  
1
H NMR (CDCl3, 400MHz)  (ppm):  1.34 – 1.42 (m, 2H, CH2), 1.60 
– 1.69 (m, 4H, CH2), 2.31 (t, J = 7.6 Hz, 2H, CH2), 2.60 (t, J = 6.4 Hz, 2H, CH2), 2.75 (t, J = 
6.8 Hz, 2H, CH2), 2.80 (t, J = 6.4 Hz, 2H, CH2), 4.06 (t, J = 6.8 Hz, 2H, CH2), 4.34 (t, J = 6.4 
Hz, 2H, CH2).  
13
C NMR (CDCl3, 100 MHz)  (ppm): 24.6, 25.5, 28.3, 34.2, 37.4, 41.5, 59.1, 
64.2, 64.7, 172.8, 173.4, 205.9.  Mw = 20410 g/mol by GPC. 
 
 
Poly(-caprolactone – co – - hydroxyl--caprolactone) (122) 
Poly(-caprolactone – co – 4-keto--caprolactone) 120 (3.52 g, 2.74 mmol ketone content) 
was dissolved in CH2Cl2 (30mL) in a round bottom flask and ethanol (12mL) added.  Sodium 
borohydride (0.21 g, 5.48 mmol) was added slowly to a stirring solution with effervescence 
observed.  The reaction mixture was left stirring for 24 h at room temperature, before the 
reaction mixture was concentrated and precipitated in cold hexane (250 mL) to yield a white 
solid which was collected by suction filtration (3.37 g, 96 %).  
1
H NMR (CDCl3, 400 MHz)  
(ppm): 1.28 – 1.44 (m, 2H, CH2), 1.55 – 1.71 (m, 8H, CH2), 2.34 (t, J = 4 Hz, 4H, CH2), 3.65 
(t, J = 6.4 Hz, 1H, CH), 4.06 (t, J = 6.4 Hz, 4H, CH2).  
13
C NMR (CDCl3, 100 MHz)  (ppm): 
24.7, 25.5, 28.4, 32.3, 34.1, 34.2, 34.8, 62.8, 64.2, 68.5, 173.9, 174.0.  Mw = 19570 g/mol by 
GPC. 
 
 
2-Acetoxybenzoic acid (125) 
Salicylic acid 123 (5.00 g, 36.2 mmol) was dissolved in acetic anhydride 124 (6.8 mL, 71.9 
mmol) in a round bottom flask and conc sulphuric acid (few drops) was added, the reaction 
mixture was then heated to 80 
o
C for two h.  The reaction mixture was poured into cold 
distilled water (50 mL) and placed in an ice bath.  White crystals were filtered off and 
recrystallized using hot ethanol with the addition of a small portion of cold water.  This 
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yielded the product as white needle crystals (5.19 g, 80 %).  M.p. 132-135 
o
C (lit M.p. 134-
136 
o
C)  IR.  
1
H NMR (CDCl3, 400 MHz)  (ppm):  2.38 (s, 3H, CH3), 7.17 (dd, J = 1.2, 8 
Hz, 1H, ArH), 7.39 (dt, J = 1.2, 8 Hz, 1H, ArH), 7.66 (dt, J = 1.6, 8 Hz, 1H, ArH), 8.18 (dd, J 
= 1.6, 8 Hz, 1H, ArH).  
13
C NMR (CDCl3, 100 MHz)  (ppm): 21.1, 122.2, 124.1, 126.3, 
132.6, 135.0, 151.3, 169.6, 169.8.  MS-ESI found 203.0315 C9H8O4Na , [M+Na]
+
 requires 
203.0315.  
 
 
Poly(-caprolactone – co – - benzoyl ester--caprolactone) (128) 
To a dry round bottom flask  under nitrogen was added poly(-caprolactone – co – - 
hydroxyl--caprolactone) 122 (0.30 g, 0.23 mmol alcohol content) and anhydrous THF (2 
mL).  Dry triethylamine (0.48 mL, 3.4 mmol) was added and benzoyl chloride 127 (0.27 mL, 
2.3 mmol) was dropise added to produce a cloudy white solution.  After complete addition 
the reaction mixture was left stirring for 17 h at room temperature.  Distilled water (5 mL) 
was added followed by extraction with CH2Cl2 (3 x 10 mL).  The organic extracts were 
washed with saturated sodium hydrogen carbonate, hydrochloric acid (1 M), brine and dried 
using magnesium sulfate.  Solvent was concentrated under reduced pressure and precipitated 
in cold hexane (100 mL) to yield a white solid which was collected by suction filtration (0.27 
g, 83 %). IR (CH2Cl2) max 1724, 1630 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm): 1.32 – 
1.39 (m, 2H, CH2), 1.58 – 1.70 (m, 6H, CH2), 1.75 – 1.78 (m, 2H, CH2), 2.28 (t, J = 8 Hz, 
4H, CH2), 4.03 (t, J = 6.8 Hz, 4H, CH2), 4.29 (t, J = 6.4 Hz, 1H, CH) 7.40 (t, J = 7.2 Hz, 2H, 
ArH), 7.50 (t, J = 7.6 Hz, 1H, ArH), 8.01 (d, J = 7.2 Hz, 2H, ArH).  Mw = 33690 g/mol by 
GPC. 
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Poly(-caprolactone – co – - methacryloyl ester--caprolactone) (130) 
To a dry round bottom flask under nitrogen was added poly(-caprolactone – co – - 
hydroxyl--caprolactone) 122 (0.30 g, 0.23 mmol alcohol content) and anhydrous CH2Cl2 (2 
mL).  Dry triethylamine (0.48 mL, 3.4 mmol) was added and the reaction mixture cooled to 0 
o
C.  Methacryloyl chloride 129 (0.22 mL, 2.25 mmol) was added dropwise over 1 h.  The 
reaction mixture was allowed to warm to room temperature and was washed with 
hydrochloric acid (1 M), saturated sodium hydrogen carbonate, brine, dried using magnesium 
sulphate and filtered.  The reaction mixture was concentrated under reduced pressure and 
precipitated in cold hexane to yield a white solid which was collected under suction filtration 
(0.14 g, 45 %). IR (CH2Cl2) max 1724, 1630 cm
-1
.  
1
H NMR (CDCl3, 400 MHz)  (ppm):  
1.37 – 1.47 (m, 2H, CH2), 1.63 – 1.71 (m, 8H, CH2), 1.96 (s, 3H, CH3), 2.33 (t, J = 8 Hz, 4H, 
CH2), 4.08 (t, J = 6.4 Hz, 4H, CH2), 4.17 (t, J = 6.4 Hz, 1H, CH), 5.57 (t, J=1.6 Hz, 1H, CH), 
6.11 – 6.12 (m, 1H, CH).  13C NMR (CDCl3, 100 MHz)  (ppm): 14.1, 24.4, 25.6, 28.4, 31.2, 
34.2, 35.6, 45.8, 61.0, 62.9, 64.2, 125.4, 136.5, 167.5, 173.6, 173.8.  Mw = 33300 g/mol by 
GPC. 
 
 
Poly(-caprolactone – co – - ciprofloxacin ester--caprolactone) (132) 
Poly(-caprolactone – co – - hydroxyl--caprolactone) (122, 0.30 g, 0.23 mmol alcohol 
content) was dissolved in CH2Cl2 (5 mL) in a round bottom flask and pyridine (5 drops, 
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catalytic) added.  ciprofloxacin 131 (0.38 g, 1.15 mmol) was then added and the reaction 
sturred at room temperature for 72 h.  The reaction mxture was then passed through a celite 
plug, using CH2Cl2 as the eluent.  The filtrate was concentrated and then precipitated in cold 
hexane to yield a white solid.  The solid was then redissolved in CH2Cl2 and passed through a 
second celite plug to ensure all particles of ciprofloxacin were removed.  The filtrate was 
concentrated under reduced pressure and precipitated in cold hexane to yield a white solid 
which was collected using suction filtration (0.09 g, 26 %). IR (CH2Cl2) max 1725, 1626 cm
-
1
.  
1
H NMR (CDCl3, 400MHz)  (ppm):  1.21 – 1.26 (m, 2H, CH2), 1.39 – 1.44 (m, 4H, CH2), 
1.65 – 1.70 (m, 8H, CH2), 2.23 (t, J = 7.6 Hz, 4H, CH2), 3.13 (t, J = 5.2 Hz, 4H, CH2), 3.33 
(t, J = 5.2 Hz, 4H, CH2), 3.57 (m, 1H, CH), 3.67 (t, J = 6.4 Hz, 1H, CH), 4.08 (t, J = 6.4 Hz, 
4H, CH2), 7.38 (d, J = 7.2 Hz, 1H, ArH), 8.06 (d, J = 13.2 Hz, 1H, ArH), 8.81 (s, 1H, CH).  
13
C NMR (CDCl3, 100 MHz)  (ppm): 8.3, 24.7, 25.3, 25.4, 28.4, 32.4, 34.2, 34.3, 35.3, 45.8, 
50.1, 62.8, 64.2, 77.3, 106.4, 111.2, 111.4, 112.2, 122.1, 139.7, 148.4, 152.5, 166.5, 173.4, 
173.6, 179.9.  Mw = 16540 g/mol by GPC. 
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9. Surface modification of polyesters 
with biologically active molecules 
through aminolysis 
 
9.1. Introduction 
 
This section of the thesis will cover the use of surface chemistry as an alternative to generate 
polymer – drug conjugates.  This area of research will be undertaken with the intent of 
utilising a simple surface modification technique, to generate a functional polymer via a 
process called aminolysis. 
Initially literature surrounding surface modification and its applications will be discussed as 
an introduction to the field.  This will include a brief summary of the modification of surfaces 
through various methods including how PCL can be modified, as this will be the polymer 
used in this research. 
The literature review will continue in looking at how surfaces are analysed.  These techniques 
are extremely varied and can be used to analyse a broad range of parameters.  The overview 
will cover several techniques with XPS being used specifically in this research (although the 
others could become applicable in future work). 
Following the section on surface analysis, aminolysis will be introduced not only from a 
surface point of view, but its use in organic chemistry.  The principles of aminolysis will be 
further discussed as this will be the main technique used in the following research. 
After the literature review, the aminolysis of PCL and PLA films will be shown, along with 
extensive XPS analysis.  This will lead into the biologically important molecules of 
ciprofloxacin and penicillin G being successfully attached to these substrates, using amide 
coupling chemistry. 
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9.2. Types of surface modification 
 
The area of research being undertaken in this section is centred on surface chemistry as a way 
of functionalising polyesters; therefore the examples of this chemistry and the ways in which 
they are analysed will be discussed.  These modifications are incorporated into materials to 
create a difference in properties between the bulk material and the surface.  These can range 
from simple roughness (to increase surface area)
 
to hydrophilicity and biocompatibility. 
 
 
Figure 14:  Polymer brush formation; (A) physisorption, (B) chemisorption and (C) surface initiated
65 
 
One of the most utilised and researched surface modification techniques is the use of polymer 
brushes.  Polymer brushes are chains of polymer that create an ultra-thin coating, with a chain 
end tethered directly to the surface of a substrate.
65
  There are two methods of attaching these 
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polymers to the surface, the grafting to and grafting from approaches.
66
  The former involves 
the attachment of pre-existing polymers through either physisorption or chemisorption (i.e. a 
covalent bond).  In the grafting from approach, the polymerisation is initiated from an 
initiator-functionalised surface allowing accurate manipulation of the resulting polymer.  To 
create a dense polymer brush the surface initiated approach is usually used,
67
 due to the steric 
hindrance found when trying to manipulate pre-existing polymers.
68
 
The previously mentioned technique is used predominantly in the functionalisation of silicon 
or metal based materials, by utilising the chemistry of silicon – oxygen bonds,69 or the 
reactivity of the metal involved (e.g. the reaction between gold and thiols) (Scheme 48).
70
 
 
Scheme 48:  Surface initiated polymerisation from a gold substrate 
 
The previous example of surface chemistry focused on the activation of metal based 
materials, and this is not so applicable to polymers.  For polymers, such as polyesters, surface 
activation is highly desireable in the field of tissue engineering.  Tissue engineering is a 
multidisciplinary field consisting of chemists and material scientists’ right through to cellular 
biology and genetic engineers.  A challenge that is faced by such teams is to find materials 
that are compatiblte within the body, do not cause or trigger an immune response, but that 
contain enough reactivity as to be further utilised for specific applications.   
A whole range of natural materials are already employed in tissue replacement such as 
collagen, laminnin and fibronectin because they exhibit exceptional biodegradability, 
biocompatibility and cell adhesion.
71
  The major drawback of such materials is that when 
placed in an environment where physical properties are required, they are very weak.  This is 
where synthetic polymers such as polyesters can be used to give better physical 
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characteristics.
72
  Another problem that presents itself when solely using polymers, is that 
they themselves are not favourable surfaces from which to propagate cells due to their 
hydrophobicity, whereas hydrophilic surfaces have been shown to be advantageous.
73
  
There are several techniques employed throughout the literature focusing on increasing the 
hydrophilicity of polyesters.  Although the previous polymer brush examples used existing 
surfaces that then reacted, in the case of polymers, their surface are relatively inert and need 
to be activated.  Once such method is the use of plasma to generate radical species on the 
surface, these are then reacted with air to produce peroxides from which to react from. 
 
Scheme 49:  Functionalisation of a PCL film using argon plasma 
 
This process used by Cheng et al.
74
 utilised argon plasma to generate surface radicals, which 
upon standing in air, generated peroxides (Scheme 49).  These peroxides were then grafted 
with acrylic acid using UV light to generate a hydrophobic layer of carboxylic acid 
functionality.  These acid moieties were then activated using a water soluble carbodiimide 
(WSC) and then treated with a collagen solution to create a biologically active surface.  The 
ability of the surface to increase the rate of proliferation was then tested using a human 
dermal fibroplast culture, with the biologically activated films showing a far greater level of 
proliferation compared to the pure unreacted film (Figure 15). 
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Figure 15:  Human dermal fibroplast cell proliferation on a pure PCL film (PCL) and on a collegen 
activated surface (PCL-Col), after 1, 4 and 8 weeks using confocal laser scanning miscroscopy 
 
Although successful in increasing cell proliferation, treatment using plasma has potential side 
effects.  Due to the radical nature of the plasma (i.e. argon radicals in the previous example) 
undesiered side reactions can occur due to the uncontrollable formation and reaction of 
radicals.  One such side reaction is the crosslinking of the treated material.  This is shown in 
work by Tajima et al.
75
 who utilised this crosslinking nature when using 
octafluorocyclobutane (C4F8) plasma.  By exploiting the crosslinking nature of plasma, they 
were able to form fluorocarbon films onto polyethylene substrates (Figure 16).  Although the 
crosslinking nature of plasma treatment has been exploited in this example, in the previous 
work by Chang et al. this crosslinking would be determental therefore for the purposes of this 
research plasma will not be used. 
94 
 
 
Figure 16: Flurocarbon films on polyethylene substrates when using (a) low-intensity plasma and (b) 
high-intensity plasma 
 
A far simpler approach is to use the swelling nature of a polymer to modify the surface.  In 
certain solvents polymers do not dissolve but rather swell as the molecules of solvent diffuse 
into the polymer structure.  This allows the development of pores from which to embed other 
molecules.  This method was first investigated by Desai and Hubbell who were using 
polyethylene terephthalate (PET) and embedding other polymers within the swollen surface 
to increase hydrophilicity and by extension, cell viability.
76
  They chose trifluoroacetic acid 
as the solvent as although it dissolves PET, when used at a more dilute level the swelling can 
be controlled.  This dilution was made using a solution of water soluble polymers (such as 
polyethylene glycol) in distilled water.  A range of these soluble polymers were embedded 
and then analysed using contact angle measurements.  Once surface chemistry has been 
utilised a variety of techniques can be used to determine the nature and characteristics of the 
newly created surface.  A sample of these techniques will now be discussed to give a brief 
overview of how surfaces can be analysed. 
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9.3. Surface analysis 
 
There are several ways in which scientists can monitor or analyse a surface.  These 
techniques are varied and if used together they can provide a detailed look towards what, if 
any, changes are occurring on a materials surface.  The main method utilised in this research 
is XPS however, several different techniques will be discussed to give a broader scope to how 
surfaces can be analysed, as they could potentially be used in furture work.      
An example previously alluded to in the swelling polymer modification type was the use of 
contact angles (Figure 17).  Although not used in this research, due to the hydrophobic 
nature of PCL and the increase of hydrophilicity when aminolysing the surface, this 
technique alongside XPS would indicate successful functionalisation of the polyester surface, 
therefore the principles will be discussed.   A contact angle is the angle between a solid 
surface and the tangent of a droplet.
 77
  It is used to determine the ‘wettability’ of a surface, 
i.e. how much the surface likes water (hydrophilicity).  Small contact angle means that the 
droplet has flattened and covered a greater area on the solid surface (i.e. it has a high affinity 
for the surface, hydrophilic), whereas a large contact angle shows a greater degree of 
repulsion from the surface indicating a more hydrophobic nature.  The limitation of contact 
angle measurements is that although they allow an indication that surface modification has 
taken place, it does not indicate the reason why, i.e. it cannot indicate what particular 
chemistry or characteristic of the surface has changed, only that it has.  
 
Figure 17:  Contact angle () diagram and Young's equation 
A key part of any surface reaction or chemistry is how much of the surface is available to 
react.  This is governed by the total surface area of the material and is generally called surface 
roughness.  Topography of the surface can be measured using two main techniques, scanning 
electron microscope (SEM) or atomic force microscopy (AFM).  The research following this 
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introduction could utilise surface imaging as a way of investigating the effect of aminolysis, 
and whether or not it affects surface roughness, therefore a brief overview of each technique 
will covered. 
A commonly employed technique used to analyse surface roughness is atomic force 
microscopy (AFM).  This method uses a cantilever and atomic precise tip to measure the 
profile of a surface.
78
  It does this in two ways.  The first is called the contact mode and 
measures the force required to move this tip across the surface.  When moving along a flat 
surface the force required is constant, however when there is a depression or a rise in 
topography, there is a change in force to reflect this.  The change of this together with the 
mapping of the stage creates a depth profile and therefore topography of the surface (Figure 
18).
79
 
 
Figure 18:  AFM images of an unmodified polyurethane film (a) and a polyurethane film treated with 5 
minutes of UV ozone (b) 
However if the sample’s surface is ‘soft’ or brittle it could be damaged using the previous 
mode of AFM.  This is because force applied while moving the tip across the surface could 
damage the sample.  An alternate approach is called the tapping mode.  This mode oscillated 
the tip and uses the frequency of the oscillation to guage the depth profile of the sample and 
thus the topography.  On a flat surface the oscillation frequency is constant, but upon 
reaching a peak or depression in the sample the frequency increases or decreases respectively 
mapping the surface.  This is because when the tip reaches a peak the distance of the 
oscillation becomes smaller and therefore the frequency rises (and vice versa for the 
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depression).  This reduces the stress on the surface and therefore there is no damage to the 
sample. 
The other method commonly employed to analyse surface roughness is scanning electron 
microscopy (SEM).  SEM relies on the emission of electrons when a surface is subjected to a 
focused beam of electrons.  The focused or high energy electrons used by this method collide 
with electrons within the energy shells of an atom and ejects one from the shell effectively 
replacing it.  The electron ejected from the atom (known as the secondary electron) has far 
lower energy and can be analysed using a detector.  The relative intensity of these secondary 
electrons is what creates the surface image.  The contrast of this image is determined from the 
location the secondary electron is emmited from.  The closer the location is to the detector the 
brighter the contract on of the produced image, and conversely the darker the image in a 
depression.  This creates a three dimensional representation of the surface’s topography and 
an indication of surface roughness.  A limitation of this technique is the sample itself.  The 
technique requires the sample to be conductive, which in the case of conducting metals is not 
an issue; however for non-conducting materials such as polymers sample preparation is 
required.  This is usually carried out by deposition a layer of gold, or a gold/palladium alloy, 
on the surface of a sample to generate the conductivity.
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Figure 19:  SEM images of a clean Ti Surface (left) and an HCl/HNO3 etched Ti surface (right).  Bar 
indicated 10M 
 
A very simple method of increase the surface area or roughness is to either physically or 
chemically etch a polished metal surface.  Boyan et al.
81
 used titanium discs for use in 
observing the effect of surface roughness on the cellurar response/propagation of cells.  They 
utilised a variety of methods to increase surface area.  The most simple of these methods was 
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to etch the surface using acid.  This was carried out using a hydrochloric/nitric acid mixture.  
A physical method they employed was to sandblast the surface using 0.25 – 0.50 M 
corundum grit at 5 bars of pressure.  Both techniques were also employed together to see if 
the effect could be cumulative. 
What is clear to see in Figure 19 is that the surface topography has clearly changed, and that 
the roughness has greatly increased.  This increase in surface area is also reflected in the 
responses of the tested cells.  MG63 osteoblast-like cells (those involved in agglomerating 
and depositing calcium in bone formation) were cultured on the clean and etched surfaces, 
and then treated with a hormone solution to gauge the response and therefore proliferation of 
the cultered cells.  There was a surface-roughness dependant increase in hormone activity 
where an increase in surface roughness gave a higher activity.  This shows the importance of 
surface topography when trying to utilise surfaces for biological applications.   
Although surface roughness has been shown to increase cell proliferation,
82
 come biomedical 
applications require a smooth surface, such as stents that are being forced along arteries, to 
avoid cellular damage.  In the work by Vaithilingam et al.
55
 surface roughness of a titanium 
surface was mechanically polished using a series of silicon carbide grits (200, 400, 600, 800 
and 1200 µm) followed by diamond paste of 6 and 1 µm.  This created a smoother surface 
from which to functionalise from (Figure 20).  
 
Figure 20:  SEM micrographs showing an untreated titanium surface (a and b, 50x and 500x 
magnification respectively), and the mechanically polished surface (c) 
 
The titianium surface was further functionalised through the use of a carboxylic acid 
terminated phosphonate.  Due to the structure of the phosphonate (amphiphilic) a self 
assembled monolayer (SAM) was formed generating carboxylic acid functionalised surface.  
Acid chloride chemistry was then utilised to generate the mixed anhydride with the 
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ciprofloxacin (Scheme 50).  This work shows that the route of surface functionalisation is a 
viable approach to polymer – drug conjugates.   
 
 
Scheme 50:  Functionalisation of a titanium surface with ciprofloxacin 
 
Another key feature of a surface is elemental composition.  A key technique in this field is X-
ray photoelectron spectroscopy (XPS) and will be used extensively in this research in looking 
for successful aminolysis of polymer surfaces but also for drug attachments.  This technique 
uses the unique binding energies of electrons within different elements to determine what 
elements are present on a surface.  An X-ray beam is directed at the sample and electrons 
from different orbital shells are ejected from the atoms of the surface.  The energy of these 
electrons are then measured at the detector and correspond to the exact binding energies of 
electrons found in the orbitals of specific atoms.  This means that when looking at the 
produced spectrum the composition can be deduced from the intergals of the peaks and their 
element identified from the specific binding energy (Figure 21).  This information can be 
especially useful when looking at polymers where the specific bonding modes of atoms can 
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be deduced (as the electrons in the bonds have different energies, for example the difference 
between the electrons in a carbonyl or C-C bond). 
 
 
Figure 21:  XPS spectra of the binding energies of the C1s electrons within different bonding 
environments of PLA 
 
Following on from surfaces and how their chemistries can be analysed is a brief look at how 
amines can alter the surface functionality for polymers, through a process known as 
aminolysis.  
9.4. Aminolysis 
 
Aminolysis is the chemical reaction in where a compound is reacted with an amine and is 
cleaved into two new species.  This process is commonly used in the production of amides 
from carboxylic acids or derivatives of.
83
  As the polymers being using in the following 
research are polyester based, aminolysis is an elegant way of introducing functionality and 
will therefore be discussed as this technique will be the heavily used in this project.  Such 
examples are show in the work by Lima et al.
84
 who use DBU as a catalyst during peptide 
synthesis, with the reaction being carried out neat to give an indication towards how 
preferable this method can be (Scheme 51). 
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Scheme 51:  Aminolysis of methyl benzoate with benzyl amine using DBU as a catalyst 
 
The use of amine to convert esters to amide has also been utilised in the field of polymers.  
The previous example using methyl benzoate was aminolysed using a mono functional 
amine, giving rise to the corresponding amide.  The other functionality found on the amine is 
a benzyl group but if there was another amine (to create a diamine) then there would be a free 
amine from which to react.  This style of aminolysis via the use of a diamine is common 
place in polyester surface modicfication. 
A commonly used polymer for this aminolysis reaction is PCL.  The reason that this is a 
target for aminolysis is because it has desireable biocompatibility and biodegradation, but it is 
very hydrophobic in nature.  The aim of the aminolysis reaction is to generate a more 
hydrophilic surface (through the introduction of polar amine groups) and increase the 
compatibility with proliferating cells. 
Although the choice of material is an important one, equally so is the choice of the diamine 
used in the aminolysis stage. Although any diamine would give the corresponding boost in 
hydrophilicity desired from the reaction, the size of the diamine plays an important role.  Zhu 
et al.
85
 found that a decrease in the chain length of the diamine (i.e. going from 1,8-
octanediamine to 1,2-ethanediamine) resulted in a higher density of amine groups.  The likely 
cause of this increase is due to the lack of steric hindrance found in the smaller chain 
diamines, giving rise to a greater depth penetration into the surface (Figure 22, left).  Another 
important note is that having far more amine density might seem like an advantage, however 
after a certain length of time the structural integrity of the material suffers as a function of 
aminolysis (Figure 22, right).  This is due to the very nature of the aminolysis reaction where 
you split a molecule in two using an amine, therefore what is effectively happening is for 
each successful reaction you are reducing the molecular weight of the polymer. 
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Figure 22:  The relative increase in amine density when altering the diamine (left) and the observed 
weight loss of a PCL film during extended aminolysis experiments (right) 
     
The most common diamine used in the aminolysis of PCL is 1,6-hexamethylenediamine 
(HMDA) .  This is shown in work from Gao et al.
86
 who employ HMDA in an isopropyl 
alcohol solution to aminolyse PCL films prepared by slow evaporation in a petri dish.  Once 
aminolysed their approach was the react the free amino group with glutaraldehyde (a di-
aldehyde) from which to immobilise their biomacromolecule.  They did this so that the free 
amine would form the imine and a free aldehyde.  This aldehyde can then further react with 
the free amine found on a biomacromolecules (Scheme 52). 
 
Scheme 52:  Use of HMDA and glutaraldehyde to attach macromolecules to a PCL surface 
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An alternate approach used by Mattanavee et al.
87
 was to use an activating group rather than 
adding another reactive moiety.  The activating agent used was N,N’-
disuccinimidylcarbonate (DSC) which when reacted onto the free amine, produces an 
activated carbonyl group giving rise to a more susceptible centre for nucleophilic attack from 
biomacromolecules (Scheme 55). 
 
Scheme 53: Use of DSC as an activating agent in the attachment of biomacromolecules to a PCL surface 
 
A novel twist on the aminolysis of PCL is used in work from Zhang et al.
88
 who manufacture 
a 3D scoffold of PCL from which to aminolyse and functionalise with RGD.  The structure 
was created using an inverse wax mold manufactured on a 3D printer.  This mold was placed 
in molten PCL at just below 80
o
C (just below the melting point of the wax but above the 
PCL), followed by allowing the construct to cool overnight.  The wax was removed using 
ethanol (which PCL is insoluble in).  The 3D scaffold of PCL was then treated with HMDA 
in IPA to aminolyse the surface.  This aminolysed surface was activated in a similar fashion 
as discussed in previous work, followed by a solution of the RGD peptide to bind it to the 
surface. 
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Figure 23:  3D PCL scaffold aminolysed using HMDA and stained using ninhydrin 
 
What is also important to consider is that although the previous examples have focused on 
PCL, other polyesters are also applicable.  Work by Zhu et al.
89
 utilise PLA instead of PCL in 
the synthesis of a polymer-drug conjugate.  PLA undergoes the same aminolysis pathway 
yielding a free amine from which to react further.  In this research both the newly formed 
amine and alcohol are reacted with -bromoisobutryl bromide (BIBB) to generate a terminal 
bromide.  This bromide is then used in a polymerisation mechanism called atom-transfer 
radical polymerisation (ATRP) together with methacrylic acid (MAAS).  The pendant 
carboxylic acids are then esterified using gelatin to form the polymer-drug conjugate 
(Scheme 54). 
 
Scheme 54: Aminoylsis of PLA and further synthesis to achieve a polymer-drug conjugate 
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Aminolysis has been shown to give rise to free amine groups when reacted with polyesters.  
However due to the variety of reactions that amines can undergo, other functionalities can be 
aminolysed in a similar fashion to polyesters.  Work by Horning et al.
90
 has utilised 
aminolysis to yield thiol bearing polymers through the cleavage of dithioesters used in 
reversible addition-fragmentation chain transfer (RAFT) polymerisation.  During the RAFT 
process the polymer is always capped with the thioester group, which in this research was 
reacted with an amine to afford the corresponding thio terminus polymer and the thioamide 
by-product (Figure 24). 
 
Figure 24: Aminolysis of a polymer utilising RAFT chemistry to yield thiol terminal polymers 
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9.5. Results and discussion 
 
The literature discussed in the aminolysis section previously, shows how a polyester surface 
can be aminolysed to yield pendant amine groups.  These groups can then subsequently be 
further functionalised to incorporate biologically active molecules.  This gives a clear 
indication that aminolysis can be utilised in the formation of polymer – drug conjugates.  The 
route in which these polymer – drug conjugates are synthesised also shows that they can be 
made fairly straight forward utilising well understood chemistry. 
With the literature proving that aminolysis is a viable method, focus is shifted towards work 
being carried out within the Christie group.  As previously mentioned in the introduction, 
ciprofloxacin was successfully attached to a titanium surface.  The aim of this research is to 
transfer that idea to a fully biodegradable system using a polyester.  What can be gained from 
this previous work is that there is sufficient sensitivity when using XPS to detect successful 
attachment (Figure 25).  The key to using ciprofloxacin is that it can be the only source of 
fluorine, giving rise to a distinctive signal in the XPS spectrum. 
 
Figure 25: XPS spectra showing the successfull attachment of ciprofloxacin to a titanium surface 
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 9.5.1. Research Plan 
 
The work by Gao et al.
86
 used HMDA to aminolyse a PCL film, followed by glutaraldehyde 
to further functionalise the aminolysed surface, whereas Mattanavee et al.
87
 also used HMDA 
for the aminolysis however chose to use DSC to activate the pendant amine.  Imide chemistry 
was used in the first work and an activating group for the latter, however both created an 
extra synthetic step towards attaching the biomacromolecule of choice. 
 
 
Scheme 55:  Proposed route to a polymer - drug conjugate through amide coupling chemistry 
 
In this research the knowledge of aminolysis using HMDA will be utilised however rather 
than either inserting extra functionality or activating the amine, amide coupling chemistry 
will be used.  This will allow the use of a well established field in the form of peptide 
synthesis along with shortening the steps needed to attach a drug molecule. 
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9.5.2. Aminolysis of a PCL film 
 
Firstly, the PCL was synthesised using the same method as previously used earlier in this 
thesis (Scheme 56).  This produced PCL in quantitative yields and was achieved on a 
multigram scale. 
 
Scheme 56: Polymerisation of CL to PCL 
 
The next stage in this research was to create a surface from which to aminolyse.  This was 
carried out by the manufacture of PCL films.  The films were produced by the slow 
evaporation of solvent from a polymer solution (typically 10 % polymer), which was poured 
into a petri dish.  These petri dishes were then heated to 37 
o
C overnight and the solvent 
slowly removed, to yield a uniform PCL film.  Common solvents that dissolve PCL are 
dichloromethane and THF however upon slow evaporation at 37 
o
C from a 10 % PCL 
solution, the produced films were broken and instead of a uniform film, large pieces of brittle 
PCL were collected.  A potential reason for this could be due to the volatility of these 
solvents.  Both dichloromethane and THF are highly volatile and the broken films would 
suggest that rather than allowing the PCL to distribute itself evenly across the petri dish, the 
solvent evaporated too quickly leading to aggregates of PCL and therefore no film.  Another 
potential cause of this could lie with water that has condensed due to the fast evaporation, 
leading to defects and holes.  This problem was overcome with the use of chloroform.  
Although still volatile in its own right, chloroform does not exhibit the evaporation speed 
shown by either dichloromethane or THF.  This allowed the even distribution of PCL not 
only through the solution, but more importantly it retained this during evaporation.  Due to 
the robustness of the polymerisation technique (ie, the fact it can be multi-gram) a large 
number of films could be produced in a single batch. 
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A key technique that was mentioned in the literature review (especially when concerning 
surfaces) is XPS, or X-ray photoelectron spectroscopy. Figure 26 shows the survey XPS 
spectrum of a pure PCL film.  A survey spectrum contains all the data over a wide range of 
binding energies.  This gives a general overview of what elements are present.  The large 
peak at 533 eV indicates the presence of oxygen and the peak at 285 eV is that of carbon.  
What the ‘1s’ donates is that the electron which has been detected comes from the 1s shell 
orbiting the atoms nucleus. 
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Figure 26:  XPS survey spectrum of pure PCL 
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The following figures show the respective high resolution scans of both the carbon and 
oxygen regions.  What these scans show is a data collected over a more narrow range of 
binding energies, but with far higher sensitivity, giving rise to a greater level of detail.  
 
Figure 27: High resolution XPS spectrum of the carbon region in pure PCL 
 
Environment C-C/H C-O C=O 
Atomic % 43.55 13.59 9.7 
Ratio 4 1 1 
Table 5: Atomic % and ratio for the carbon region of pure PCL 
 
The blue line is the raw data with the yellow lines correspond to those that are peak fitted.  
These peaks take into account that the shoulder present on a peak is there because it is infact 
two peaks overlapping.  The red line is the sum of the fitted curves which when compared to 
the blue, shows a good fit for the peak fitted data.  The peak fitting is carried out because of 
the broad peaks often observed when using XPS compared to those with other techniques, 
e.g. NMR, which have far better resolution.  As with NMR the binding energy (chemical shift 
in the NMR example) is affected by what the atom in question is bonding to.  This is because 
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the change in electronegivity between the atom and heteroatoms alters the binding energy of 
the electrons within the atom.  The high resolution spectrum of the C1s signal shows four 
distinct carbon environments.  Three of these are equal in area with the other being roughly 
three times as large.  This is because the larger peak (284.6 eV) represents the three aliphatic 
carbon atoms present in the PCL backbone.  The other peaks are shifted due to their 
proximity to oxygen.  The least effects by oxygens presence is the carbon alpha to the 
carbonyl (285.2 eV) followed by the carbon attached to the ester oxygen (286.2 eV).  The 
final peak belongs to that of the carbonyl (288.7 eV), all corresponding to literature values.
74
 
 
Figure 28: High resolution XPS spectrum of the oxygen region in pure PCL 
 
Environment O=C C-O 
Atomic % 14.59 9.38 
Ratio 1 1 
Table 6: Atomic % and ratio for the oxygen region of pure PCL 
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The above figure is the high resolution spectra showing the oxygen region.  As expected there 
are two peaks of equal area with one belonging to the carbonyl oxygen (531.9 eV) and the 
other to that of the ester (533.2 eV). 
 
 
Figure 29:  High resolution XPS spectrum of the nitrogen region in pure PCL 
 
Environment N1s 
Atomic % 0.54 
Table 7: Atomic % for the nitrogen region of pure PCL 
 
The figure above (Figure 29) shows the nitrogen 1s region in the same high resolution 
previously shown for carbon and oxygen.  The key point to note is that when compared to the 
previous high resolution spectra the counts are extremely low.  This would indicate that there 
is only trace nitrogen present in the pure PCL film, as the peak is for all intents and purposes 
in the baseline noise.  These trace levels could be attributed to could be the incorrect handling 
of the sample and therefore the potential presence of a fingerprint (protein signal). 
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Once the pure PCL films had been successfully cast into films and their surface chemistry 
analysed, aminolysis reactions were investigated to transform the polyester surface into a 
functionalised one capable of further manipulation.  The mechanism behind aminolysis is that 
a primary amine reacts with an ester linkage to form the corresponding amide bond and 
generate a free alcohol terminated chain.  The challenge that PCL films present is that 
solvents such as dichloromethane or THF cannot be used as the film would dissolve, and 
carrying out reactions at elevated temperatures would result in the film melting and losing its 
structural integrity (and therefore far more difficult to analyse surface chemistry) as the 
melting point of PCL is roughly 60 
o
C.  For this reason IPA was chosen with the reaction 
temperature not exceeding 37 
o
C.  Another consideration is that when you start to react the 
ester bonds of the PCL and begin creating smaller chains through the mechanism of 
aminolysis, you degrade the polymer’s physical properties.  This results in loss of the PCL 
film thickness and therefore reaction times need to be considered or else there will be no film 
left to analyse (or it will become too brittle to handle and effectively use it in subsequent 
stages and reactions). 
 
Scheme 57:  Aminolysis of a pure PCL film using HMDA in IPA at 37 
o
C for one h 
 
The final consideration to make is which diamine to use.  The smaller the alkyl chain 
between the primary amines, the greater the penetration depth and therefore the higher degree 
of aminolysis.
85
  The initial investigations were carried out using hexamethylene diamine 151 
(HMDA).  This was used at 10 % (w/w) in IPA, with the film being immersed for 1 h at 37 
o
C (Scheme 57).  The film was then washed using copious distilled water to both remove any 
alcohol solvent and more importantly any residual diamine.   
A quick method to see if any aminolysis has taken place is the use of a ninhydrin stain.  
Ninhydrin solutions are used in organic chemistry during TLC analysis as a way of staining 
amines.  The aim of a TLC stain is to provide a visual aid when determining a compound 
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purity (or for use in chromatography to aid in finding a compound among fractions of a 
column), with ninhydrin the characteristic colour is purple for primary amines and yellow for 
secondary amines.  The purple colour (known as Ruhemann’s purple) is the result of the 
primary amine acting as a linker between 2 ninhydrin molecules creating an extended 
chromophore and a distinctive purple colour (Scheme 58).
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Scheme 58:  Formation of Ruhemann's purple using ninhydrin 
 
The ninhydrin stain of the aminolysed PCL film was compared to that of a pure unreacted 
PCL film, and the results clearly show the presence of free amine groups.  The ninhydrin test 
first involves the bathing of a film in a 1M ninhydrin in ethanol solution before being 
dissolved in 1,4-dioxane and heated to drive the formation of the stained compound and 
therefore the purple colour.  As expected, a film that has not been aminolysed shows a clear 
solution compared to that of the aminolysed film which shows the purple colouration (Figure 
30). 
 
Figure 30:  Pure PCL film (left) and aminolysed PCL film (right) after ninhydrin treatment 
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Another quick analytical method to qualitatively identify if aminolysis occurred is attenuated 
total reflectance infra-red (ATR-IR).  In Figure 31 there is a strong carbonyl signal for the 
pure PCL film at 1720 cm
-1
 due to the ester bond, however there is no amide peak.  The 
ATR-IR of the aminolysed film, clearly showing the amide peaks present at 1637 cm
-1
 and 
1562 cm
-1
, together with the ester peak at 1720 cm
-1
(comparison also shown in Figure 32). 
 
Figure 31: ATR-IR spectrum of an aminolysed PCL film 
 
Figure 32:  ATR-IR comparison of a pure PCL film (blue) and an aminolysed film (red) in the carbonyl 
region 
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The aminolysed films were then analysed using XPS to further investigate whether 
aminolysis had occurred (to confirm what is observed in the FTIR). 
 
Figure 33:  High resolution XPS spectrum of the oxygen region in HMDA aminoylsed PCL in IPA for 1 h 
at 37 
o
C 
 
Environment O=C C-O 
Atomic % 14.0 9.34 
Ratio 1 1 
Table 8: Atomic % and ratio for the oxygen region in HMDA aminoylsed PCL in IPA for 1 h at 37 
o
C 
 
0.00E+00
1.00E+04
2.00E+04
3.00E+04
4.00E+04
5.00E+04
6.00E+04
7.00E+04
526527528529530531532533534535536537538539540541542543544545
C
o
u
n
ts
 /
 s
 
Binding Energy  (eV) 
118 
 
 
Figure 34:  High resolution XPS spectrum of the carbon region in HMDA aminolysed PCL in IPA for 1 h 
at 37 
o
C 
 
Environment C-C/H C-O C=O 
Atomic % 48.6 14.3 9.8 
Ratio 4 1 1 
Table 9: Atomic % and ratio for the oxygen region in HMDA aminoylsed PCL in IPA for 1 h at 37 
o
C 
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Figure 35:  High resolution XPS spectrum of the Nitrogen region in HMDA aminoylsed PCL in IPA for 1 
h at 37 
o
C 
 
Environment N-C=O NH2 
Atomic % 9.16 27.68 
Ratio 1 3 
Table 10: Atomic % and ratio for the nitrogen region in HMDA aminoylsed PCL in IPA for 1 h at 37 
o
C 
 
There is no real change when looking at the oxygen and carbon high resolution spectra 
however there is now a clear peak in the nitrogen region.  The high resolution spectrum 
clearly shows one peak far larger than the other.  In XPS the area of a peak is proportional to 
its content within the sample, indicating that in this scenario there is a difference in the 
abundance of one nitrogen environment with repect to another.  If the film had been 
successfully aminolysed then there would be a peak for the newly formed amide and also a 
peak for the free amine, at equal intensity.  The two peaks do correspond to the literature 
values (399.4 and 401.1 eV) however due to the difference in peak area, not all of the 
nitrogen can be associated to successful aminolysis.
85
  Contamination of the film was a 
possibility, i.e. incomplete washing of the film to remove the excess HMDA.  This was 
investigated using the ninhydrin test previously discussed.  The presence of the Ruhemann’s 
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purple gives a visual indicator of the presence of free amine (qualitative), utilising this colour 
with UV spectroscopy can quantify the amount of free amine.  The key wavelength to use is 
538 nm, with the film being prepared as previously discussed.  The absorbance obtained 
when aminolysing a PCL film using HMDA in IPA at a 10 % (w/w) concentration was 0.458 
Abs.  This method of anaylsis has been used in the literature with a calibration graph giving 
the amount of free amine using this result as being orders of magnitude higher than in the 
reported literature.  This can be interpreted as confirming the hypothesis that free HMDA has 
not been washed off, and that the colour obtained from the ninhydrin test cannot prove that 
aminolysis has actually taken place. 
 
Figure 36:  Angle resolved XPS 
The ‘aminolysed’ film was then placed in a beaker of water overnight (using a shaker to 
encourage cleaning), in an attempt to remove the excess HMDA.  In this case angle resolved 
XPS was utilised to investigate the penetration of the aminolysis.  Angle resolved XPS 
(ARXPS) uses the exact same principles of XPS but alters the angle of the stage on which the 
sample sits.  The penetration depth of the x-rays used in an experiment is <10 nm, by altering 
the angle of the sample stage, this penetration depth decrease.  This is because when the X-
ray is pointed direct at the stage (with 0
o
 from perpendicular), the depth profile is directly 
down into the sample.  This gives data from further within the sample to give bulk 
information.  When the angle is increased through to 80 
o
, the X-ray penetrates far less, 
giving data concentrating on the surface.  Comparison of these data sets allows the difference 
in bulk and surface elemental composition to be determined (shown in Figure 36 with the 
example of an oxide layer). 
 
121 
 
 
 
Figure 37: ARXPS spectrum showing the carbon, oxygen, nitrogen and silicon regions.  Angles used were 
0 
o
 (red), 30 
o
 (green) and 60 
o
 (blue) 
The key piece of information observed when using ARXPS is that as you increase the angle, 
the intensity of the signal drops.  This is, as previously mentioned, due to the loss in 
penetration.  The relative loss in intensity between different angles and different elements 
gives an indication of the composition of the bulk and surface.  As expected the intensity of 
the carbon and oxygen reduce as the angle increases (due to the material being made of PCL).  
What these spectra show is that the decrease in nitrogen is far more pronounced, shown not 
only by the increase in noise (showing a far more reduced abundance of nitrogen, and only 
partial aminolysis), but by the fact that at 60 
o
 there is almost none present.  This coupled 
with the fact that the silicon signal is still strong at this angle, indicates that the bulk contains 
more nitrogen and the surface contains more silicon (possible contamination from silicon in 
the lab like grease for joints).  This translates to there being a large surface contamination, 
meaning that only a small amount of aminolysis can take place below this layer.  This could 
also be the reason why the aqueous washing post aminolysis was less effective and why the 
prolonged water soak (overnight) removed the excess HMDA.     
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It was then decided to try a cleaning regime prior to aminolysis in an attempt to remove the 
contaminent layer.  Films were soaked in an ethanol:water (1:1) solution at 37 
o
C for 1 h and 
then dried using a flow of nitrogen.  After further looking at the aminolysis process, it was 
decided to run the reaction in water at pH = 11.5.  This is because this ensures that the 
diamine exists as the amine and can therefore react.  The theory being that if the pH was not 
adjusted, the amine would protonate using hydrogens from water (due to the water being acid 
at pH 7, relative to the amine).  This would in turn create an ammonium ion which would be 
unreactive towards the ester due to its lone pair not being available. 
 
Scheme 59:  Aminolysing conditions including the aqueous ethanol clean 
The newly cleaned films were submerged into a solution of HMDA (10 % in water adjusted 
to pH 11.5).  This was carried out immediately after the films were cleaned to avoid 
contamination between conditions.  The films were left as before for 1 h at 37 
o
C, before 
being washed with water and dried under a flow of nitrogen.  The films were analysed using 
XPS to give the nitrogen high resolution spectrum shown in Figure 38. 
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Figure 38:  High resolution spectrum of the nitrogen region of a PCL film, when using an aqueous 
ethanolic wash and aminolysing using HMDA 10 % in water adjusted to pH 11.5 
 
Environment N-C=O NH2 
Atomic % 1.67 1.34 
Ratio 1 1 
Table 11: Atomic % and ratio for the nitrogen region of a PCL film, when using an aqueous ethanolic 
wash and aminolysing using HMDA 10 % in water adjusted to pH 11.5 
   
What is clear to see is that the intensity of the peaks match giving rise to two different 
nitrogen environments in equal abundance, leading to the conclusion of all the nitrogen 
content coming from a successful aminolysis reaction. 
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Figure 39:  High resolution XPS of the oxygen region of a PCL film when using an aqueous ethanolic 
wash and aminolysing using HMDA 10 % in water adjusted to pH 11.5 
 
Environment O=C C-O O-H 
Atomic % 10.97 9.25 1.59 
Ratio 1 1 0.16 
Table 12: Atomic % and ratio for the oxygen region of a PCL film, when using an aqueous ethanolic wash 
and aminolysing using HMDA 10 % in water adjusted to pH 11.5 
 
The nitrogen region gives a clear indication of aminolysis as the only source of nitrogen can 
come from successful aminolysis.  Another indicator is the oxygen region and the presence of 
a third peak.  For every successfully aminolysed ester bond you generate the corresponding 
amide and free amine, but also the free alcohol generated from the ester cleavage.  This peak 
is clearly visible in the spectrum shown in Figure 39, whereas the peak is absent when 
looking at the pure PCL film. 
With a successful aminolysis regime in place a different aminolysing reagent was used.  
Another readily available diamine is ethylene diamine (EDA).  This diamine was chosen as 
the shorter alkyl chain length grants greater penetration depth and theoretically a larger 
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degree of aminolysis.  The conditions used for aminolysis are identical to those of the HMDA 
aminolysed films (including the cleaning of the films).  XPS data shows that aminolysis has 
successfully occurred (although the difference in peak intensity would indicate some residual 
EDA, potentially due to the increase in penetration depth and therefore the more difficult to 
wash). 
 
Figure 40:  High resolution XPS of the nitrogen region of a PCL film when using an aqueous ethanolic 
wash and aminolysing using EDA 10 % in water adjusted to pH 11.5 
 
Environment N-C=O NH2 
Atomic % 2.5 3 
Ratio 1 1.2 
Table 13: Atomic % and ratio for the nitrogen region of a PCL film, when using an aqueous ethanolic 
wash and aminolysing using EDA 10 % in water adjusted to pH 11.5 
 
Another indicator of successful aminolysis when using the oxygen region was also noticed 
with the appearance of the hydroxyl peak (Figure 41). 
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Figure 41: High resolution XPS of the oxygen region of a PCL film when using an aqueous ethanolic wash 
and aminolysing using EDA 10 % in water adjusted to pH 11.5 
 
Environment O=C C-O O-H 
Atomic % 12 8.6 3.4 
Ratio 1 1 0.33 
Table 14: Atomic % and ratio for the oxygen region of a PCL film, when using an aqueous ethanolic wash 
and aminolysing using EDA 10 % in water adjusted to pH 11.5 
 
The theory that EDA can penetrate the films deeper than HMDA and therefore increase the 
degree of aminolysis, is shown in Figure 42.  In both comparisons there is a clear increase in 
the degree of aminolysis.  The intensity difference between the green (HMDA) and blue 
(EDA) lines shows that more aminolysis has taken place when using EDA.  The unfortunate 
side effect of this increase in aminolysis, is that films lose too much of their physical 
properties and become too brittle to work with, often crumbling under the force of a nitrogen 
flow while driving.  With this in mind, it was decided to utilise the HMDA aminolysing 
conditions to further manipulate the PCL films in drug attachment reactions. 
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Figure 42:  Comparsison of the nitrogen (top) and oxygen (bottom) regions.  Pure PCL (red), HMDA 
aminolysed (green) and EDA aminolysed (blue) 
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Environment N-C=O NH2 O-H 
Pure PCL 0.27 0.27 - 
HMDA aminolysed 1.67 1.34 1.59 
EDA aminolysed 2.5 3 3.4 
Table 15: Comparsison of the atomic % of nitrogen and oxygen species of PCL films used in various 
aminolysis conditions 
 
Following the successful aminolysis of the PCL surface using both a short (C2) and longer 
(C6) chain diamine, other aminolysing regeants were investigated.  Two new reagents 
ethanolamine and butylamine were chosen.  The reasoning behind using ethanolamine was to 
synthesise the aminolysed product and generate an alcohol tether from which to functionalise 
from (in contrast from an amine tether).  The hexylamine was chosen as it would only 
generate an alkyl chain length.  This was important as it was unknown how the ethanolamine 
would react during the ninhydrin stain, and therefore the hexylamine was used to see if a 
hydroxyl group could be differentiated using the test.  PCL films were used as before, 
including the same cleaning regime, and treated with a 10 % solution of each respective 
aminolysis reagent at 37 
o
C for one h.  The ninhydrin test provided evidence of aminolysis 
for both the new reagents, which could lead to ethanolamine being utilised in a similar 
fashion to the amine tether (ester formation over amide linkages). 
 
 
Figure 43: ninhydrin stains when using different aminolysis reagents.  Left: butylamine, middle: 
hexamethylene diamine, right: ethanolamine 
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9.5.3. Ciprofloxacin attachment to a PCL film 
 
The biologically important molecule chosen to attach to the PCL film was ciprofloxacin.  The 
key reason for this choice is because of the presence of an element that is not carbon, oxygen 
or nitrogen.  Ciprofloxacin has a fluoride atom attached to a benzene ring which can be used 
as an indicator of the drug’s presence on the film using XPS analysis. 
 
Figure 44:  Ciprofloxacin 
 
Another feature of ciprofloxacin is that there is a carboxylic acid moiety meaning that amide 
coupling chemistry can be used to attach to the free amine on the aminolysed surface.  One 
such coupling agent is 1-propanephosphonic anhydride (T3P
®
) which is used in conjunction 
with N,N-diisopropylethylamine (Hünig’s base or DIPEA) (Figure 45). 
 
Figure 45: T3P
®
 and Hünigs base 
 
Both the coupling agent and the base are commercially available with T3P
®
 being available 
in a solution of either ethyl acetate or acetonitrile.  Ethyl acetate was chosen purely based on 
availability within the lab, as both solvents have similar properties with respect to PCL 
solubility
92
.  Literature methods use ~3 mg/mL solutions when trying to attach molecules to 
aminolysed films, therefore this amount was utilised in drug attachment reactions.
86
  The first 
attachment was trialled using ciprofloxacin, T3P
®
 and Hünig’s base in ethyl acetate at room 
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temperature under an inert atmosphere of N2.  As previously mentioned the amount of 
ciprofloxacin used was 3 mg/mL in ethy acetate, with 1.1 equivalents coupling agent and 2 
equivalents of base (calculated using 5 mL of ciprofloxacin solution, enough to completely 
submerge the PCL film in a 25 mL flask).  
 
Scheme 60:  Ciprofloxacin attachment using T3P
® 
Films were washed with ethanol (to remove any ethyl acetate), then with copious water (to 
remove any ethanol) before being washed in fresh water overnight (to diffuse out any residual 
solvents or reagents).  After being dried using a flow of N2 the films were analysed using 
XPS.  Specifically looking at the fluorine region (679 – 699 eV), no peak was observed. 
 
Figure 46:  High resolution XPS showing the fluorine region of a ciprofloxacin attached film when using 
T3P
® 
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It is clear from the high resolution XPS spectrum that the attachment was not successful 
(Figure 46).  The attachement was then carried out using cirpoflaxacin hydrochloride 
(CIP.HCl).  The reason behind this switch was the presence of the secondary amine on the 
ciprofloxacin molecule.  Although the primary amine of the surface should be more reactive, 
the aminolysed film is added to the reaction last.  This is because in the mechanism of 
couling when using T3P
®
 requires the carboxylic acid, coupling agent and base to be stirred 
prior to the introduction of the amine.  This could lead to the coupling of ciprofloxacin with 
itself, which would be prevented if the secondary amine was present as the hydrochloride 
salt.  The attachment reaction was repeated using the hydrochloride salt however no peak was 
observed in the XPS fluorine region.  Regardless of how successful using T3P
® 
was, a new 
approach was required as it was noticed that the structural integrity of the films was being 
comproimised through the use of ethyl acetate.  The films were extremely brittle and this 
made extracting them from reaction flasks a tedious and destructive process, damaging and 
sometimes destroying potential samples for analysis.   
A different approach was to use water as the solvent to increase the solubility of the 
ciprofloxacin hydrichloride.  This would mean changing the coupling agent as T3P
®
 
hydrolyses in aqueous conditions.  A common motif found in some coupling agents is the 
carbodiimide, with such a reagent being 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC).  EDC is used in combination with an activating reagent called hydroxybenzotriazole 
(HOBt), and is available as the hydrochloride (EDC.HCl) for use in aqueous media.   
 
 
Figure 47:  EDC and HOBt 
 
The next iteration of the attachment reaction was the use of CIP.HCl, EDC.HCl, HOBt in 
water at 37 
o
C overnight.  The films were analysed using XPS to show the spectrum shown in 
Figure 48.   
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Figure 48:  High resolution XPS showing the fluorine region of a ciprofloxacin attached film when using 
CIP.HCl, EDC.HCl and HOBt in water at 37 
o
C overnight 
 
Environment F1s 
Atomic % 0.95 
Table 16: Atomic % and ratio for the fluorine species of a ciprofloxacin attached film when using 
CIP.HCl, EDC.HCl and HOBt in water at 37 
o
C overnight 
 
The high resolution XPS spectrum clearly shows the presence of fluorine and therefore 
successful attachment of ciprofloxacin to the aminolysed surface (Figure 48).  The next stage 
of investigation was to test that the coupling agents are the reason for this result; therefore 
conditions without these reagents were conducted.  The conditions used to compare the 
coupling result were using water at 37 
o
C overnight and the same but at rt. 
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Figure 49:  Comparison of the ciprofloxacin attachment conditions; water at rt overnight (red), water at 
37 
o
C overnight (green) and using EDC.HCl, HOBt at 37 
o
C overnight (blue) 
 
Environment F1s 
Room temperature 0 
37
o
C 0.2 
37
o
C, EDC.HCl and HOBt 0.95 
Table 17: Comparsison of the atomic % of fluorine species of PCL films used in various ciprofloxacin 
attachment conditions (all overnight) 
 
The comparison shows that there is certainly a need to have the attachment at 37 
o
C as no 
coupling has taken place at room temperature (Figure 49).  Although some attachment has 
occurred without coupling agents at 37 
o
C, it is clear to see that the use of those agents (EDC 
and HOBt) has a pronounced effect with the observation of a far stronger fluorine signal 
observed in the XPS spectrum.  To demonstrate that previous synthetic steps had not 
contributed to the fluorine, and furthermore proving that the signal could have only come 
from successful attachment of ciprofloxacin, a direct comparison at each synthetic stage was 
conducted. 
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Figure 50:  Comparison of the fluorine high resolution XPS region of each synthetic stage in the 
attachment of ciprofloxacin; pure cleaned PCL film (green), aminolysed film (blue) and the attached film 
using EDC.HCl and HOBt (red) 
 
Environment F1s 
Pure PCL 0 
Aminolysed PCL 0 
37
o
C, EDC.HCl and HOBt 0.95 
Table 18: Comparsison of the atomic % of fluorine species of a pure PCL, an aminolysed film and a 
ciprofloxacin attached film 
 
What the comparison shows is that there is no contamination of fluorine leading upto the 
coupling reaction, giving greater confidence that the signal is from successful coupling 
(Figure 50). 
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9.5.4. Penicillin G attachment to a PCL film 
 
Following the successful attachment of ciprofloxacin, another biologically active compound 
was chosen to test the robustness of the newly developed coupling method.  Penicillin G was 
chosen as it has the same structural motif required for coupling (a carboxylic acid) and also 
an element not present in any other step, sulfur. 
 
Figure 51:  Penicillin G 
The exact same methods used to cast, clean and aminolyse (HMDA 10 % in water at pH 
11.5) the PCL films were employed.  Previously the hydrochloride salt was utilised in an 
attempt to aid water solubility, however when using penicillin G the sodium salt was 
commericially available and was therefore used.  
 
Scheme 61:  Attachment of penicillin G to an aminolysed PCL film, using EDC.HCl, HOBt in water at 37 
o
C overnight 
 
The produced films were as before washed with copius distilled water to ensure that all of the 
reagents were removed, before being analysed in the same way in which the ciprofloxacin 
films were.  The high resolution XPS spectrum of the sulfur region clearly shows attachment 
of the penicillin G. 
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Figure 52: High resolution XPS showing the sulfur region of a penicillin G attached film when using PEN 
Na salt, EDC.HCl and HOBt in water at 37 
o
C overnight 
 
Environment S2p 
Atomic % 0.3 
Table 19: Atomic % and ratio for the sulfur region of a ciprofloxacin attached film when using CIP.HCl, 
EDC.HCl and HOBt in water at 37 
o
C overnight 
 
The high resolution XPS spectrum of the sulfur region clearly shows the presence of sulfur 
and of the successful attachment of penicillin G (Figure 52).  Following on from this positive 
result, the same validation analysis as previously conducted for the ciprofloaxacin attachment 
was undertaken.  These were as before to compare the attachment conditions and to make 
sure that the source of sulfur was from successful attachment and not carried through to from 
previous steps. 
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Figure 53:  Comparison of the sulfur high resolution XPS region of each synthetic stage in the attachment 
of penicillin G; pure cleaned PCL film (green), aminolysed film (blue) and the attached film using 
EDC.HCl and HOBt (red) 
 
Environment S2p 
Pure PCL 0 
Aminolysed PCL 0 
37
o
C, EDC.HCl and HOBt 0.3 
Table 20: Comparsison of the atomic % of sulfur species of a pure PCL, an aminolysed film and a 
ciprofloxacin attached film 
 
The XPS spectrum shows that there was no contamination carried through from casting the 
films and then aminolysing them, indicating that the source of sulfur is the successful 
coupling of penicillin G (Figure 53).  The spectrum below (Figure 54) again shows the 
requirement for the presence of EDC.HCl and HOBt during the coupling reaction.      
500
600
700
800
900
1000
1100
1200
1300
157159161163165167169171173175
C
o
u
n
ts
 /
 s
 
Binding energy / eV 
138 
 
 
Figure 54:  Comparison of the penicillin G attachment conditions; water at room temperature overnight 
(red), water at 37 
o
C overnight (blue) and using EDC.HCl, HOBt at 37 
o
C overnight (green) 
 
Environment S2p 
Room temperature 0 
37
o
C 0.0 
37
o
C, EDC.HCl and HOBt 0.3 
Table 21: Comparsison of the atomic % of sulfur species of PCL films used in various penicillin G 
attachment conditions (all overnight) 
 
9.5.5. Aminolysis of a PLA film 
 
After successfully attaching two biologically active molecules to a PCL surface, a change of 
substrate was inestigated.  Another common and readily available polyester is PLA.  The key 
difference between the two polymers is the increase in steric hinderance around the ester 
linkages, with PLA having a methyl group alpha to carbonyl compared to the linear PCL 
backbone.  This tertiary centre and small repeat unit means that the PLA polymer backbone is 
more tightly packed and could prove to be a more challenging substrate to aminolyse. 
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Figure 55:  Polylactic acid (PLA) 
 
A readily available source of PLA is plastic cups so a sample was analysed using NMR to see 
how pure and therefore suitable this was for use in further research.  The 
1
H NMR showed a 
clear doublet and quartet corresponding to the CH3 and CH respectively with no noticeable 
impurities; therefore films were cast using this material. 
A solution of 10 % PLA in chloroform was used to cast films by pouring into a petri dish and 
evaporating slowly overnight at 37
o
C to yield a uniform film.  These films were treated 
before aminolysis using the same 1:1 aqueous ethanol solution as used for the PCL films (3 
7
o
C for 1 h).  Once the films had been dried using a nitrogen flow they were analysed using 
XPS. 
 
Figure 56: High resolution XPS spectrum of PLA showing the carbon region 
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Environment C-C/H C-O C=O 
Atomic % 31.7 16.5 16.4 
Ratio 2 1 1 
Table 22: Atomic % and ratio for the carbon region of pure PLA 
 
Figure 57:  High resolution XPS spectrum of PLA showing the oxygen regions 
 
Environment O=C O-C 
Atomic % 19.9 15.5 
Ratio 1 1 
Table 23: Atomic % and ratio for the oxygen region of pure PLA 
 
The spectrum of the carbon region shows three clear peaks corresponding to the methyl, CH 
and carbonyl (285, 287 and 289 eV respectively), and the spectrum of the oxygen region 
gives rise to two peaks corresponding to the carbonyl and ester (532 and 533 eV 
respectively). 
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Figure 58: High resolution spectrum of the nitrogen region of a PLA film, when using an aqueous 
ethanolic wash and aminolysing using HMDA 10 % in water adjusted to pH 11.5 
 
Environment N-C=O NH2 
Atomic % 0.9 1.16 
Ratio 1 1.3 
Table 24: Atomic % and ratio for the nitrogen region of a PCL film, when using an aqueous ethanolic 
wash and aminolysing using HMDA 10 % in water adjusted to pH 11.5 
 
The cleaned PLA film was then subjected to the same aminolysis conditions as before 
(HMDA 10 % in water adjusted to pH 11.5 at 37 
o
C for 1 h), and analysed using XPS to give 
the spectrum shown in Figure 58.  The two peaks show successful aminolysis of the 
polyester. 
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9.5.6. Ciprofloxacin attachment to a PLA film 
 
 
Scheme 62:  Attachment of ciprofloxacin (HCl) to an aminolysed PLA film using EDC.HCl and HOBt in 
water at 37 
o
C overnight 
 
Following the aminolysis of the film, investigation into coupling reactions was conducted.  
The success of using the EDC.HCl and HOBt combination was used in conjunction with 
ciprofloxacin hydrochloride to see if a coupling would occur when using PLA. 
 
Figure 59:  High resolution XPS showing the fluorine region of a ciprofloxacin attached film when using 
CIP.HCl, EDC.HCl and HOBt in water at 37 
o
C overnight 
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Environment F1s 
Atomic % 1.32 
Table 25: Atomic % and ratio for the fluorine species of a ciprofloxacin attached film when using 
CIP.HCl, EDC.HCl and HOBt in water at 37 
o
C overnight 
 
The XPS spectrum in Figure 59 shows a clear fluorine signal, indicating successful coupling 
of the ciprofloxacin to the PLA surface.  The same validation analysis to prove that the 
fluorine signal was from successful attachment, were carried out.    The first spectrum shows 
that there was no comtamination of fluorine during the casting or aminolysis stage (Figure 
60).  The second specrum shows the difference in conditions when attaching the 
ciprofloxacin.  The comparison again clearly shows the need for the coupling reagents, with 
only a small amount of coupling being observed at the higher temperature (37 
o
C) and none 
when conducting the coupling at room temperature (Figure 61).  
 
Figure 60:  Comparison of the fluorine high resolution XPS region of each synthetic stage in the 
attachment of ciprofloxacin; pure cleaned PLA film (green), aminolysed film (blue) and the attached film 
using EDC.HCl and HOBt (red) 
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Environment F1s 
Pure PCL 0 
Aminolysed PCL 0 
37
o
C, EDC.HCl and HOBt 1.32 
Table 26: Comparsison of the atomic % of fluorine species of a pure PLA, an aminolysed film and a 
ciprofloxacin attached film 
 
Figure 61:  Comparison of the ciprofloxacin attachment conditions; water at room temperature overnight 
(blue), water at 37 
o
C overnight (green) and using EDC.HCl, HOBt at 37 
o
C overnight (red) 
 
Environment F1s 
Room temperature 0 
37
o
C 0.35 
37
o
C, EDC.HCl and HOBt 1.32 
Table 27: Comparsison of the atomic % of fluorine species of PLA films used in various ciprofloxacin 
attachment conditions (all overnight) 
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9.5.7. Penicillin G attachment to a PLA film 
 
The next stage was to investigate whether or not penicillin G could be attached to the 
aminolysed PLA surface.  The same set of conditons as the PCL films were used, however no 
substantial coupling was noticed.  The previous conditions that have given the best 
attachment results, ie the EDC.HCl and HOBt at 37 
o
C overnight, did show the most promise 
however the signal for the S1s peak was still very close to the background level (when 
compared to all previous attachments), therefore it was not conclusive if the attachment was 
successful (Figure 62). 
 
Figure 62: High resolution XPS showing the sulfur region of an aminolysed PLA film when using 
penicillin G, EDC.HCl and HOBt in water at 37 
o
C overnight (red) and pure PLA (blue) 
 
Environment S2p 
Pure PLA 0 
37
o
C, EDC.HCl and HOBt 0.2 
Table 28: Comparsison of the atomic % of fluorine species of a pure PLA, an aminolysed film and a 
ciprofloxacin attached film 
  
600
700
800
900
1000
1100
1200
1300
1400
157158159160161162163164165166167168169170171172173174175
C
o
u
n
ts
 /
 s
 
Binding energy / eV 
146 
 
To conclude, PCL and PLA films were successfully cast and aminolysed using HMDA.  
Ciprofloxacin was successfully attached utilising amide coupling chemistry in the form of 
HOBt and EDC.  Penicillin G was also attached to PCL using the same conditions previously 
mentioned, however translating this to PLA proved ineffective.  All reactions were analysed 
using XPS showing effective aminolysis and attachment products.  The research will now 
move away from polymer – drug conjugates however still remain with the idea of functional 
polyesters, utilising it in the field of 3D printing. 
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9.6. Experimental 
 
General 
Commercially available reagents and solvents were used throughout without further 
purification, unless otherwise stated.  ATRIR spectra were recorded using a Perkin Elmer 
FTIR Spectrometer (Paragon 100).  XPS was carried out on a Thermo Fisher K-Alpha using 
an aluminium monochromatic X-ray source with survey scans at 200 eV and high resolution 
scans at 50eV pass energies.  GPC was carried out on a Phenogel 10u column using 
polystyrene standards.  Samples were run at 0.2 wt% in THF with diphenylether as a flowrate 
marker. 
 
Film synthesis 
Firstly PCL was synthesised as previously described in this thesis.  A flame dried round 
bottom flask under nitrogen was charged with -caprolactone 5 (5 mL, 45.1 mmol) and tin 
octanoate (53, 0.3 M in toluene, 1.5 mL, 0.45 mmol, 1 mol%).  Reaction mixture was heated 
to 130 
o
C for 17 h.  The reaction mixture was dissolved in CH2Cl2 (20 mL) while warm, and 
precipitated in cold methanol (250 mL).  White solid was collected via filtration (5.03 g, 100 
%, Mw = 21380 g/mol by GPC).   
PCL (1 g,) was dissolved in chloroform (9 mL, 10 % solution) and poured into a glass petri 
dish.  The petri dish was placed into a vacuum oven at 37 
o
C overnight (not under vacuum).  
Once the solvent had evaporated the films were cut into 2 x 2 cm squares from which to 
further functionalise. 
PLA films were synthesised using PLA plastic cups (Mw = 398500 g/mol by GPC) and were 
created using the sample procedure replacing for PCL at the same weights, times and 
temperatures. 
 
Aminolysis of films 
Both PCL and PLA films were aminolysed using the same conditions.  Briefly, PCL films 
were first washed in an aqueous ethanol solution (1:1) for 1 h and dried using a N2 flow.  The 
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washed films were immediately placed into a solution of hexamethylene diamine in distilled 
water (10 %) adjusted to pH = 11.5 at 37 
o
C.  No agitation was used and the PCL films were 
incubated for 1 h, washed with copius distilled water and dried under a N2 flow. 
 
CIP/PEN attachment 
Freshly aminolysed films were submerged into distilled water at 37
o
C containing EDC.HCl 
(5 mg/mL), HOBt (5 mg/mL) and ciprofloxacin hydrochloride (5 mg/mL) overnight.  Films 
were then washed with copious distilled water before being dried under an N2 flow. 
PCL and PLA films were treated using the same procedure, times and temperature with 
penicillin G sodium salt replacing ciprofloxacin hydrochloride where applicable. 
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10. UV curing semi-biodegrable ink for 
3D printing technology 
 
10.1. Introduction 
 
This section of the thesis utilises functional polyesters but applied it in the field of 3D 
printing.  This will be again using PCL synthesised with UV cureable terminus, allowing 
crosslinking from a liquid to a solid.  When combined with 3D printing technology this will 
provide a material that can be printed into a variety of constructs while maintaining a degree 
of degradability.  
As 3D printing will be the final use for the produced material in this research, a brief 
overview of printing techniques will be discussed.  Although this will include a wide range of 
techniques, those involving UV light will be of key importance, as these are techniques which 
may be applicable for the following research. 
The compounds produced in this research will utilise radical chemistry to generate a 
crosslinked material.  Therefore the field of radical chemistry will be discussed focusing on 
how radicals can be generated using UV light and polymerisations that also utilise radicals.  
Polymerisation techniques will be discussed as although synthesising a polymer is not of 
importance in this research, the UV curing terminus attached to the PCL in this work can 
undergo polymerisation in a variety of ways.  These are the polymerisation techniques that 
will be discussed. 
Following the literature review will be the research into synthesising UV cureable polyesters.  
This will be achieved through acid chloride attachment to PCL diol and subsequent UV 
curing using suitable photoinitiators.  Ratios of these initiators and their type will be varied to 
find the optimal system for use in inkjet printing.  3D printed constructs made using material 
from this project will also be shown, demonstrating their viability in this field. 
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10.2. Additive manufacturing 
 
Additive manufacturing (AM) will be utilised as a way of testing materials made in this 
research therefore an overview of this technique and its varients will be discussed.  AM is a 
method in industry which builds complex models using a layer-by-layer approach and is 
otherwise known as rapid prototyping or 3D printing.
93
  This method of manufacturing 
operates on the principle of adding material to a build, rather than the conventional route of 
the removal of material from a bulk mass.  The term 3D printing, refers specifically to the 
jetting type of manufacturing, but is used interchangeably with other techniques in the field.  
This technique was first employed in the 1980’s and has grown in its ability to create 
extremely complicated designs.
94
  These designs are initially made using computer aided 
design (CAD) where prototype is visualised through a software program until a finished 
design is reached.  The CAD design is then subjected to slicing program which analyses the 
model and dissects it into a series of cross-sections.  This dissected model is then turned into 
the prototype by ‘printing’ each layer in sequence. 95 
 
10.2.1. Types of additive manufacturing 
 
Although all the methods discussed in this section are involved with the addition of material 
in a layer by layer fashion, each carries this out in a unique manner.  The first and most 
accessible technology is fused deposition modelling (FDM) which uses a filament that is 
extruded via a nozzle to generate designs.  Although not used in this research, it could be 
utilised in the previous section (aminolysed films), as both PCL and PLA are possible 
feedstocks for this process allowing parts made to be potentially aminolysed.  A typical 
schematic of the instrumentation used in FDM is shown below (Figure 63).  The nozzle is 
heated to extrude the filament which is guided using three axis build tray according to a 
predesigned path generated from a CAD file.  Upon reaching the build the melted material 
solidifies generating the desired design.
96
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Figure 63: Schematic of a FDM printer 
 
A recent development is that the diameters of filaments have greatly reduced, increasing the 
resolution of the technique.  Filaments with diameters in the range of 250 – 700 nm have 
been successfully produced using a process called electrospinning Electrospinnig is a process 
of utilising an electric force to draw out polymer strands from a solution.  In the work shown 
by Croisier et al.
97
 PCL was dissolved in a 1:1 THF:DFM solution at 15 wt% and extruded 
from a syringe at 1 mL h
-1
 onto an aluminium plate.  When the plate is charged (in this case 
at 12 kV) charged material is drawn out of solution onto the plate forming fibres of a few 
hundred nanometers (Figure 64). 
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Figure 64: SEM images of PCL electrospun fibers with bars indicating (a) 10 µM and (b) 1 µM 
   
The reason for FDM’s popularity is that it is a very inexpensive process but has the limitation 
of having a limited choice of feedstock (a thermoplastic with a processable viscosity when 
melted); however another highly developed technique is stereolithography (SLA).  This 
method utilises a bath of photocureable resin as its feedstock and then polymerises it using 
one of two methods.  As the feedstock for this technique is a UV cureable resin, although not 
used in this research it could be viable in the future.  The first method employs the use of a 
focused UV laser which cures the resin into a solid form through photoinitaited 
polymerisation.  The UV laser traces the CAD generated design layer by layer, lowering the 
photcureable resin after each successeful layer, building on the previously cured material 
generating a three dimensional structure.
98
  The second method is a more modern take on the 
technology commonly employing a projected image rather than a UV laser.  A CAD design is 
split into several layers and each layer is ordered using a program than displays images in a 
sequential fashion (such as PowerPoint).  These slides are then sequentially projected into the 
same photocureable resin.  After every slide the stage is lowered allowing the image to be 
built up in layers (Figure 65).
99
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Figure 65:  (left) typical setup for a stereolithography utilising the 'Powerpoint approach' and (right) a 
produced part using SLA 
 
Another rapid prototype method which uses a photocuring resin is injet printing.  This will be 
the technique used to test the viability of the material produced in this research.  A polymeric 
resin is ejected from a print head, moving in the X and Y axis, onto a support material, or 
build tray, acting as the platform for the build.  Between layers the photo-polymer is cured 
using UV light to form a solid construct from which to build the next layer from.  Once a 
layer is complete and fully cured, the build tray is lowered in the Z direction to allow the 
prototype to be constructed in three-dimensions (Figure 66).
100
  
 
Figure 66: Diagram of a typical jetting machine 
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A key example of how 3D printing is being used in real world biomedical application comes 
from work by Probst et al.
101
 who utilise a PCL filament in FDM.  Firstly a 3D scaffold was 
designed using a CT scan from a patient.  This was then printed using an FDM machine using 
a PCL-calcium phosphate filament, before being implanted onto a calvarial deftect.  The 
implant stimulates the growth of bone along the scaffold before consolidation of the defect is 
observed six months from implantation (Figure 67). 
 
Figure 67:  A calvarial defect treated using a 3D printed scaffold. (A) 3D printed scaffold using FDM (B) 
Calvarial defect (C) implantation of the scaffold (D) Consolidation of the defect 6 months after 
implantation 
 
The methods of stereolithography and inket printing are dependand on the UV curing nature 
of the resins used.  The following section will discussing the UV curing process involving 
radical chemistry, radical generation and processes which utilise these properties.  
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10.3. Radical polymerisation  
 
10.3.1. Characteristics of radical polymerisation 
 
Radical chemistry is extensively used in the polymerisation industry for a variety of 
polymers.  For example, all commercial poly(methyl methacrylate) is produced using radical 
polymerisation.  All radical polymerisations are governed by the same 3 steps; initiation, 
propagation and termination.  Initiation is the step involved with the formation of the radical.  
The two most common types of initiators are those that generate radicals by thermal 
decomposition or photolysis (the latter being discussed later on).  Thermal decomposition 
initiators are those that produce radicals as a function of heat.  An example would be the 
thermal decomposition of AIBN, above 60 
o
C, to yield two 2-cyanoprop-2-yl radicals.
102
  
Propagation is the process in which a polymer spends most of its time in a reaction.  This is 
the stage involved with increasing chain length and molecular weight.  The propagation of an 
alkene proceeds through the repetitive attack of a radical to one carbon atom of the alkene 
(179).  This then not only creates a new bond but also creates the next radical from which to 
propagate (180).  This reacts with another alkene and the process continues (182).  
 
Scheme 63: Radical Polymeristation of alkenes 
 
Termination is the combining of radicals at the end or during of the propagating step.  The 
recombination of the radicals can be between different species.  For example the combination 
of two propagating species results in the doubling of the molecular weight and an element of 
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symmetry.  Other cases include the reaction of a propagating species and an initiator, or even 
with inhibitors such as oxygen.  The final method of termination is called disproportionation, 
where two radical species react to form two non radical species.  Rather than the joining of 
two radical species, in this instance one radical is an acceptor and the other the donor. 
Another important factor to consider especially when looking at the previous example is 
tacticity.  This is the description of the relative stereochemistry of adjacent chiral centres in a 
polymer and is generally not very well controlled in free radical polymerisations.  In Scheme 
64 every time a new monomer is attacked by the propagating radical a new chiral centre is 
produced.  The order of these stereocentres is what tacticity describes.  There are three types 
of tacticity; isotactic (184), syndiotactic (185) and atactic (186) (Figure 68).  Isotactic refers 
to polymers which have all stereocentres of either the R or S configuration.  Syndiotactic  
polymers have perfectly alternating stereocentres, i.e.  R, S, R, S, R, S, etc.  Both of these 
polymers are formed from catalytic cycles specifically designed to give these structures 
(Kaminsky catalyst for example). 
 
 
Figure 68:  Illustration of tacticity 
 
10.3.2. Controlled radical polymerisation 
 
Controlled radical polymerisations are those whose mechanism involves the specific control 
of molecular weights, giving rise to polymers with low polydispersions.  A very relavent and 
important paper with respect this research is the the work carried out by Atzet et al.
103
 as they 
utilised a methacrylate bearing PCL to generate crosslinked networks, a key target in the 
following research.  Oligomeric PCL diol was reacted with methacryloyl chloride to yield a 
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radical crosslinker.  What was also intruging about this research was the synthesis of a 
polycaprolactone radical initiator.  The same PCL diol was used however instead of an acid 
chloride, -bromoisobutryl bromide (BIBB, 187) was used.  This generated terminal bromide 
groups from which to initiate the controlled radical process known as ATRP (Scheme 64). 
 
Scheme 64:  Synthesis of a PCL crosslinking initiator 
        
The approach shown in Scheme 64 has also been employed using a PEG backbone.  The 
work by Ercole et al.
104
 use acrylate terminaleted polymers to act as a crosslinking agent 
compared with the PCL group previously shown.  What was key in this research was not only 
were the terminus acrylate motifs, but were also bound to a UV degrading group.  The 
degradation of o-nitrobenzyl groups is well understood,
105
 and is shown at the bottom of 
Scheme 65 allows the diacrylate macromonomer (91) to not only crosslink but also to 
degrade under certain UV conditions. 
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Scheme 65:  Synthesis and degradation pathway of a diacrylate bearing PEG macromonomer 
 
The PCL initiator shown in Scheme 64 can initiate a type of controlled radical 
polymerisation called atom-transfer radical polymerisation (ATRP).  ATRP, discovered 
independently by Sawamoto et al.
106
 and Matyjaszewski in 1995,
107
 is involved with the 
transfer of a monomer (195) to a propagating species (197), usually using a transition metal 
complex (196).  There is some key optimisation that is required when carrying out ATRP as 
it is the rate constant between active (197) and dormant species (195) that controls the narrow 
polydispersity of the product. 
 
Scheme 66: ATRP equilibrium 
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In simplistic terms the fact that the rate constant to left, kdeact (Scheme 66), is greater than the 
activating one (kact) means that there are only ever a few propagating species at any one time 
(197).  This means that the chance of terminating via propagation chain combination is very 
low (199, kt).  As the propagating species is only short lived, the chain length grows at a 
steady rate until all monomer is used.  This allows the molecular weight to be controlled 
directly by the amount of monomer in a controlled manner, generating low polydispersity. 
 
10.3.3 UV  photopolymerisations 
 
UV photopolymerisations are extensively used in this research therefore how these reactions 
are initiated and propagate will be discussed.  UV light can also be used to generate radicals 
and therefore initiate polymerisation.  This occurs through the absorbance of UV light into 
the bonds of photoinitiators.  A photoinitiator is a molecule that when excited by UV light 
forms radicals, either by the breaking of a bond or by the excitation of a functional group.  
There are two types of photoinitiators, type-I and type-II.  A type-I photoinitiation is a 
unimolecular process involving the homolytic bond cleavage upon absorption of light.  A 
typical type-I photoinitiator is benzoin (200) (and derivatives containing the same structural 
motif), with the bond between the ketone and hydroxyl carbons being the one cleaved 
(Scheme 67). 
 
 
Scheme 67:  Photolytic cleaving of benzoin 
 
The type-I photoinitiators cleave by what is called a Norrish type I reaction.  When benzoin is 
irradiated with UV light, the ketone group absorbs the energy and is excited into a singlet 
state.  From here the excited electron can change into a triplet state (unpairing of electron 
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spin) with both of the excited states resulting in cleavage of the -carbon of the ketone.  This 
gives rise to the initiating radical species (201, 202).
108
 
Type-II photoinitiators act in a biomolecular fashion as opposed to a unimolecular one.  The 
other component of a type-II photoinitiating system is an electron transfer reagent (in 
addition to the UV absorbing molecule).  Motifs can include derivatives of benzophenone,
109
 
camphorquinone,
110
 and thioxanthone,
111
 however the example below will utilise a 
benzophenone (Scheme 68). 
 
Scheme 68:  An example of a type-II photoinitiator 
 
The initial stage involves the UV light being absorbed by the benzophenone (203) to create a 
photoexcited state (204).  Radicals are generated by the electron transfer (or hydrogen 
transfer) to a suitable accelerator (205) to generate the hydroxyl bearing radical centre 
(Scheme 68, 206, 207).
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The main drawbacks when using photopolymerisations is the high sensitivity to oxygen.  This 
is because of the ability for oxygen to generate radicals, therefore if dissolved in a sample 
they can become radical scavengers, reacting with radicals at all stages of radical 
polymerisation.  The main way in which oxygen sensitivity is reduced is through 
deoxygenation with nitrogen and carrying out the experiment under an inert atmosphere.
113
   
The examples of UV initiator above, regardless of type I or II, only generate radicals once.  
Work by Fisher et al.
114
 initiate radical polymerisations using biacylphosphine oxides 
(BAPO, 208).  These photo initiators undergo fast cleavage to create the first round of 
radicals, followed by the cleavage of the remaining phosphine oxide to generate a second set 
of radicals (Scheme 69). 
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Scheme 69:  Photoinitiation of BAPO to generate two sets of radicals 
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10.4. Results and discussion 
 
The literature previously discussed in this section showed that a degradable material can be 
synthesised and successfully crosslinked using UV light.  The work by Ivirico et al.
115
 shows 
that this idea can be implemented using a PCL based material utilising the UV reactivity of 
methacrylates.  This work demonstrates that the methacrylated PCL can in fact crosslink with 
itself, but also allows the incorporation of other UV reactive molecules such as HEA to 
generate extended crosslinked systems.  Although this work investigated the use of these 
crosslinked systems in water uptake, it demonstrates the versatility of the PCL dimethacrylate 
as a crosslinkable reagent for potential use in inkjet printing, where UV curing is essential in 
creating constructs. 
 
 
Scheme 70:  Synthesis and crosslinking of a PCL based oligomer 
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Further to the previously mentioned research is work carried out by Atzet et al.
103
 who use 
the same material to generate hydrogels.  In this work they again utilise the incorporation of a 
comonomer to the crosslinking process in the form of HEMA, and investigate the degredation 
of the crosslinking networks (i.e. the PCL content).  They found that there was degradation of 
the crosslinked network not only when using NaOH, but also in vivo conditions using lipase 
solutions.  This gives credibility to the hypothesis that when constructs are made using a 3D 
printing inkjet technique, they would be degradable and therefore the material made during 
this research could be classified as a biodegradable UV curing ink for 3D printing 
technology. 
 
 
 
 
Figure 69: Mass loss of a PCL pHEMA crosslinked netwrok as a function of time using lipase solutions 
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10.4.1. Research plan 
 
The aim of this area of research is to investigate and evaluate the use of PCL based UV 
curing oligomers in the field of 3D printing.  The work previously mentioned by both Ivirico 
and Atzet both synthesise a UV curing PCL bearing oligomer, and successfully crosslinked 
the material.  Their work will act as a starting point from which to investigate both the 
oligomer and the UV curing reaction.  However before synthesising the PCL derivatives a 
commercially available PEG diacrylate will be used to establish a model for investigating 
further oligomers. 
 
Figure 70:  UV photoinitiator used in this research; Irgacure 2959 and DEXT/EDB 
 
After the commercially available material has been investigated, the PCL derivative will be 
both synthesised and testing in similar fashion.  The initial UV photoinitiator to be used is 
Irgacure 2959 (219) which is an example of a type I photoinitiator.  The research will then 
investigate the use of type II photoinitiators.  This is because previous research discussed so 
far does not require the same fast curing speeds that 3D inkjet printing requires; therefore the 
curing rates of both the commercially available and synthetically made materials will be of 
upmost importance throughout the research.   
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10.4.2. UV crosslinking material 
 
The use of UV radicals in polymerisation has previously been discussed in the introductory 
chapter with particular attention towards the use of alkenes.  When a short chain monomer 
contains two alkene units and is subjected to UV photo polymerisation conditions, a highly 
cross-linked network is created (Figure 71).  These cross-linked polymers are extremely stiff 
and brittle and are insoluble in solvent.  This research proposes that, using the correct 
chemicals and methods, a liquid ‘ink’ containing a UV photo polymerisable monomer and a 
UV photoinitiator can be jetted into a specific pattern an inkjet printer.  This pattern could 
then be cross-linked using a UV light source and built upon to create a 3D structure using a 
layer by layer approach. 
 
Figure 71:  Representation of a crosslinked material
116
 
 
It is important to consider what type of material to use, as both mono- and diacrylated 
components have the ability to UV cure and potentially make a crosslinked structure.  
Diacrylates are more attractive than a mono-acrylated monomer because there is a higher 
concentration of alkene groups from which to crosslink.  This reasoning is founded on one of 
Carother’s equations regarding gel point.  Gel point, or the point at which a material is 
classed as crosslinked, is dependent on the conversion of the reactive species and the number 
of bonds created by each monomer during the polymerisation process. 
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Figure 72:  Carother equation of gel point 
 
For instance, when using only one acrylate group, two new carbon – carbon bonds are 
formed, therefore favg = two.  This would mean that the percentage conversion required to 
generate a crosslinked material, Pc, equals one or 100 %.  As chemical reactions almost never 
go to complete conversion this makes it almost impossible to create a crosslinked material 
using only a mono-acrylated polymer.  However when you increase the number of acrylates 
to two, the amount of new carbon – carbon bonds increases to four, meaning that you only 
need 50 % conversion of monomer to generate a crosslinked material (Pc = 0.5).  The 
importance of this crosslinking parameter is because once a material becomes crosslinked, it 
quickly solidifies.  This is extremely important in the field of inkjet printing where the 
quicker an ink solidifies, the faster the solid construct can form and therefore accept the 
subsequent layer. 
 
Figure 73:  Poly(ethylene glycol) diacrylate (PEGDA) 
 
A commercially available molecule that contains two alkene groups is poly(ethylene glycol) 
diacrylate (Figure 73, 222).  Before moving towards any 3D printing machine, tests on the 
bench were carried out using PEGDA and the UV photoinitiator Irgacure 2959 (Figure 69, 
219).  Irgacure 2959 was chosen because of its non-toxic nature and ease of availability.
117
  
Although irgacure 2959 has been identified for use in 3D printing,
118
 the novelty of this work 
surrounds its use with diacrylated PEG and PCL. 
The UV absorption profile for Irgacure 2959 (219) is shown below (Figure 74), with the 
main absorption occurring at ~275 nm.
119
 There is a small absorption at 365 nm which is 
important as most commercially available UV sources operate at this wavelength.  A sample 
of PEGDA of average molecular weight of ~250, containing 3 % (w/w) of Irgacure 2959, 
was placed in a small sample vial and irradiated under UV torch (one Watt, 365 nm).  The 
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sample had to be warmed slightly to ensure complete dissolution of the photoinitiator.  
Although being irradiated for an hour under the UV torch, only a small film was observed on 
the surface with no crosslinked material observed in the bulk of the material.  The reasoning 
behind this lack of curing was the presence of dissolved oxygen within the sample, 
essentially acting as radical traps (ie the generated radicals intended for the acrylate 
monomers was instead reacting with the oxygen and therefore no crosslink was observed). 
 
 
It was then decided to deoxygenate the sample before irradiation using nitrogen for 15 min, 
coupled with maintaining a nitrogen blanket during the exposure to the UV light.  The 
deoxygenation process involved the bubbling of nitrogen through the sampele for the stated 
amount of time using a needle and nitrogen supply.  A film of cross-linked polymer was 
observed in a matter of minutes with the entire sample being observed to be cross-linked 
(hard to the touch) within 1 h.   
r 
Figure 74:  UV absorption of Irgacure 2959 
219 
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At this stage the amount of catalyst was investigated to gain a better understanding of what 
amount gave the best curing condition.  It was also noted that although the one hour of curing 
time was more than ample in a laboratory situation, if this process was the utilised in a 3D 
printing scenario the time would have to be significantly reduced.  This is because in the 
laboratory example the UV source is irradiating the whole sample for the duration of the 
experiment, whereas this is not the case in the inkjet scenario.  The UV light is attached to the 
inkjet printhead meaning the deposited sample has a far less irradiation time, therefore 
requiring a far faster curing response.  This required a new approach to carrying out the UV 
curing.  All credit for the development of a new curing method and preliminary work goes to 
Kang Wu (Materials department MSc Student).  The curing method utilised a UV lamp found 
in high street nail salons.  This lamp produced 365 nm light at 36 watts, which is far more 
powerful than the one watt torch.  
 Once the sample was irradiated (for the specified time) it was immediately soaked in acetone 
to identify the quantity of material that was cured.  The thought was that the unpolymerised 
material would dissolve in the acetone, leaving only the crosslinked material behind.  The 
acetone soak was carried out for 24 h followed by the decanting of the solvent and drying the 
cured material under vacuum.  Using the weight of the sample used initially and the amount 
of cured material left after drying, a percentage conversion could be calculated. 
 
Figure 75: % Cure of PEG DA after 1 minute irradiation as a function of Irgacure 2959, under air and 
deoxygenated conditions 
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The first investigation was to alter the catalyst loading of Irgacure 2959 from 1 – 5 % to see if 
there was an optimum amount.  All conditions had an irradiation time of 1 min (as compared 
to the 1 h of the previous experiments).  The curing was carried out in air and also with the 15 
min deoxygenation (N2 flow bubbled through the sample), using nitrogen to illustrate the 
importance of an oxygen free sample (Figure 75). 
Although there was a medium level of curing when using a sample without the 
deoxygenation process (indicating the power of the UV source compared to before), the 
levels achieved under the deoxygenation scenario are far higher almost achieving a perfect 
cure.  The best level of curing was achieved when using Irgacure 2959 at a 4 % loading, and 
when deoxygenating the sample before irradiation using a nitrogen bubble. 
It was decided to compare a type I and II system and see if there was an improvement in 
curing levels.  The type II system that was chosen was the initiator DETX (2,4-Diethyl 
thioxanthone, 220) and accelerator EDB (Ethyl-4-(dimethylamino)benzoate, 221) (Figure 
70), based on literature stating that EDB was a successful accelerator (in combination with 
ITX) and that DETX had increased absorbance at 365 nm compared to ITX.
120, 121 
Initial tests using the type II system were to find the best loading of the initiator and 
accelerator.  This was conducted by keeping one component at a fixed level and varying the 
other.  The first investigation kept the accelerator EDB at 3 % while varying the DETX 
loading between 1 – 5 %. 
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Figure 76: % Cure of PEG DA after 1 minute irradiation as a function of DETX loading while 
maintaining 3 % of EDB, under air and deoxygenated conditions 
 
The data shown above (Figure 76) shows the expected trend when increasing photoinitaitor 
loading, an increase in the level of cured material.  This was the case for both the air and 
nitrogen conditions, with the nitrogen deoxygenate samples showing a far higher percentage 
of cured material, again showing the importance of oxygen removal.  A key difference 
between the use of the type I Irgacure 2959 and the type II DETX and EDB system is that 
there is a slight increase in the level of cured material when conducting the experiment in air.  
This is due to the slightly higher tolerance to dissolved air within the sample.  The conditions 
giving the most cured material was found to be using the photoinitator DETX at 3 % loading, 
as that gave the highest curing percentage of 98 %.  This value was also found when using 5 
% photoinitiator however due to the strong colour associated with the inititor, having the 
lowest loading leads to a less coloured cured material (a possible consideration when thinking 
about the asthetics of 3D printed parts). 
The next investigation is the reverse of the previous one in which the accelerator loading is 
varied with a constant level of photoinitiator.  The amont of photoinitiator is kept at 3 % for 
every sample and the accelerator is varied between 1 – 5 %. 
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Figure 77: % Cure of PEG DA after 1 minute irradiation as a function of EDB loading while maintaining 
3 % of DEXT, under air and deoxygenated conditions 
 
The experiments have found that you again get a near complete cure when undertaking the 
irrdiation after conducting a nitrogen deoxygenation.  The best of these conditions is found 
when using 4 % EDB as a 98 % cure was achieved.  The key information found from this 
investigation is that when the UV irradiation was carried out in air, there was a considerable 
decrease in the curing amount (Figure 77).  This is potentially due to the rapidly reacting 
EDB with the abundance in oxygen.  Tertiary amines are known to react with radical 
peroxides formed when oxygen reacts with a propagating radical.
122
  These inactive peroxide 
radical are reacted with the teriary amine to yield active alkylamino radicals.  However if 
there is an abundance of these radicals along with the those generated under standard UV 
conditions, the rate of termination could potentially be higher and therefore leading to a lower 
cure rate. 
With the preliminary results using PEG DA showing promise, the idea of a semi-
biodegradable cross-linked structure was pursued.  PCL, as previously discussed, is widely 
used for its biodegradability and was chosen as the starting material for this research.  
Unfortunately the diacrylate of PCL is not commercially available as in the PEG case, so this 
was synthesised through the use of PCL diol (at average molecular weight of ~ 530) and the 
corresponding acid chloride.   
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Scheme 71: Synthesis of poly(caprolactone) dimethylacrylate (PCLDMA) 
 
The reaction of the PCL diol (187) and methacryloyl chloride (129), in the presence of 
anhydrous triethylamine (to precipitate the triethylammonium chloride salt), produced the 
dimethacrylate product (217), with 
1
H NMR indicating the methacrylate protons at 1.91, 5.52 
and 6.06 ppm (Scheme 71).  The reasoning behind the methacrylate useage was that initial 
reactions using acryloyl chloride proved problematic whereas the methacryloyl addition 
proceeded successful.  The only issue with NMR analysis is that due to the polymer 
containing an undisclosed ‘n’ value, the integrations in the 1H NMR spectrum are non 
indicative of chain length as they would change depending on the value of n.  What the 
spectrum does confirm is the presence of the methacrylate, not the relative chain length of the 
polymer. 
After successful synthesis of the polycaprolactone dimethacrylate (PCL DMA), the initial 
experiments using Irgacure 2959 were carried out, with the loading ranging from 1 – 5 %.   
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Figure 78: % Cure of PCL DMA after 1 minute irradiation as a function of Irgacure 2959 loading, under 
air and deoxygenated conditions 
 
What the graph shows is the same relationship between the presence and lack of oxygen with 
the nitrogen deoxygenation showing a far higher cure (Figure 78).  What is noticeable is that 
the usual mid – high 90 % cure that is observed with the PEG DA is not present.  This could 
be the result of the reactivity difference between an acrylate group and a methacrylate.  An 
acryloyl group is far more reactive than a methacryloyl group due to the lack of a tertiary 
centre on one end of the alkene 
A sample of PCL DMA was given to collaborators (Yinfeng He, Nottingham University) 
who utilised the UV curing polymer in 3D printing.  The technology chosen was inkjet 
printing where the setup was available to directly UV cure a deposited layer before printing 
the subsequent one. 
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Figure 79:  UV curing inket printhead (courtesy of Yinfeng He) 
 
A key parameter that is crucial in inkjet printing is the viscosity of the ink.  The PCL DMA 
was found to be too viscous therefore PEG DA was used as a reactive diluent.  PEG DA was 
chosen based on its low viscosity and high UV curing ability which would aid the ink in 
curing during printing.  The use of PEG DA in the final ink reduces the biodegradability of 
any produced constructs, therefore the higher ratio of PCL DMA:PEG DA is preferable.  The 
optimal printing ratio with the highest PCL DMA content was found to be 70:30 by wt (PCL 
DMA:PEG DA).  To test the ink a 10 layer construct was printed, with each layer being cured 
before printing the next using the attached UV unit (Figure 79). 
 
The variable UV initiator levels previously tested using PCL DMA and PEG DA were then 
investigated using the 70:30 mixture.  What Figure 80 shows is that as expected the samples 
that have not undergone deoxygenation were far poorer in performance than their nitrogen 
deoxygenate counterparts. 
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Figure 80: % Cure of PCL DMA:PEG DA (70:30) after 1 minute irradiation as a function of Irgacure 
2959 loading, under air and deoxygenated conditions 
 
Our collaborators noticed that upon receiving synthesised samples the viscousity was 
different between batches.  The reproducibility of the jetting experiments required a constant 
viscocity to be met therefore this issue was investigated to ensure a consistant viscosity 
between batches. 
When looking at a stored sample in the lab, a clear oil, together with a sediment of white 
solid was observed at the bottom of the vial.  This sediment was filtered in an attempt to 
isolate and analyse the solid, however it proved too fine to collect by filtration with the solid 
being removed only through the use of a celite plug.  In the mass spectrum of the sample (ie 
not specifically the solid) it was noted that each peak did not fit the exact mass of the 
methacrylated polymer.  The extra mass was attributed to the polymer ionising with a 
triethylammonium cation (Figure 81), as the peaks were 102.13 mass units greater than the 
what was expected for the repeating PCL units.   
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Figure 81: Mass spectrum of PCL DMA showing the polymer ionising with a triethylammonium cation 
 
This was due to not all of the salt being removed during work-up.  Due to the oligomeric and 
also viscous nature of the produced polymer, the work-up procedure following the reaction 
was problematic, with emulsions being a common problem when trying to wash with aqueous 
media.  The reaction is carried out in anhydrous THF with the solvent being removed and 
replaced with dichloromethane for the work-up.  This was chosen because THF is miscible 
with water whereas dichloromethane is not; making it theoretically possible to carry out 
aqueous base washes.  The emulsions occurred because of the large amount of salt being 
dissolved into the aqueous media.  This would increase the density of the aqueous layer and 
therefore ‘fall’ into the organic layer causing the emulsion.  This issue was resolved by 
replacing the organic solvent from dichloromethane to diethyl ether.  The reason for this 
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choice is that diethyl ether is again not miscible with water but also is less dense and creates a 
layer above the aqueous phase rather than below, allowing the aqueous layer to increase in 
density without compromising the organic phase and therefore the separation.  Another way 
in which the triethylammonium salt was removed was through columning the polymer using 
a standard silica system. 
 
 
Figure 82: % Cure of PCL DMA purified by three different methods after 1 minute irradiation as a 
function of Irgacure 2959 loading under deoxygenated conditions 
 
What the data shows in Figure 82 is that although there was almost 75 % curing observed 
using the dichloromethane work-up method (at 5% Irgacure 2959), changing to an ether 
work-up greatly inproved the curing results.  It was also observed that the product produced 
in switching to ether was clearer and more stable over time, leading to the conclusion that the 
triethylammonium salt was being removed.  When looking at the column method, only a 
small increase was noticed above the ether work-up product.  Considering that to get to the 
column purification stage requires to have worked-up the reaction, for only a small increase 
in performance, it would not be an attractive option when considering the scale our 
colleagues required (100 g +). 
Our collaborators with the newly optimised material began the process of generating more 
complicated architecture in their products.  They chose to generate square mesh of varying 
dimensions to investigate the accuracy of the newly developed ink. 
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Figure 83:  SEM pictures of square mesh printed constructs of different wall thickness, (a) 150m, (b) 300 
m and (c) 500 m  
 
The SEM images in Figure 83 show that regardless of wall thickness the edges of each 
intenral square were not well defined.  This could be due to the ink not curing very fast as 
rather than hardening, the droplet of ink has time to spread out (both due to gravity and the 
movement of the printing platform) and subsequently becomes cured in a flatter, less defined, 
final position.  This can be clearly observed in image (c) (Figure 83) where the increased 
wall thickenss requires the deposition of more ink with resulting in a more pronounced 
deviation between layers.  There are several ways to increase the rate of curing and therefore 
increase the definition during printing.  In Figure 79 the UV unit is shown attached to the 
printhead, with every layer of deposited material recieveing one pass of UV light.  A more 
constant source of UV could potentially help the curing rate.  Oxygen inhibition has been 
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shown in the curing studies to have a dramatic impact to curing levels.  Although the ink is 
deoxygenated and sealed before use, jetting in an inert amtopshere would increased the 
efficiency of the photoinitiator and allow a faster rate of curing.   
Both of the previous examples would require modification to the existing equipment 
therefore the next logical step was to utilise the stronger curing potential of a di-acrylate as 
opposed to the di-methacrylate in conjunction with PCL diol.  This was achieved by using 
acryloyl chloride instead of methacryloyl chloride when using PCL diol (Scheme 72). 
 
Scheme 72:  Synthesis of poly(caprolactone) diacrylate (PCL DA) 
 
Initial trials using anhydrous THF and slow addition of the acryloyl chloride (in an ice bath) 
yielded an orange solid during addition (potentially acrylate oligomerisation).  This effect 
was lessened when using ahydrous toluene however there was no acrylate addition to the 
PCL diol.  Success was found using the conditions of Jaiswal et al.
 123
 by using a slightly 
elevated temperature (45 
o
C) in anhydrous toluene, and adding the acryloyl chloride in one 
charge rather than over an hour through slow addition.  This material was then tested using 
the same Irgacure 2959 loadings as before to compare against the methacrylate verison. 
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Figure 84: % Cure of PCL DA after 1 minute irradiation as a function of Irgacure 2959 loading, under 
air and deoxygenated conditions 
 
The same dramatic increase in curing percentage shows that a nitrogen gas deoxygenatation 
is essential for curing conditions (Figure 84).  What the graph does show is an increase on 
performance from the PCL DA however not reaching that of the PEG DA.  The main 
reasoning behind this would likely be as a result of the molecular weight and the abundance 
of acrylate groups between the two compounds.  Although the acrylate groups would react 
very similarly on each oligomer, the Mw of PCL diol initially used is ~530 whereas the PED 
DA used has a Mw of 250.  This therefore means there is a far higher molar concentration of 
acrylate groups when using the PEG DA when compared to the PCL DA, with a high 
concentration giving rise to a fast curing rate. 
At this stage each material has been evaluated against each other using Irgacure 2959 with 
the irradiation time and catalyst levels remaining constant.  The next investigation would be 
into the kinetics of these materials and how they perform over far shorter irradiation times.  
This is important as this will better reflect conditions found during inkjet printing. 
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Figure 85: Comparison of curing speeds using 5 % Irgacure 2959 (top) and 3 % DETX and 3 % EDB 
(bottom) 
 
The data from both graphs confirms the results already observed in this study so far.  The 
PEG DA achieves the highest cure percentage with the PCL DMA achieving the lowest.  This 
is due to the reactivity of acrylates vs methacrylates and the molar amounts previously 
discussed.  The cured amount found in the PCL DA and the PCL DMA:PEG DA at 70:30 are 
closer however due to the presence of acrylates as the faster curing group, with the results 
from the two graphs showing comparable curing amounts (Figure 85). 
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A final use of the 70:30 PCL DMA:PEG DA ink was to test a curved structure architechure 
(similar to figure 76, but utilising a curved motif).  50 layers were printed to observe the 
effect of a far larger difference in the top and bottom printed layers (Figure 79).  Although 
different motifs can be used, the same problem of definition was observed using optical 
microscopy. 
 
Figure 86:  (a) Curved printing pattern, (b) Sample after being removed from pprinting platform, (c) 
Surface depth profile 
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10.4.3. Acrylate monomer synthesis 
 
The jetting research was carried out using end functionalisation of polymers to achieve the 
UV curing properties.  As previously shown functionality can be introduced to the PCL 
backbone through the copolymerisation of functional monomers.  Work therefore began on 
the synthesis of an acrylate containing CL monomer.   
The reasoning behind this project was that the increased number of acrylate groups on the 
crosslinking precursor.  If the oligomer backbone had an acrylate group every repeat unit, the 
percentage conversion required to generate a crosslinked material would be far lower than in 
previous work (due to favg being far higher, Carother’s equations (Figure 71).  The work 
previously shown in the first section of the thesis, has several post polymerisation reactions 
before the step allowing addition of a cureable group (deprotection then reduction).  The 
approach followed in this section allows the large scale synthesis of the UV curing monomer, 
which would only require one polymerisation step to become viable for crosslinking tests. 
The starting material would be the commercially available 1,4-cyclohexanediol.  This was 
treated with one equivalent of acryloyl chloride to yield the monoacrylated alcohol in a 27 % 
yield.  The reason the yield was poor is the statistical nature of the reaction.  It could be 
clearly observed through thin layer chromatography that starting material, mono- and di-
acrylated were in the product.  The di-product is undesirable as it would not allow further 
oxidation to the ketone in subsequent reactions.   The reaction was analysed to show a clear 
carbonyl peak in the IR at 1719 cm
-1
, with the distinct 
1
H NMR signals of an acrylate group 
present also present. 
 
Scheme 73: Synthesis of acrylate CL monomer 
The monoacryloyl alcohol was then treated with pyridinium chlorochromate (PCC) to 
convert the alcohol to the ketone.  The reaction yielded the ketone in a 77 % yield as shown 
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by the disappearance of the hydroxyl peak at 3398 cm
-1
, and also by the loss of the CH 
multiplet between 3.70 – 3.82 ppm.  The next stage of this synthesis would be to carry out a 
Baeyer-Villiger reaction and then co-polymerise with PCL to form a UV cureable 
biodegradable polymer which is purely polyester based (compared to the inclusion of 
polyether of PEG DA as shown earlier). 
 
To conclude, UV cureable groups were successfully attached to PCL diol in the forms of 
methacrylate and acrylate.  They were successfully cured under UV light, using both type I 
and II photoinitiators to generate solid crosslinked materials.  The initiator ratios were 
altered to provide an insight into the optimal loadings.  Materials were then jetted using an 
inket printer to generate a variety of solid construsts, demonstrating that they are viable 
materials for use within this field. 
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10.5. Experimental 
 
General 
Commercially available reagents and solvents were used throughout without further 
purification, except for tetrahydrofuran which was freshly distilled (over benzophenone/Na).  
Light petroleum refers to the fraction with bp 40-60 ºC. Thin layer chromatography was 
carried out on Merck Kieselgel 60 GF254 aluminum foil backed plates. The plates were 
visualized under UV light, phosphomolybdic acid stain and/or vanillin stain. Flash 
chromatography was carried out using Merck Kieselgel 60 H silica or Matrix silica 60, with 
the eluent specified. 
1
H and 
13
C NMR spectra were recorded using Bruker 400 MHz NMR 
machine (
1
H 400 MHz, 
13
C 100 MHz); chemical shifts are quoted in ppm and coupling 
constants, J, are quoted in Hz; d-Chloroform was used throughout unless otherwise stated. 
Spectra were calibrated to residual solvent peaks.  In the 
13
C spectra, signals corresponding to 
C, CH, CH2 or CH3 groups, as assigned by DEPT, are noted. High and low resolution mass 
spectra were carried out on a Thermofisher exactive (orbi) resolution mass spectrometer.  IR 
spectra were recorded using a Perkin Elmer FTIR Spectrometer (Paragon 100) as solutions 
using CH2Cl2 as solvent.  36 W UV box was used for the curing of samples with light at 365 
nm. 
Crosslinking procedure 
Samples were prepared in a glass vial (~ 5mL) and warmed to encourage the initiators and 
accelerator to dissolve.  A flow of nitrogen was passed through the sample to deoxygenate 
prior to irradiation.  Immediately after deoxygenation, the vial lid was placed on top of the 
sample and the vial places under the UV lamp for one min.  Acetone (3 mL) was then added 
to the vial to dissolve and uncured material.  This solution was allowed to stir for 24 h before 
being decanted followed by drying of the cured material under vacuum at room temperature 
for 24 h (vacuum applied gradually to reduce the chance of material loss).     
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Poly(-caprolactone) dimethacrylate (217) 
A flame dried round bottomed flask under nitrogen was charged with dry THF (100 mL), 
PCL diol (187, 110 mL, 20.2 mmol) and dry triethylamine (8.46 mL, 60.7 mmol).  The 
reaction mixture was cooled to 0 
o
C and wrapped in tin foil (to avoid crosslinking in ambient 
light).  Methacyrloyl chloride (129, 5.92 mL, 60.7 mmol) was added slowly over one hour 
using an automatic syringe pump.  The syringe containing the methacryloyl chloride was 
similarly wrapped in tin foil.  The reaction mixture was left for 17 h and allowed to warm to 
room temperature after complete addition of the acid chloride.  The solvent was removed on 
the rotary evaporator and diethyl ether (100 mL) and distilled water (100 mL) added and 
allowed to stir for 15 mins.  The layers were separated and the organic layer washed water (3 
x 100 mL).  Organic layer was dried using magnesium sulphate, filtered and volatiles 
removed under reduced pressure to yield a pale yellow oil (13.187 g, 98 %).  IR (CH2Cl2) 
max 1729, 1637cm
-1
.  
1
H NMR (CDCl3, 400MHz)  (ppm):  1.42 – 1.45 (m, 2H, CH2), 1.60 – 
1.71 (m, 4H, CH2), 1.93 (s, 3H, CH3), 2.28 – 2.37 (m, 2H, CH2), 3.67 – 3.75 (m, 2H, CH2), 
4.05 (t, J = 6.4 Hz, 2H, CH2), 4.21 – 4.31 (m, 2H, CH2), 5.54 (s, 1H, CH), 6.08 (s, 1H, CH). 
 
 
Poly(e-caprolactone) diacrylate (225) 
A flame dried flask under nitrogen was charged with dry toluene (5 mL), PCL diol (187, 1 
mL, 2.02 mmol) and dry triethylamine (0.62 mL, 4.45 mmol).  The reaction mixture was 
stirred for 20 minutes at room temperature and wrapped in tin foil (to avoid crosslinking in 
ambient light).  Acryloyl chloride (224, 0.36 mL, 4.43 mmol) was added and the reaction 
heated to 45 
o
C for 6 h.  The volatiles were removed under reduced pressure and the resulting 
white semi solid was redissolved in diethyl ether (50 mL).  The reaction mixture was washed 
with water (3 x 50 mL), dried using magnesium sulphate, filtered  and volatiles removed to 
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yield a pale yellow oil (1.26 g, 98%).  IR (CH2Cl2)max 1733,1636 cm
-1
.
 1
H NMR (CDCl3, 
400MHz)  (ppm):  1.32 – 1.43 (m, 2H, CH2), 1.59 – 1.71 (m, 4H, CH2), 2.27 -2.36 (m, 2H, 
CH2), 3.66 – 3.75 (m, 2H, CH2), 3.04 (t, J = 6.4 Hz, 2H, CH2), 4.19– 4.23 (m, 2H, CH2), 5.80 
(dd, J = 1.6, 10.4 Hz, 1H, CH), 6.09 (dd, J = 10.4, 17.2 Hz, 1H, CH), 6.37 (dd, J = 1.6, 17.2 
Hz, 1H, CH). 
 
 
4-Hydroxycyclohexyl acrylate (cis:trans mixture) (228) 
1,4-Cyclohexanediol (226, 5.00 g, 43 mmol) was added to a flame dried 3-neck flame under 
nitrogen.  Dry CH2Cl2 (100 mL), dry THF (50 mL) and dry triethylamine (6 mL, 43 mmol) 
were added and the reaction cooled to 0 
o
C.  The reaction was covered in tin foil and acryloyl 
chloride (224, 4.17 mL, 52 mmol) was added slowly over one h using an automatic syringe 
pump.  The syringe containing the acryloyl chloride was similarly wrapped in tin foil.  The 
reaction mixture was left for 17 h and allowed to warm to room temperature after complete 
addition of the acid chloride.  Reaction was washed with HCl (1 M), distilled water, dried 
using magnesium sulphate and filtered.  Volatiles were removed under reduced pressure to 
yield a yellow semi-solid.  Collected product was purified using column chromatography 
(petrol:ethyl acetate, 6:4) to give a clear oil (1.95 g, 27 %).  IR (CH2Cl2) max 3398, 1719, 
1636 cm
-1
.  
1
H NMR (CDCl3, 400MHz)  (ppm):  1.36 – 1.53 (m, 2H, CH2), 1.60 – 1.78 (m, 
4H, CH2), 1.88 – 2.04 (m, 2H, CH2), 2.21 (bs, 1H, OH), 3.70 – 3.81 (m, 1H, CH), 4.78 – 4.96 
(m, 1H, CH), 5.81 (dd, J = 1.6, 5.2Hz, 1H, CH), 6.10 (dt, J = 10.4, 17.2Hz, 1H, CH), 6.38 
(dd, J = 1.2, 7.6Hz, 1H, CH).  MS-ESI found 193.0834 C9H14O3, [M+Na]
+
 requires 
193.0834. 
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4-Oxocyclohexyl acrylate (228) 
4-Hydroxycyclohexyl acrylate (227, 0.49 g, 2.90 mmol) dissolved in CH2Cl2 (50 mL).  
Addition of PCC (0.75 g, 3.48 mmol) produced an orange solution.  The reaction mixture was 
left for 17 h at room temperature.  Reaction mixture was filtered through a silica plug using 
ethyl acetate as eluent.  The reaction was washed with NaOH (1 M) to remove any residual 
chromium followed by brine.  Organic layer was dried with magnesium sulphate, filtered and 
volatiles removed under reduced pressure to yield a pale yellow oil (0.42 g, 85 %).  IR 
(CH2Cl2) max 1720, 1637 cm
-1
.  
1
H NMR (CDCl3, 400MHz)  (ppm): 2.06 – 2.21 (m, 4H, 
CH2), 2.37 – 2.44 (m, 2H, CH2), 2.55 – 2.63 (m, 2H, CH2), 5.25 – 5.30 (m, 1H, CH), 5.90 
(dd, J = 1.2, 10.4Hz, 1H, CH), 6.18 (dd, J = 10.4, 17.2Hz, 1H, CH), 6.47 (dd, J = 1.2, 
17.2Hz).  
13
C NMR (CDCl3, 100MHz)  (ppm): 30.4, 37.3, 68.7, 128.5, 131.2, 165.5, 209.8.  
MS-ESI found 167.0680 C9H12O3, [M-H]
+
 requires 167.0703. 
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11. Conclusions and further work 
 
To conclude this project was successful in synthesising polymer – drug conjugates through 
the use of the functional monomer approach, and also the surface modification route.  The 
functional monomer route was also ulitilised in generating a UV curable PCL derivative. 
 
Figure 87: Functional CL monomers synthesised during this project 
 
A series of functional CL monomers were synthesised, including a CBz and BOC protected 
amine and also an acetal protected ketone.  These were synthesised from the commercially 
available trans-4-aminocyclohexanol for the amine examples, and 1,4-cyclohexanedione 
monoethylene acetal for the protected ketone derivative.  The amine examples utilised a 
similar synthetic route where the amine was first protected, followed by subsequent oxidation 
of the alcohol to the ketone, using PCC, and then the lactone using mCPBA (with the acetal 
variant only requiring oxidation to the lactone using mCPBA). 
 The above monomers were also successfully polymerised together with CL using stannous 
octanoate to yield random copolymers.  Although the CBz group was unsuccessfully 
removed, the acetal protected ketone was converted to the ketone and then subsequently 
reduced to the alcohol.  From this alcohol a polymer – drug conjugate was successfully 
synthesised using ciprofloxacin. 
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Figure 88:  Polymer - drug conjugate using ciprofloxacin 
Future work in this area would include the removal of either the CBz or BOC group to yield a 
free amine from which to attach ciprofloxacin using amide coupling chemistry.  The removal 
of the CBz group would yield a free amine which could be an issue regarding rearrangement, 
however when removing the BOC protecting group the acidic environment would yield the 
ammonium ion therefore potentially being a more attractive.  Once synthesised both the 
amide and ester linked ciprofloxacin polymer – drug conjugates, could be tested using cell 
culture experiments. 
Following the functional monomer approach was the successful synthesis of polymer – drug 
conjugates through the technique of aminolysis.  Both PCL and PLA films were successfully 
cast and subsequently aminolysed using HMDA, to yield the corresponding aminolysed and 
amine functional surfaces. 
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Figure 89: High resolution spectrum of the nitrogen region of a PCL film, when using an aqueous 
ethanolic wash and aminolysing using HMDA 10 % in water adjusted to pH 11.5 
 
The aminolysed films were then further functionalised through amide coupling chemistry to 
yield ciprofloxacin and penicillin G attached PCL surfaces, and also the ciprofloxacin PLA 
conjugate. 
Work in this area should continue with the testing of these biologically active surfaces in cell 
culture studies.  Pending thise results, 3D printed constructs generated using either PCL or 
PLA feedstock could be aminolysed and then biologically activated, with the resulting 
structures not only being biologically tested but also physically to understand the impact that 
aminolysis and functionalisation has on such properties. 
The route of functional monomers was also investigated in the field of 3D printing, with a 
UV crosslinking monomer synthesised using PCL diol and either methacryloyl or acryloyl 
chloride. 
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Scheme 74: Synthesis of a UV cureable monomer using PCL diol 
 
These monomers along with the commercially available PEG DA were investigated using 
both type I (Irgacure 2959) and II (DETX/EDB) photoinitaiators, to compare the speeds at 
which the neat and mixed materials cured under UV light.  The ratio of photoinitiators was 
investigated and the combination of 3 wt% DETX and 3 wt% EDB found to give the best 
curing speed.  This data along with cureable material were given to collaborators who 
successfully printed 3D constructs demonstrating the potential for these materials in the field 
of 3D inkjet printing. 
 
Figure 90:  3D printed construct using PCL DMA:PED DA (70:30) and 3 wt% DETX, 3wt% EDB 
 
As curing speed was of key importance during this work, a further investigation of 
photoinitiators could be conducted.  This would focus around the use of BAPO, a 
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photoinitaitor capable of forming more radicals upon UV irradiation.  This could lead to a far 
fast curing rate, increasing the resolution of 3D printed constructs. 
 
Figure 91: Biarylphoshine oxide (BAPO) 
 
A key piece of further investigation would be the inclusion of a biologically active molecule 
into the UV curing ink.  After the successful printing of a 3D construct, the biological activity 
could be probed to investigate whether this could be a viable route to a drug eluting, 
customisable 3D printed construct. 
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13. Appendix: Research Papers  
13.1. A Biodegradable Polycaprolactone based ink developed for 3D Ink 
Jetting 
13.2. Immobilisation of an antibacterial drug to Ti6Al4V components 
fabricated using selective laser melting 
13.3. Functionalisation of Ti6Al4V components fabricated using selective 
laser melting with a bioactive compound 
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13.4. Publication contributions 
 
In this section the contribution towards the three publications by the thesis author will be 
discussed. 
The contribution towards the paper titled ‘A Biodegradable Polycaprolactone based ink 
developed for 3D Ink Jetting’ was through both synthesis of the polycaprolactone ink as well 
as the testing of curing conditions.  The main contribution came with the synthesis of 
polycaprolactone dimethacrylate (a component of the jetted ink), with scale-up and 
optimisation of the synthesis allowing the author to successfully tested a variety aspects of 
both the ink and jetted materials, as without a robust source of UV curable material the 
research would have not been possible. 
The following two papers (10.2. and 10.3.) were contributed towards through the synthesis of 
the biologicaly active surfaces.  This involved the conversion of the carboxylic acid to the 
corresponding acid chloride and then the further reaction with ciprofloxacin and paracetamol 
(respectively).  Although the carboxylic bearing surfaces were previously prepared by the 
publication’s author, knowledge of inert atmospheric chemistry set-up and coupling reactions 
from the thesis author, allowed a biologically active molecule to be attached to the surface.  
Without this key synthetic step, subsequent analysis and testing (XPS, cell culture, etc) would 
not have yielded successful findings. 
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